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PI(3)P Phosphatidylinositol 3-phosphate
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Rab Ras-related in brain
Ras Rat sarcoma
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Rho Ras homolog
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1. Small GTPase proteins
The Rat sarcoma (Ras) superfamily of small GTPases is made up of a plethora of 20 
to 40 kDa proteins that share the ability to bind to a GTP nucleotide and hydrolyze it to 
GDP, which determines their activation state. The Ras, Rho, Rab, Arf and Ran protein 
families represent the majority of proteins in this family (Figure 1), which share some 
similar domains but also contain specific structural determinants that endow each 
protein with unique conformational and signaling characteristics, as reviewed in (Takai 
et al., 2001). This superfamily is named after the first small GTPases that were studied:
the Ras proteins (Barbacid, 1987). Some of the first oncogenes identified are part of this 
family and play crucial roles in cell survival, proliferation and signaling, as reviewed in 
(Ridley, 2001; Schmitz et al., 2000).
The Rho protein family was identified as containing sequences homologous to Ras 
(Ras homolog) and includes three Rho isoforms (RhoA, B and C), three Rac isoforms 
(Rac1, 2 and 3) as well as Cdc42, among others (Bustelo et al., 2007; Madaule and Axel, 
1985). Rho proteins regulate cytoskeletal functions such as actin stress fiber induction 
(RhoA) or lamellipodia and filopodia formation (Rac and Cdc42, respectively), as 
reviewed in (Hall, 2005; Matozaki et al., 2000). Another member, RhoB, is known to 
induce stress fibers but also plays a role in vesicular transport (Aspenström et al., 2004; 
Gampel et al., 1999), as will be discussed below in detail. The Rab GTPases (Ras-related
in brain) comprise the largest of the Ras families, with more than 60 isoforms identified 
in humans (Touchot et al., 1987). They are responsible for membrane trafficking 
processes including endocytosis, exocytosis, transcytosis, and general vesicle 
maturation, as reviewed in (Stenmark, 2009).
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Figure 1. Human Ras superfamily phylogenetic tree. 
Representation of the different Ras families from a phylogenetic standpoint, as represented by 
the tree inside the circle. The major Ras groups are shown in different colors, i.e. blue for the 
Ras family, green for Rho, red for Rab, cyan for Arf, and yellow for Ran. ©Rojas et al., 2012. 
Originally published in The Journal of Cell Biology. doi: 10.1083/jcb.201103008. (Rojas et 
al., 2012)
Small GTPases act as molecular switches, transitioning between a GDP-bound,
inactive state and a GTP-bound, active state, as depicted in Figure 2. Their activation is 
mediated by varied stimuli, which can initiate signaling cascades affecting guanine 
nucleotide exchange factors (GEF), which favor GTP incorporation, as reviewed in 
(Geyer and Wittinghofer, 1997). Active states of small GTPases arise from
conformational changes that allow these proteins to bind to effectors and hence 
propagate signals intracellularly. Considering that the intrinsic GTPase activity of these 
proteins is rather low, they require GTPase activating proteins (GAP) to effectively 
hydrolyze GTP to GDP, returning to their inactive state. A further level of regulation 
involves specific GDP dissociation inhibitors (GDI), which bind to inactive Ras
superfamily proteins to detach them from membranes, thus retaining them in the 
cytosol (Figure 2). 
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Figure 2. Small GTPase GDP/GTP cycle. 
The inactive form of the Ras superfamily protein (square Ras) is bound to GDP. For some 
GTPases, binding to RhoGDI stabilizes this inactive form. Small GTPase binding to GTP is 
facilitated by GEF and allows interaction with effectors to induce signal transduction (circular 
Ras). Enzymatic hydrolysis of GTP for GDP is stimulated by GAP and leads to GTPase 
inactivation, terminating its effector binding and activation.
GEF, GAP and GDI proteins are inherent to the process of Ras protein regulation, 
so that each subfamily is modulated by a specific subset of activators, inhibitors or 
overall modulators, each with their feedback or feed-forward regulation. Thus, this 
complex network of Ras protein-related effectors generates fine-tuned signaling 
cascades within the cell, as reviewed extensively in (Cherfils and Zeghouf, 2013). It is 
therefore evident that small GTPases entail tight regulatory mechanisms to correctly 
carry out their intracellular functions (Matozaki et al., 2000).
1.1 Endolysosomal GTPases
Numerous members of the Ras superfamily appear at endolysosomal 
compartments, particularly Rab proteins, as well as the Ras proteins Rap2A, Rap2B, and 
H-Ras, or the Rho proteins TC10 and RhoB (Valero et al., 2010), as will be described 
throughout this work. Specific members of the Rab protein family associate at defined 
vesicles along the endocytic pathway and assist in the maturation of these membrane 
compartments by mediating vesicle budding, fusion, motility, coating and uncoating, 
which endows endomembranes with an extremely dynamic quality (Stenmark, 2009). 
The core endosomal Rabs may be laterally segregated into specific domains of the same 
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vesicles, which allows for a flexible flow of compartments within the cell. Except in the 
case of Ran proteins, which contain a nuclear import signal, lipids modify proteins 
belonging to the Ras superfamily posttranslationally in order to associate with
membranes. The combination of these lipid anchors and other structural determinants 
gives rise to subcellular localizations at specific membrane compartments, as discussed 
below for RhoB in greater detail.
1.2 RhoB
RhoB is located on the cytoplasmic side of the plasma membrane and late 
endosomes, from which it plays important roles in trafficking of signaling molecules
(Gampel et al., 1999). It is a short-lived protein with a half-life of approximately 2-3 
hours, which differs from the relative stability of other Rho proteins (24-hour half-lives)
(Engel et al., 1998; Stamatakis et al., 2002). RhoB is an immediate early response gene 
that is rapidly induced by DNA damage or growth factors (Fritz and Kaina, 1997; 
Malcolm et al., 2003). Therefore, maintaining a high RhoB turnover ensures the rapid 
response of RhoB levels to various stimuli. Though in vitro studies have shown similar 
effectors for RhoA and RhoB, cellular approaches have shown that each has its own set 
of interactors to carry out specific functions. As summarized in Figure 3, RhoB presents
unique functions that set it apart from other Rho proteins by controlling endocytic 
traffic and affecting the sorting of growth factor receptors or signaling kinases 
(Fernández-Borja et al., 2005; Huang et al., 2007b; Mellor et al., 1998; Sandilands et al., 
2004; Wherlock et al., 2004). Hence, there are associated consequences for growth factor 
signaling, cell survival, proliferation, and apoptosis, which contribute to the proposed
dual role of RhoB as both a tumor suppressor and an angiogenesis inducer (Gerald et 
al., 2013; Huang et al., 2006; Liu et al., 2001). RhoB is involved in modulating cell death 
through genotoxic stress (Fritz and Kaina, 2000; Liu et al., 2001) and controlling c-myc 
stability (Huang et al., 2006), as well as signaling and trafficking of Akt kinase (Adini et 
al., 2003). Furthermore, RhoB could play a role in apoptosis following Ras inhibition 
(Kamasani et al., 2004; Liu et al., 2001). RhoB has also been shown to mediate actin 
dynamics upstream of Dia1 (Diaphanous-related formin 1), which is necessary for actin 
coat formation around endosomes (Fernández-Borja et al., 2005). Additionally, reduced 
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cell spreading and adhesion to different substrates was noted in several RhoB-depleted 
cell types, which could be due to the concomitant reduction of surface β1 integrin levels 
in these cells and accountable for decreased focal adhesions, resulting in increased 
migration rates (Vega et al., 2012). 
Figure 3. Schematic of RhoB functions.
A ribbon diagram of the RhoB structure attached to an isoprenoid moiety (curved, gray chain) 
and two palmitates (straight chains) is shown in the center. The small GTP-binding protein 
RhoB performs specific tasks within the cell that set it apart from other proteins of the Ras 
superfamily, including roles in cancer progression related to angiogenesis or apoptosis, 
regulating receptor trafficking or actin polymerization at endosomes, and cell migration. See 
text for details.
RhoB is highly homologous to RhoA in structural terms, though under resting 
conditions, RhoGDI retains RhoA in the cytosol (Dransart et al., 2005) whereas RhoB is 
bound to the plasma membrane or endolysosomal membranes (Oeste et al., 2014; 
Pérez-Sala et al., 2009; Stamatakis et al., 2002). These differences in localization are 
related to the distinct residues present at the carboxy-terminal (C-terminal) 
hypervariable region (Chiu et al., 2002; Gorfe et al., 2007), which contains the –CAAX 
box and could bear phosphorylation sites as well as sites for additional lipidation 
(Hancock et al., 1989; Wennerberg and Der, 2004), as will be described in detail below.
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In the case of RhoB, upon isoprenylation of its –CAAX box cysteine (C193), two nearby 
cysteines (C189 and C192) are further modified by palmitate moieties (Wang and Sebti, 
2005), whereas RhoA fosters a polybasic sequence.
RhoB therefore presents several distinguishing features that endow it with
unique cellular behavior. The specific lipidation sequence at its C-terminus acts as a 
plasma membrane and endolysosomal anchor. Furthermore, these lipid modifications 
determine RhoB degradation through a lysosomal pathway distinct from the 
proteasomal degradation typical of other GTPases of its family (Pérez-Sala et al., 2009; 
Stamatakis et al., 2002). 
2. Posttranslational modifications of GTPases
Posttranslational modifications constitute an essential regulatory mechanism for 
protein function, activation, localization and half-life. Most of these changes result in 
conformational shifts that alter activation states, allow modified proteins to interact 
with effectors or expose otherwise hidden motifs within their sequence. Common 
posttranslational modifications include processes such as phosphorylation, 
hydroxylation and nitrosylation (inorganic residue addition), ubiquitination and 
glutathionylation (peptide addition), or isoprenylation, myristoylation and 
palmitoylation (lipid addition), among many others, as reviewed in (Walsh et al., 2005).
The resulting functional outcomes range from marking proteins to be degraded, as in 
ubiquitination, to direct activation for effector interaction, i.e. phosphorylation.
Ras superfamily proteins undergo several posttranslational modifications, including 
irreversible alteration of their carboxy-terminal sequence by isoprenylation and 
proteolysis, as well as methylation and further lipidation by palmitate moieties in some 
instances. Other residues within these proteins can undergo other modifications such as 
peptidyl-prolyl isomerization, phosphorylation, ubiquitination, glycosylation,
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nitrosylation, and ADP ribosylation, as reviewed in (Ahearn et al., 2012). As will be 
discussed below, some of these modifications alter Ras protein localization, in turn 
determining the effectors with which they can interact and ultimately their activation 
patterns.
2.1 Lipidation at C-terminal ends
Lipidation involves covalent attachment of lipids to protein residues and can take 
place spontaneously or through enzymatic mechanisms. Isoprenylation and 
myristoylation are irreversible enzymatic modifications that significantly increase 
protein hydrophobicity, thus elevating the probability of their interaction with 
membranes. Whereas myristoylation takes place at a glycine residue located in the first 
position of the protein sequence (after methionine removal), isoprenylation occurs at 
cysteines in the C-terminal segment. Palmitoylation usually takes place at cysteines that 
are in the vicinity of isoprenylated or myristoylated residues and confers a more flexible, 
reversible mode of regulation of protein localization, as reviewed in (Aicart-Ramos et 
al., 2011). Several Ras proteins become palmitoylated following isoprenylation to better 
anchor them to membranes, as will be discussed below in further detail. Protein 
modification by lipids is therefore a crucial tool to modulate subcellular localization and 
hence site-specific activation and recruitment of proteins, affecting a myriad of signaling 
platforms.
2.1.1 Isoprenylation
Isoprenylation is an enzymatic process affecting more than 300 proteins in 
humans by which isoprenoid lipids bind to cysteines through a thio-ether bond, as 
reviewed in (McTaggart, 2006). Specific prenyl transferases recognize particular
sequences to catalyze farnesylation, in the case of farnesyl transferase (FT) or 
geranylgeranylation, in the case of geranylgeranyl transferases (GGT) I and II. Many Ras 
proteins contain a “-CAAX box” at their C-terminus, where “C” is the cysteine 
amenable to isoprenylation, “A” stands for aliphatic residues and “X” can be any amino 
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acid (Hancock et al., 1989). As depicted in Figure 4, -CAAX boxes undergo 
modifications including isoprenylation, proteolysis and methylation.
Figure 4. Protein isoprenylation and CAAX box processing.
Proteins containing a CAAX box undergo posttranslational processing, beginning with 
isoprenylation by prenyl transferases. An endopeptidase cleaves the last three amino acids (-
AAX), and methylation of the C-terminal end is brought about by a methyl transferase. Shown 
here is farnesyl pyrophosphate (C15), though some proteins become geranylgeranylated by 
GGT using a geranylgeranyl pyrophosphate moiety (C20) as a substrate. See text for details.
In the case of FT- and GGT I-mediated isoprenylation, the X residue in –
CAAX boxes of target proteins determines whether the cysteine will be modified by a 
farnesyl or geranylgeranyl isoprenoid. FT modifies proteins in which the X residue is 
methionine, serine, alanine or glutamine, whereas GGT I acts on proteins bearing a 
leucine residue. However, certain proteins can be modified by either FT or GGT I 
depending on other biochemical features of the –CAAX box surroundings (Hartman et 
al., 2005) or on isoprenoid availability (Whyte et al., 1997). FT and GGT-I share an a
subunit and possess specific b subunits that recognize CAAX motifs and transfer either 
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farnesyl pyrophosphate or geranylgeranyl pyrophosphate, respectively. In contrast,
GGT II requires an accessory protein, Rab escort protein (Rep) that recognizes whole 
Rab proteins and presents them to the catalytic subunit (Nguyen et al., 2010). GGT II is 
responsible for single or double geranylgeranylation of Rab proteins at their C-terminal 
–CAC, -CC, -CCX, -CCXX, -CCXXX or –CXXX motif cysteines (Desnoyers et al., 1996; 
Leung et al., 2006; Maurer-Stroh et al., 2003). Once isoprenylation has taken place, the 
amino acids that remain at the carboxy end of the isoprenylated cysteine are cleaved by 
a specific endoprotease and the carboxyl group of the cysteine is methylated by a 
specific methyltransferase for isoprenylated proteins (Pérez-Sala et al., 1991; Sinensky, 
2000; Tan et al., 1991). 
2.1.2 Palmitoylation
Palmitoylation is the addition of a palmitate moiety (C16:0) to a cysteine 
residue through a thioester bond, as reviewed in (Dietrich and Ungermann, 2004). As 
shown in Figure 5, the cysteine sulfhydryl group needs to be in its thiolate form, i.e. 
unprotonated, in order to carry out a nucleophilic attack on the α carbon of palmitoyl-
CoA. This reaction can occur spontaneously depending on the cysteine pKa, which is 
determined by the intra- and intermolecular surroundings, but is greatly enhanced
when catalyzed by palmitoyl transferases (PAT), a.k.a. protein acyl transferases, which 
contain a conserved aspartate-histidine-histidine-cysteine (DHHC) active site rich in 
cysteine residues, as reviewed in (Aicart-Ramos et al., 2011). These enzymes and the 
substrate palmitoyl-CoA are present on membranes, so that proteins that are to be 
palmitoylated need to come in close contact with PAT-containing membranes (Dunphy 
et al., 1996). Isoprenylation increases the probability of a protein to bind to membranes, 
and palmitoylation presents a further structural determinant that stabilizes membrane 
association, as reviewed in (Smotrys and Linder, 2004; Smotrys et al., 2005).
Depalmitoylation is mediated by palmitoyl-protein thioesterases (Verkruyse and 
Hofmann, 1996), allowing proteins to undergo repeated cycles of 
palmitoylation/depalmitoylation (Aicart-Ramos et al., 2011).
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Figure 5. Protein palmitoylation.
In red, a random protein structure with its palmitoylation cysteine depicted chemically. The 
cysteine thiolate group produces a nucleophilic attack on the electrophilic carbon on the 
palmitoyl-CoA chain to yield a palmitoylated protein and free CoA. This reaction can take
place spontaneously or be catalyzed by palmitoyl transferases. Depalmitoylation is catalyzed 
by palmitoyl-protein thioesterases. Adapted from (www.lipidlibrary.aocs.org).
Many protein families provide examples of palmitoylation-mediated membrane 
association. Such is the case of a multitude of integral membrane proteins such as 
heterotrimeric G-proteins, tetraspanins, the mannose 6-phosphate (M6P) receptor, or 
synaptotagmins, all involved in general endocytic trafficking processes (Schweizer et al., 
1996; Stipp et al., 2003; Veit et al., 1996). These proteins, though already spanning the 
membrane, are able to associate at specific microdomains such as lipid rafts and hence 
form signaling platforms, as is the case for transmembrane adaptor proteins, e.g. LAT 
(Linker of Activation for T cells) (Stepanek et al., 2014). Furthermore, membrane 
anchors of peripheral membrane proteins often consist in palmitoylation either close to 
myristoylated residues, as for Src tyrosine kinases, or in the vicinity of previously 
isoprenylated cysteines, as is the case for the Ras protein superfamily (Aicart-Ramos et 
al., 2011), and is described as follows. 
Within the Ras family of proteins, H-Ras is palmitoylated at two cysteine 
residues present in the hypervariable domain (C181 and C184), N-Ras contains a single 
palmitoylation site (C181) and K-Ras4B possesses no cysteine residues but its 
interaction with cellular membranes is favored by the presence of a polybasic domain
that is attracted to negatively charged polar head groups of membrane phospholipids, 
much like RhoA. In the case of H-Ras, localization is mainly at the plasma membrane 
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and various intracellular structures, including the endoplasmic reticulum (ER), the 
Golgi complex, recycling endosomes (Gómez and Daniotti, 2005; Hancock and Parton, 
2005) and to randomly moving nanoparticles known as rasosomes (Rotblat et al., 2006).
These differences are critical to determine the specific trafficking and site of action of 
the different Ras proteins, as reviewed in (Omerovic et al., 2007; Pérez-Sala, 2007). 
Other proteins that also contain additional cysteines close to the isoprenylation site that 
are amenable to palmitoylation include TC10, Rap2, or RhoB (Aicart-Ramos et al., 2011; 
Michaelson et al., 2001; Uechi et al., 2009). TC10 has been detected at the plasma and 
perinuclear membranes, identified as components of secretory or endosomal 
compartments (Michaelson et al., 2001; Watson et al., 2003), whereas Rap2 has been 
detected in secretory granules (Mollinedo et al., 1993) and recycling endosomes (Uechi 
et al., 2009). Fully lipidated RhoB is both isoprenylated and bipalmitoylated (Wang and 
Sebti, 2005), which is required for its association with endolysosomes (Pérez-Sala et al., 
2009). 
2.2 Cyclopentenone prostaglandins
In addition to lipidation by isoprenoid or palmitate moieties, proteins may suffer 
modification by reactive lipid species of varied structure. Cell metabolism under both 
basal and pathological conditions gives rise to products derived from lipid peroxidation 
that can form stable adducts with particular protein residues (Bogatcheva et al., 2005). 
Oxidative and nitrosative stress produce many of these products, which play a role in 
numerous pathologies such as neurodegenerative diseases (Dianzani, 2003), vascular 
alterations (Lee and Park, 2013), and cancer (Garzón et al., 2011). Amongst the many 
electrophilic lipids that are produced in cells, cyclopentenone prostaglandins (cyPG) are
a family of reactive lipid species with anti-inflammatory, anti-viral and anti-tumoral 
effects, which makes them a forthcoming option as exogenous therapeutic compounds 
(Sánchez-Gómez et al., 2004; Straus and Glass, 2001). cyPG generation is increased in 
cells undergoing oxidative stress, whereas cyPG production in homeostatic cells is low 
(Ceaser et al., 2004; Koenitzer and Freeman, 2010). The electrophilic nature of cyPG 
allows them to react with nucleophilic residues including cysteines, in turn eliciting 
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structural changes within the whole protein that provide new reactivity and 
electrophilicity. cyPG of different structural characteristics present specificity towards 
particular cysteine residues, so that different cyPG enter distinctive intramolecular 
binding pockets even within the same protein. Moreover, cyPG bind to proteins 
involved in a multitude of different cellular tasks (Garzón et al., 2011; Renedo et al., 
2007). These features account for dual actions: cyPG modification of proteins involved 
in redox regulation can modulate oxidative stress pathways, whereas binding and 
subsequent inhibition of NF-κB (nuclear factor kappa-light-chain-enhancer of activated 
B cells) pathway proteins contributes to cyPG anti-inflammatory effects (Díez-Dacal 
and Pérez-Sala, 2010; Kim and Surh, 2006). The pleiotropic behavior of these 
electrophilic lipids is therefore a reflection of the variety of intracellular targets, many of 
which have been discovered in the past decade through proteomic studies, as reviewed 
in (Garzón et al., 2011; Oeste and Pérez-Sala, 2014). Interestingly, Ras proteins are 
included in this expanding list of cyPG targets (Oeste et al., 2011; Stamatakis and Pérez-
Sala, 2006), as discussed below in further detail.
As shown in Figure 6, cyPG are derived from peroxidation of membrane fatty 
acids, in particular arachidonic acid, through the action of cyclooxygenases (COX) or 
non-enzymatically through the isoprostane pathway (Funk, 2001; Gao et al., 2003). In 
the case of the COX pathway, prostaglandin synthases act on the precursor PGH2 to give 
rise to PGD2 and PGE2 (Funk, 2001). The latter two PG can also be formed by non-
enzymatic epimerization of isoprostanes through the isoprostane pathway (Gao et al., 
2003), which gives rise to trans isomers of PG, i.e. isoprostanes such as iso-PGJ2 and iso-
PGA2. J series cyPG arise from dehydration of PGD2 to PGJ2, which can be further 
dehydrated to form 15d-PGJ2 (15-deoxy- 12,14-Prostaglandin J2) or give rise to 12-PGJ2
through an albumin-dependent mechanism (Narumiya and Fukushima, 1985; Shibata 
et al., 2002). cyPG of the A series are produced upon dehydration of PGE1 or PGE2
(Ohno et al., 1986).
cyPG synthesized in this manner contain an a, β-unsaturated carbonyl group 
within their cyclopentane ring, which renders highly electrophilic -β carbons. Therefore, 
they are amenable to forming Michael adducts through nucleophilic attack by thiol 
moieties from cysteines, as seen at the bottom of Figure 6. The cysteine residues to 
which cyPG bind present structural characteristics allowing for the entry and 
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positioning of specific cyPG to form the stable, covalent Michael adducts with 
consequences on biological functions.
Figure 6. Cyclopentenone prostaglandin formation and covalent binding to proteins through 
Michael addition.
cyPG (blue shaded boxes) are formed by spontaneous dehydration of their PG precursors 
(gray shaded boxes). These precursors are generated in turn from unsaturated fatty acids such 
as arachidonic acid by the action of cyclooxygenases (COX) or through non-enzymatic 
processes, i.e. the isoprostane pathway (dashed arrows). Arachidonic acid is formed as a 
product of phospholipase A2 or C cleavage of membrane-bound phospholipids. cyPG 
contain electrophilic carbons (asterisks) that can undergo attack by nucleophilic groups such 
as cysteine thiolates and form Michael adducts (green arrows), as shown at the bottom for 
15d-PGJ2. See text for details.
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2.2.1 Cyclopentenone prostaglandin modification of Ras proteins
cyPG containing either one or two electrophilic carbons, i.e. single enones or
dienones, can bind to different subsets of proteins depending on the steric attributes of 
the cysteines in the protein to be modified. Several studies have shown that the dienone 
cyPG 15d-PGJ2 can establish Michael adducts with cysteine residues of proteins as 
structurally and functionally different as actin, vimentin (Stamatakis et al., 2006), NF-
kB, PPARg (Peroxisome proliferator-activated receptor gamma) (Cernuda-Morollón et 
al., 2001; Shiraki et al., 2005), Keap1 or GSTP1-1 (Glutathione S-transferase P)
(Levonen et al., 2004; Sánchez-Gómez et al., 2007). The fact that electrophilic carbon 
count is particularly important for selectivity is reflected by cyPG binding to Ras 
proteins. Various cyPG have been found to modify and activate Ras proteins in an 
isoform- and site-selective manner (Oliva et al., 2003). Specifically, single enone cyPG, 
e.g. PGA1 or PGJ2 bind preferentially to C118, which is present in the GTP binding site 
in all three Ras proteins, namely H-Ras, K-Ras and N-Ras. However, the dienone 15d-
PGJ2 can bind two cysteine residues simultaneously (C181 and C184), located at the H-
Ras C-terminus (Renedo et al., 2007). Since other Ras proteins such as N- or K-Ras do 
not contain this sequence, they are not preferential targets for dienone cyPG binding. 
Interestingly, modification of the H-Ras C-terminal sequence by cyPG or other small 
reactive molecules elicits changes in its membrane partitioning and distribution along 
the endocytic pathway (Oeste et al., 2011). It is thus apparent that cyPG selectivity can 
fine-tune intracellular pathways by modifying not only specific proteins, but also 
particular cysteine residues within the same protein, which can have consequences on 
its subcellular sorting and localization.
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3. Endolysosomal sorting and degradation
Endocytosis is the means by which cells internalize extracellular material as well 
as plasma membrane proteins and lipids, among many other substances. As 
summarized in Figure 7, this material is engulfed by plasma membrane and pinched off 
to produce endocytic vesicles, which undergo multiple maturation processes on their 
way towards lysosomes, recycling compartments, autophagosomes, or other 
intracellular destinations. Trafficking of these endocytic vesicles involves signaling 
through membrane receptors from the outside-in and recycling these components for 
further receptor-effector cascades or producing metabolic building blocks, hence 
contributing to overall cell functions, as reviewed in (Huotari and Helenius, 2011). 
During their maturation process, these vesicles evolve through dynamic interaction of 
non-discrete compartments that are in constant flow from one to another. However, 
distinct proteins and lipids attach to vesicles at different points in the endocytic route, 
aiding in their categorization into specific types of endosomes. Interestingly, 
accumulating evidence points at site-selective signaling within the cell, for certain 
signaling molecules bind to different effectors depending on their subcellular 
localization (Schmidt-Glenewinkel et al., 2008), and some signaling processes require 
previous endocytosis of their components to regulate the specificity, duration and 
magnitude of the signal, as reviewed in (Sadowski et al., 2009). The components that 
attach to vesicles during their internalization will hence define their ultimate subcellular 
destination and function, such as traveling back to the plasma membrane for recycling 
or inclusion into multivesicular bodies (MVB) for secretion or degradation (Huotari 
and Helenius, 2011; Platta and Stenmark, 2011). 
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Figure 7. The endocytic pathway.
Cellular components residing at the plasma membrane such as signaling receptors (red rods) 
are internalized along with extracellular material during endocytosis. The vesicles that pinch 
off can be sent along recycling endosomes back to the plasma membrane in a process that 
recycles receptors for a new round of outside-in signaling at the cell surface. Alternatively, 
endocytic vesicles undergo a series of maturation steps from early endosomes to late 
endosomes/MVB, including membrane invagination to form intraluminal vesicles (ILV). 
Fusion with lysosomes elicits macromolecule degradation by specific enzymes working at 
low pH levels within these compartments, resulting in receptor down-regulation and 
signaling termination. Autophagosomes containing damaged organelles and cellular material 
for degradation also fuse to lysosomes to produce simpler components that can be reused by 
the cell. See text for details.
Degradation of endocytosed material implies macromolecule breakdown into its
constituent parts, e.g. proteins into amino acids to use in protein synthesis. It is 
therefore essential for cells to be endowed with several degradation machineries. The 
first protein-specific degradation mechanism described within the cell was the 
proteasome, which is a cytosolic protease that degrades misfolded and short-lived 
regulatory proteins in the cytoplasm (Schwartz and Ciechanover, 2009). Proteins that 
are destined towards this degradation machinery are modified by several ubiquitin 
moieties forming a chain that is recognized by the proteasome. Ubiquitination can also 
mark proteins for other subcellular outcomes and is a complex, target-specific process 
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involving several enzymes (Sadowski et al., 2012). In the case of transmembrane 
proteins, a single ubiquitin molecule marks them for degradation, though this process 
must necessarily occur via vesicular transport, in particular through endosomes to the 
lysosome or vacuole, where degradation takes place. Lysosomes are acidic organelles 
containing hydrolytic enzymes and are at the crossroads of several degradation 
processes, for they degrade proteins with long half-lives arriving in endosomes or aid in 
clearing away larger elements packaged in phagosomes or autophagosomes (de Duve, 
1969; Fader and Colombo, 2009; Saftig and Klumperman, 2009). It is indeed vital for
cell homeostasis to tightly coordinate the complex processes encompassing vesicular 
biogenesis, membrane trafficking and the degradation of cellular components by means 
of precise macromolecular machineries.
3.1 Protein machineries involved in sorting
Intense research in the past decades on the proteins involved in endosomal 
sorting has uncovered a plethora of interaction networks and transport systems to 
shuttle cargo to and fro within the cell, as reviewed in (Bishop, 2003). Vesicle biogenesis 
is a topologically complicated process in which the membrane must curve forcefully and 
still accommodate transmembrane or peripheral membrane proteins and their effectors
(McMahon and Gallop, 2005). Proteins responsible for inducing curvature, coating of
developing omegas and membrane scission at the plasma membrane are key players in 
the initial steps of vesicle generation (Stachowiak et al., 2013). However, once 
endosomes are formed, their destination is tightly regulated by other sets of proteins 
such as Rab proteins that assemble onto the newly formed vesicles and help in their 
uncoating, trafficking (i.e. along microtubules), tethering, and fusion with one another 
(Stenmark, 2009). Furthermore, extensive maturation gives rise to vesicles that suffer
internal processes of their own, such as the production of intraluminal vesicles (ILV) 
from the membrane of MVB mediated by the ESCRT (endosomal sorting complex 
required for transport) protein machinery (Raiborg and Stenmark, 2009) or acquisition 
of acidic pH values. The relatively recent discoveries of tethering protein complexes, 
namely, HOPS (homotypic fusion and vacuole protein sorting complex) (Seals et al., 
2000) and CORVET (class C core vacuole/endosome tethering complex) (Peplowska et 
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al., 2007) unveil the role of these multi-protein machineries in homotypic fusion of
endocytic compartments prior to SNARE (Soluble NSF (N-ethylmaleimide-sensitive 
factor) Attachment Protein Receptor) participation, as reviewed extensively in (Solinger 
and Spang, 2013). Furthermore, anterograde transport from the Golgi to late endosomes 
or lysosomes and vacuoles is mediated by carboxypeptidase Y and AP-3 
(heterotetrameric adaptor protein complex 3) pathways, whereas retromer governs 
retrograde trafficking within these compartments with the help of other proteins such as 
sorting nexins (Cullen and Korswagen, 2012; Epp et al., 2011). However, these 
complexes are beyond the scope of this dissertation, in which attention will be focused 
on the Rab and ESCRT protein machineries involved in endolysosomal trafficking and 
MVB biogenesis, to contextualize the localization of the endosomal GTPases under 
study.  
3.1.1 Rab proteins
As described above and seen in Figure 1, Rab proteins constitute the largest of 
the Ras subfamilies. Membrane tethering is determined by their two C-terminal 
geranylgeranyl moieties and the immediate upstream protein sequence (Chavrier et al., 
1991), as well as binding to specific GDI or GDI recycling factors (Dirac-Svejstrup et al., 
1997; Ullrich et al., 1994; Ullrich et al., 1993). The multitude of Rab proteins contained 
in human cells and the processes in which they are involved are reflected in Table 1. 
Rab functions that are basic to cell homeostasis include trafficking between the 
ER, plasma membrane or endosomes and the Golgi apparatus, as well as intra-Golgi 
trafficking. Distinct Rab proteins also mediate early and late endosome biogenesis, 
maturation and fusion with lysosomes, as shown in Table 1. Endocytic recycling, 
exocytosis or phagosome dynamics also involve members of this protein family. 
Furthermore, Rab proteins also mediate other more specific, cell-type dependent 
transport mechanisms, such as melanosome biogenesis and transport, ciliogenesis, or 
tight junction assembly in epithelial cells (Stenmark, 2009). Many of these Rab proteins 
mediate trafficking steps, which are controlled by feedback mechanisms involving their 
effectors: sorting adaptors, motor adaptors for vesicle transport on actin or tubulin, 
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tethering factors or simply their respective GAP, GDI or GEF. These interactions are at 
the core of Rab protein involvement in vesicle budding, motility or fusion (Stenmark, 
2009). 
Table 1. Functions of Rab GTPases.
Rab GTPases are crucial for a wide variety of intracellular tasks, which they perform at 
specific subcellular localizations. Where indicated, several Rab proteins act in concert to 
regulate a particular trafficking or biogenesis event. See text for details.
Amongst the trafficking routes mediated by Rab proteins, the most important 
step in endosome biogenesis is the exchange of Rab5 for Rab7 on early endosomes 
maturing to late endosomes. In this process, early endosomes derived from 
internalization the plasma membrane are covered by Rab5, which is replaced by Rab7 
following an exchange of their GEF (Poteryaev et al., 2010; Rink et al., 2005). Switching 
Rab5 for Rab7 implies that recycling Rabs such as Rab4 and Rab11 are lost, whereas late 
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endosomal Rab9 is recruited. Other concomitant endosomal maturation steps include
phosphatidylinositol species turnover, acquisition of hydrolases and other proteins from 
the trans-Golgi network, lumen acidification by V-ATPases, and morphological or size 
variations (Huotari and Helenius, 2011). 
Due to the importance of Rab proteins in intracellular trafficking, mutations in 
several of these proteins give rise to pathological scenarios including congenital 
disorders such as Griscelli Syndrome 2, in which Rab27a is mutated (Menasche et al., 
2003; Mitra et al., 2011), or X-linked choroideremia, arising from Rep-1 mutation and 
subsequent deficits in Rab27a geranylgeranylation (D'Adamo et al., 1998; Seabra et al., 
1993; Seabra et al., 1995). In addition, Rabs can mediate tumorigenesis (Recchi and 
Seabra, 2012) and are involved in infectious processes, since many pathogens hijack Rab 
pathways either during endocytosis while entering the cell, e.g. Salmonella enterica
serovar Typhimurium or coxsackie virus (Coyne et al., 2007; Smith et al., 2007), or 
interfering with endosome maturation steps once inside the cell, e.g. Lysteria 
monocytogenes and Helicobacter pylori (Prada-Delgado et al., 2005; Terebiznik et al., 
2006).
The concerted action of Rab proteins with other machineries adds further
complexity to endosomal sorting. For example, late endosomes that have acquired Rab7 
undergo internal rearrangements such as acquisition of material from the Golgi, 
homotypic fusion instead of fusion with early endosomes, or ILV formation giving rise 
to MVB (Huotari and Helenius, 2011). This latter process is catalyzed by yet another
multi-protein sorting machinery, the ESCRT proteins.
3.1.2 ESCRT proteins in MVB biogenesis
There is a multitude of proteins involved in the formation of MVB that function 
sequentially from cargo recognition, deformation of the membrane, to internalization of 
cargo into ILV of MVB (Raiborg and Stenmark, 2009). The components involved in 
recognizing ubiquitin on cargo to be degraded were studied in yeast and termed Class E 
Vacuolar protein sorting (Vps) proteins (Raymond et al., 1992). It was soon determined 
that Vps proteins combine at MVB membranes to form the multi-subunit ESCRT 
machinery represented in Figure 8 to mediate ILV biogenesis.
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Figure 8. Schematic of the ESCRT protein machinery.
The ESCRT machinery aids in sorting endosomal cargo and MVB biogenesis through ILV 
production. Dark blue rods bound to light blue circles represent receptors bound to their 
ligand that have been internalized from the plasma membrane and arrive at the MVB limiting 
membrane during endocytosis. Ubiquitin binds to these receptors and is recognized by 
ESCRT-0 (green components) through binding of Hrs to PI(3)P (red phospholipid). ESCRT-I 
(red shapes) is recruited by this machinery and cargo is transferred along the pathway such 
that ESCRT-I together with ESCRT-II (orange shapes) gives rise to MVB membrane 
invagination. ESCRT-III (purple spiral) binds to ESCRT-II along with other associated proteins 
responsible for deubiquitinating cargo. ESCRT-III forms spiral filaments surrounding the 
forming vesicle neck to induce its pinching off from the limiting membrane to form an ILV. 
Ultimately, the ATPase Vps4 (teal hexagon) is recruited by ESCRT-III and promotes its 
disassembly to recycle components. The nomenclature used here refers mostly to yeast 
proteins, though alternative nomenclatures have developed for mammalian orthologues. 
Adapted from (Rusten et al., 2012).
As addressed above, protein complexes aid vesicles in diverse maturation steps 
along the endocytic route (see Figure 7), including membrane budding events that elicit 
multivesicular compartment formation. The ESCRT –I, -II and –III complexes were 
described as assemblies of Vps proteins, each involved in a specific step of MVB 
biogenesis (Babst et al., 2002a; Babst et al., 2002b; Katzmann et al., 2001). A fourth 
complex, ESCRT-0, was defined later on, though it is the first to act by recognizing 
ubiquitinated cargo such as monoubiquitinated cytosolic domains of membrane 
receptors and forming a protein mesh on endosomes (Raiborg et al., 2001; Raiborg and 
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Stenmark, 2009). The fundamental ESCRT-0 protein is Vps27p, or Hrs (Hepatocyte 
growth factor-regulated tyrosine kinase substrate) in humans (Figure 8, green). Hrs 
recognizes ubiquitinated cargo and also contains a phosphoinositol-3-phosphate 
(PI(3)P) binding domain termed FYVE. ESCRT-I is responsible for binding to 
ubiquitinated cargo and ESCRT-0 simultaneously (Katzmann et al., 2001). Vps23p or its 
homolog in humans, Tsg101 (Figure 8, red), is at the core of ESCRT-I, for it directly 
binds to cargo and Hrs. Once ESCRT-0 is recycled, ESCRT-I can interact with ESCRT-
II (Figure 8, orange), which aids in early steps of membrane curvature and in 
assembling the next complex (Babst et al., 2002b). ESCRT-III function is one of the 
most important steps in MVB biogenesis, since a subset of its subunits is in charge of 
generating membrane curvature to accommodate ILV production, while other proteins 
in this complex aid in vesicle abscission (Babst et al., 2002a; Hanson et al., 2008). 
Currently, there is still debate as to how ESCRT-III subunits (in humans, charged 
multivesicular proteins, or CHMP) assemble to deform membranes, with two main 
hypotheses still standing, i.e. the helical and dome models, represented by purple spirals 
in Figure 8, as reviewed in (Henne et al., 2013). In turn, several ESCRT-associated 
proteins perform crucial tasks such as deubiquitinating cargo or aiding in membrane 
deformation (Clague and Urbe, 2006). Vps4 is an ATPase that is in charge of 
terminating ILV formation by providing energy for membrane scission at the vesicle 
neck and promoting ESCRT-III dissociation from the MVB (Shim et al., 2008). 
Interestingly, ESCRT machineries do not accompany cargo into ILV, but rather are all 
recycled for subsequent rounds of endolysosomal sorting (Babst et al., 1998; Williams 
and Urbe, 2007).
Though the canonical ESCRT sorting pathway begins with cargo ubiquitination, 
several studies have shown that this route can also be responsible for ubiquitin-
independent sorting. In yeast, acid trehalase is targeted to lysosomes via MVB in an 
ubiquitin-independent manner (Huang et al., 2007a). In mammalian cells, several 
cytokine receptors and the G-protein coupled receptors (GPCR) DOR (delta opioid 
receptor) and PAR1 (protease-activated receptor 1) are similarly sorted into MVB
through ubiquitin-independent mechanisms involving at least part of the ESCRT 
machinery (Amano et al., 2011; Dores et al., 2012; Hislop et al., 2004). A recent study 
further suggests that binding to any ESCRT protein can mediate ubiquitin-independent 
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sorting, such that weak affinity for ESCRT and strong membrane association will 
mediate internalization into MVB, whereas a strong interaction with ESCRT but weaker 
membrane binding will send proteins along the recycling pathway to the plasma 
membrane, regardless of their ubiquitination state (Mageswaran et al., 2014). Therefore, 
some MVB cargo contains structural determinants that allow for ESCRT-dependent 
sorting into ILV in the absence of ubiquitin. 
The ILV inside MVB can have different fates. If retained in the endosomal route,
they will be taken to the lysosome to be degraded (Futter et al., 1996). Alternatively, ILV 
can be liberated to the extracellular space after fusion of MVB with the plasma 
membrane, hence becoming exosomes, as reviewed in (Simons and Raposo, 2009). 
Whether degradative and exocytic ILV are contained within distinct MVB or can be 
found in the same MVB has been the subject of much debate. Recently, two 
subpopulations of ILV have been shown to coexist within the same MVB (Edgar et al., 
2014), as depicted in Figure 9. 
Figure 9. ILV biogenesis and destination.
The limiting membrane of MVB invaginates to form either large ILV through ESCRT-
dependent mechanisms (machinery shown in green, red and purple) or to form small ILV in a 
process involving CD63 (shown in orange). In this model, the same MVB holds both types of 
ILV, as described recently (Edgar et al., 2014); however, it is not yet clear whether this is the 
case or if specific MVB exist for each type of ILV. Small ILV containing CD63 and material to 
be secreted (blue squares) are released into the extracellular milieu upon fusion of the MVB 
with the plasma membrane during exocytosis. On the other hand, large ILV containing cargo 
such as signaling receptors (red rods) fuse with lysosomes to elicit degradation of ILV content.
Introduction
24
The two types of ILV differ in size, biogenesis and cellular fate. Large, sorting 
ILV are formed Hrs-dependently, whereas small, exocytic ILV appear due to sorting 
mediated by the tetraspanin CD63, as will be explained below. It is therefore possible 
that both ESCRT-dependent and -independent ILV generation occur simultaneously 
within the cell, giving rise to specific types of vesicles with unique destinations. This 
point is further substantiated by the fact that CD63-positive ILV still appear in the 
absence of members of all ESCRT complexes, suggesting that ESCRT-independent 
mechanisms of MVB biogenesis are still operative in this setting (Stuffers et al., 2009). 
Indeed, the major histocompatibility complex-II (MHC-II) in dendritic cells can be 
sorted to lysosomal ILV when ubiquitinated under resting conditions via an ESCRT-
dependent process, whereas cell activation abolishes MHC-II ubiquitination and 
promotes its internalization into exosomal ILV that are liberated towards the T cells 
with which they interact (Buschow et al., 2009).
Though represented as distinct processes in Figure 9, crosstalk most likely exists 
between degradative or exocytic ILV biogenesis pathways, as reflected in a recent report 
presenting an RNA interference screen of 23 ESCRT proteins.  Several ESCRT proteins, 
e.g. Hrs or Tsg101, were found necessary not only for degradative ILV formation but 
also for exosome biogenesis, suggesting that exosomes can be formed by the ESCRT 
machinery as well as by ESCRT–independent pathways (Colombo et al., 2013).
3.1.3 CD63-mediated sorting
The role of CD63 in formation of exosomal ILV highlights the fact that this 
tetraspanin is inextricably involved in late endosomal trafficking, as reviewed in (Pols 
and Klumperman, 2009). Tetraspanins are a family of proteins containing four 
transmembrane domains, glycosylated residues and most contain cysteines amenable to 
palmitoylation, as is the case for CD63, as reviewed in (Hemler, 2005). These 
posttranslational modifications aid in homo- and heteroligomerization to produce 
tetraspanin-enriched microdomains (TEM) in which tetraspanins of several types along 
with receptors, integrins, metalloproteinases and cholesterol occupy a tightly packed 
area of membrane, particularly on the plasma membrane (Yang et al., 2002). In fact, as 
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shown in Figure 10, a cholesterol-palmitoyl interaction is also established by the 
palmitates bound to tetraspanins, further stabilizing these TEM (Charrin et al., 2003).
Figure 10. CD63 tetraspanin-enriched microdomains. 
Zoom-in of a membrane from an ILV destined for exosomal release. CD63 molecules are 
shown in orange, containing four transmembrane domains and two loop domains. Cysteine 
residues at their N- and C-termini become palmitoylated (blue zigzags), which allows for 
interaction with membrane-embedded cholesterol (black structures). The C-terminal YXXF
motifs that interact with AP complexes for intracellular shuttling are also depicted. 
Tetraspanins associate with each other to form oligomers, as shown here for four CD63 
molecules, to form tetraspanin-enriched microdomains (TEM).
In the case of CD63, its association with late endosomes and ILV usually 
predominates over plasma membrane localization.  Specifically, ILV destined for 
exosome formation are enriched in several tetraspanins including CD63 (Escola et al., 
1998). This tetraspanin contains the lysosomal targeting sequence “YEVM”, which 
follows a “YXXF” pattern recognized by adaptor protein complexes, in which a crucial 
tyrosine residue is followed by any two amino acids (X) and an aliphatic, bulky residue 
(F), as reviewed in (Bonifacino and Traub, 2003). Therefore, CD63 contains several 
structural determinants that direct it to the late endocytic pathway.
A newly synthesized CD63 polypeptide chain undergoes glycosylation and 
palmitoylation at the Golgi prior to export to the plasma membrane, cycling back 
inward when its sorting signal is recognized by AP-2 and traveling further from 
recycling endosomes to late endosomes/MVB and lysosomes via AP-3 binding, as 
reviewed in (Pols and Klumperman, 2009). Following these pathways, it has been 
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reported that CD63 could be involved in trafficking of MHC-II in dendritic cells (Vogt 
et al., 2002) or recycling of the H+/K+ ATPase pump in gastric parietal cells (Duffield et 
al., 2003). Additionally, a truncated form of CD63 was shown to down-regulate 
chemokine receptor CXCR4 plasma membrane levels due to receptor internalization in 
T lymphocytes (Yoshida et al., 2008). Once localized at late endosomes/MVB, CD63 can 
mediate ESCRT-independent sorting of certain proteins, as is the case for specific 
domains of the melanosomal protein Pmel17 (Theos et al., 2006; van Niel et al., 2011). 
Furthermore, CD63 plays a central role in ESCRT-independent exosome biogenesis, as 
described above, which is also reflected by its use as an exosomal marker, as reviewed in 
(Andreu and Yáñez-Mo, 2014). Recently, the direct role of TEM in exosome formation 
has been set forth by a comprehensive high-throughput proteomic analysis that 
highlights their importance in selecting receptors and signaling proteins for exosomal 
packaging (Pérez-Hernández et al., 2013). It is interesting to note that though CD63 is 
involved in sorting proteins of various origins, its knock-out (KO) mouse model is 
viable and displays normal lysosomal function, though these mice suffer kidney
pathologies. However, considering the amount of tetraspanins expressed in cells, there 
could be redundancies such that other members of this protein family could 
compensate for CD63 loss (Schröder et al., 2009). 
Though MVB biogenesis and cargo sorting require proteins such as CD63 or 
ESCRT components, it also depends on the lipid composition in which membrane 
proteins are embedded. It has been proposed that specific membrane domains and the 
lipids contained therein can play a part in the invagination of the MVB limiting 
membrane to form ILV (Matsuo et al., 2004). Moreover, it has been described that 
certain lipid compositions favor the formation of MVB in the absence of protein 
components, both in liposome models and in cells (Matsuo et al., 2004; Trajkovic et al., 
2008), as will be described in the following section.
3.2 Lipid involvement in endosomal sorting
Lipids are distributed unevenly among cellular membranes and hence play a 
significant role in the distribution of membrane proteins in different organelles. As 
schematized in Figure 11, intracellular membranes have been proposed to be divided 
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into two distinct environments according to lipid properties: the biosynthetic, pre-Golgi 
system that includes the ER, and the secretory-endocytic, post-Golgi system that 
includes the plasma membrane and endocytic vesicles (Lippincott-Schwartz and Phair, 
2010). Following this model, ER/cis-Golgi membranes contain monounsaturated lipids 
usually with neutral head groups that favor interactions with cytosolic proteins 
preferring lipid-packing defects. On the other hand, the trans-Golgi, plasma membrane
and endocytic compartments include more negatively charged lipids packed tightly (i.e. 
phospholipids with more saturated acyl chains) to favor electrostatic interactions
(Figure 11). Other specialized lipids appear at specific subcellular locations. For 
instance, cholesterol and glycosphingolipids reside on both leaflets of the plasma 
membrane, while phosphatidylethanolamine (PE) and phosphatidylserine (PS) remain 
at its inner leaflet, as reviewed in (Bigay and Antonny, 2012). Furthermore, scarce but 
highly specialized phosphoinositides appear at different membrane sites throughout the 
cell. The plasma membrane contains PI(4,5)P2 and PI(3,4,5)P3 whereas PI(3)P appears 
at early endosomes and controls many endocytic processes through proteins with 
PI(3)P binding domains (Gillooly et al., 2000; Schink et al., 2013). The specialized 
phospholipid, 2,2’-dioleoyl lysobisphosphatidic acid (LBPA, a.k.a. BMP) (Kolter and 
Sandhoff, 2005) is exclusively localized to late endosomes, particularly ILV of MVB 
(Kobayashi et al., 1999), and has the ability to deform membranes in vitro, thus possibly 
playing a role in MVB invagination, as discussed below (Matsuo et al., 2004). Therefore, 
the dynamic nature of membrane trafficking depends not only on protein-based sorting 
complexes, but also on organelle identity conferred to specific endomembranes by lipids 
of varied acyl composition, head group charge and overall physicochemical structure.
Lipid gradients exist along the biosynthetic pathway, so that there is more 
cholesterol density and sphingolipids from the ER towards the PM (Maxfield and van 
Meer, 2010), as depicted in Figure 11. Cholesterol and sphingolipids are responsible for 
thickening the membrane bilayer, which is reflected by the transmembrane span of 
proteins (Sharpe et al., 2010). In particular, cholesterol is enriched in recycling 
endosomes, as well as in ILV of MVB (Möbius et al., 2003). Cholesterol has been found 
to appear at particularly high curvature regions (Wang et al., 2007), which could explain 
its concentration in ILV. This sterol also stabilizes fluid phosphoinositide domains, 
which could be involved in forming signaling platforms that require concentrating these 
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scarce phospholipids into an area that accommodates interactions between signaling 
proteins (Jiang et al., 2014). Furthermore, in the context of signaling receptors, several 
GPCR have been shown to directly interact with cholesterol through their palmitoyl 
moieties (Cherezov et al., 2007; Zheng et al., 2012), similarly to tetraspanins (Charrin et 
al., 2003). 
Figure 11. Lipid properties defining membrane environments within the cell.
Studies based on lipidomics and probe detection point to two distinct membrane 
environments within the cell. As shown to the left of the dashed line (blue structures), the ER 
and cis-Golgi membranes are characterized by lipid-packing defects due to the unsaturated 
chains that their phospholipids contain, whose head groups are weakly charged. 
Furthermore, they present low levels of cholesterol and sphingolipids, producing thin 
membranes. In contrast, trans-Golgi, endosomal and plasma membranes (orange and red 
components to the right of the dashed line) are characterized by inner leaflet phospholipids 
with negatively charged polar groups (high electrostatics) and saturated chains, as well as 
elevated cholesterol and sphingolipid levels, rendering them thicker and more tightly packed. 
Adapted from (Bigay and Antonny, 2012).
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Regarding the formation of ILV of MVB, several in vitro studies have shown that 
lipids alone can mediate membrane invagination on liposomes with particular 
compositions (Matsuo et al., 2004; Trajkovic et al., 2008). The specialized lipid LBPA 
could be involved in the ESCRT-dependent formation of degradative ILV (Matsuo et al., 
2004), whereas the sphingolipid ceramide induces the formation of ILV destined to 
become exosomes (Trajkovic et al., 2008) (see Figure 9). These findings are in line with 
studies describing high levels of LBPA in ILV of MVB within the cell, whereas exosomes 
are not enriched in this lipid (Laulagnier et al., 2004; Wubbolts et al., 2003). Another 
report suggests that cholesterol-rich MVB are destined for exosome formation and 
cholesterol-poor vesicle populations are sent to the lysosome to be degraded (Möbius et 
al., 2003). Furthermore, ILV have been shown to undergo back-fusion and blend back 
into the MVB limiting membrane via an LBPA-mediated process employed by certain 
pathogens to escape their degradation, as reviewed in (Falguières et al., 2009). However, 
there is still debate regarding whether exosome biogenesis is dependent on ESCRT and 
its associated proteins, e.g. Hrs, Alix (Baietti et al., 2012; Colombo et al., 2013; Gibbings 
et al., 2009) or mostly lipid-based and perhaps involving CD63 (Trajkovic et al., 2008). 
It is therefore probable that ILV themselves or even specific microdomains of the MVB 
limiting membrane, though thoroughly dependent on their lipid composition, are 
regulated by tight interplay with complex protein machineries owing to their highly 
dynamic nature (Bissig and Gruenberg, 2013). 
Lipid composition also has its effects on peripheral membrane proteins such as 
Ras and Rho proteins, since their trafficking depends on lipid modifications, as 
described above. In the case of proteins that are both isoprenylated and palmitoylated, 
isoprenylation could be responsible for a weak interaction with the membrane, whereas 
single or double palmitoylation would aid in its binding to membranes with a particular 
composition (Rocks et al., 2005). These palmitate moieties are saturated chains that 
occupy a small space and can therefore force their way into tightly packed membranes 
containing saturated phospholipids, such as the plasma membrane and late endocytic 
vesicles. An elegant in silico model suggests that H-Ras forms clusters at the interface of 
lipid domains with its palmitate chains preferentially oriented towards liquid ordered 
domains (Lo, cholesterol-rich, with saturated phospholipids), whereas its 
polyunsaturated farnesyl moiety is directed towards the liquid disordered membrane 
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domain (Ld), hence increasing membrane curvature (Janosi et al., 2012). H-Ras was 
indeed found to cycle between Ld and Lo domains in its GTP- or GDP-bound form, 
respectively, underscoring the importance of lateral segregation of peripheral proteins 
on their function (Prior et al., 2001). Lipid packing, electrostatics or curvature could 
play a further role in membrane selectivity, as is the case for members of the Rho family 
(Rac1 and Rac2) or the Ras protein, K-Ras4B, which contain basic residues at their C-
terminus that allow electrostatic interactions with PS on membranes (Ahearn et al., 
2012; Bigay and Antonny, 2012). It is therefore apparent that lipid composition is 
crucial for peripheral membrane proteins to accomplish their biological roles at distinct 
subcellular locations. 
3.3 Other sorting and degradation pathways
Early stages of protein sorting within the cell involve bulk flow of many proteins 
towards the cis Golgi upon translation at the ER. However, post-Golgi trafficking events 
become increasingly specialized for the proteins to be sorted, so that more cargo-specific
sorting machineries appear further along the endocytic route towards lysosomes, 
secretion or recycling. Along with the pivotal Rab and ESCRT protein sorting 
machineries described above, other mechanisms act in parallel to coordinate the busy 
flow of material in later stages of protein shuttling within the cell. Many proteins 
contain sequences that are recognized by sorting entities (Bonifacino and Traub, 2003), 
as exemplified by soluble acid hydrolases, which are modified by M6P and recognized 
by M6P receptors in the Golgi apparatus that will accompany them to the lysosome, as 
reviewed in (Ghosh et al., 2003). However, other M6P-independent mechanisms 
involving the sorting proteins sortilin or lysosomal integral membrane protein 2 (LIMP-
2) also work in the cell to transfer soluble proteins into lysosomes (Coutinho et al., 2012; 
Ghosh et al., 2003). As for lysosomal transmembrane proteins, their targeting sequences 
contain tyrosines (such as the “YXXF” motif in CD63 mentioned above) or dileucine 
motifs that are recognized by specific AP complexes, as extensively reviewed in 
(Bonifacino and Traub, 2003). Distinct AP complexes are present on membranes such 
as the plasma membrane, Golgi, endosomes and others, from which they recognize 
motifs in cargo proteins and mediate their transport (Bonifacino and Traub, 2003).
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Additionally to protein-specific sorting, cell type-dependent processes are responsible 
for the formation and transport of certain specialized vesicles, such as lysosome-related 
organelles (LRO), e.g. melanosomes for pigmentation; basophil, azurophil and lytic 
granules or MHC class II compartments for immune responses; and platelet-dense 
granules for coagulation, as reviewed in (Dell'Angelica et al., 2000). Their biogenesis is 
mediated by yet another protein machinery termed BLOC 1-3 (biogenesis of lysosome-
related organelles complex), containing proteins that are mutated in the lysosomal 
disorder Hermansky-Pudlak syndrome (HPS), which will be considered below, as 
reviewed in (Dell'Angelica, 2004).
3.3.1 Autophagy 
The term “autophagy”, literally “self-eating”, originally was designated for a 
process in which proteins and even organelles are surrounded by double membranes of 
varied origin called phagophores, which mature to autophagosomes and fuse with 
lysosomes to degrade these large amounts of cellular material (Mizushima et al., 2008). 
The explosion of research in this field has led to the discovery of numerous autophagic 
pathways, so that the original term is now referred to as macroautophagy, to 
differentiate it from the other two main forms of autophagy, i.e. microautophagy, 
implying direct lysosomal internalization, and chaperone-mediated autophagy, in which 
the chaperone Hsc70 unfolds proteins prior to their internalization into the lysosome to 
be degraded (Cuervo and Dice, 1996; Lee et al., 2012). Cells undergo these degradation 
processes to redeliver the necessary biosynthetic building blocks to the cytosol when
they detect a nutrient or energetic shortage, or under stress conditions including 
pathogen invasion and excessive protein aggregation, as reviewed in (Yang and 
Klionsky, 2010). The autophagy-related proteins (Atg) are the core molecular 
machinery of canonical autophagy and work together in sequential complexes during 
phagophore maturation towards autophagosomes, as reviewed in (Mizushima et al., 
2011). Though autophagy was first regarded as a degradation and cell death mechanism, 
numerous reports now corroborate its role in survival, bioenergetics, cell differentiation, 
immunity, and tumor suppression, as reviewed in (Boya et al., 2013).
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Interaction between autophagy and endolysosomal sorting is obvious at the 
point of autophagosome-lysosome fusion, but some instances of autophagosome fusion 
to early and late endosomes have been documented (Berg et al., 1998; Dunn, 1994; Liou 
et al., 1997). In fact, the fusion of endocytic vesicles such as MVB and autophagosomes
gives rise to structures called amphisomes, which further fuse to lysosomes for 
degradation (Eskelinen, 2005). Moreover, some studies suggest that Rab11 could play a 
role in MVB-autophagosome fusion to form amphisomes, whereas Rab7 would mediate 
the next step of fusing to lysosomes, as reviewed in (Fader and Colombo, 2009). Other 
members of the Rab family also appear at the crossroads of endolysosomal and 
phagocytic pathways, such as Rab1 at the initial formation of the phagophore and Rab9 
during non-canonical Atg5/Atg7-independent autophagy, among others, as reviewed in 
(Chua et al., 2011). Studies both in mammalian cells and Drosophila lacking certain 
ESCRT proteins showed impaired autophagy and accumulation of ubiquitin-positive 
aggregates, again revealing that correct MVB function is necessary for autophagy 
progression (Rusten and Simonsen, 2008). It has also recently come to light that it is 
common for autophagic cargo to become ubiquitinated and sorted by autophagy 
receptors containing ubiquitin-binding domains (Boya et al., 2013). Furthermore, 
connections between autophagy and exosomal MVB have been established, since 
autophagy induction by several methods inhibits exosome release and points to a 
selective MVB fate depending on cellular energy needs (Baixauli et al., 2014). Once 
again, the boundaries between distinct organelles are often blurred during crosstalk 
between intracellular trafficking pathways.
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4. Lysosomal storage diseases
Lysosomal storage diseases are quite a numerous group of rare inherited 
metabolic disorders resulting from mutations in specific lysosome-related genes 
(Ballabio and Gieselmann, 2009; Fuller et al., 2006). Though initially attributed to acid 
hydrolases of the lysosomal lumen, it has become evident that both lysosomal integral 
membrane and luminal proteins, among others, are involved in certain lysosomal 
storage disorders (Saftig and Klumperman, 2009). There are as many as 60 lysosomal 
protein deficiencies that give rise to accumulation of material from incomplete 
degradation or trafficking in degradative compartments (Sagne and Gasnier, 2008).
Some of these disorders arise from problems in LRO biogenesis, mediated by 
transporters and tethering or sorting factors (Huizing et al., 2008). In most cases, 
manifestations appear during childhood and often include varying degrees of
neurodegeneration and immune deficiencies that can cause death at a relatively early 
age unless palliated by bone marrow transplantation or recently developed treatments 
such as enzyme replacement therapy, as reviewed in (Platt et al., 2012). Table 2
summarizes several lysosomal storage diseases and the proteins altered by mutations in 
their respective genes.
There are many pathological scenarios involving malfunction of lipid transport 
routes, but here the focus will be on alterations of late endosome lipids. In Niemann-
Pick type C (NPC) disease, a set of lysosomal integral membrane proteins that act as 
cholesterol transporters at late endosomes (NPC1/NPC2) are deficient (Table 2). Late 
endosomes and lysosomes in NPC patients accumulate massive amounts of cholesterol 
and glycosphingolipids due to abnormal low-density lipoprotein processing within the 
endocytic pathway (Mukherjee and Maxfield, 2004). Furthermore, this cholesterol 
buildup induces Rab9 sequestration, possibly in its inactive form, which disrupts M6P 
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receptor trafficking (Ganley and Pfeffer, 2006). It has been described that NPC1 cells 
could be inducing the release of exosomes loaded with cholesterol, perhaps as a means 
of circumventing the cytotoxic effects of generalized cholesterol buildup within the cell 
(Strauss et al., 2010). Alterations of lipid homeostasis are quite severe due to cholesterol 
and LBPA accumulation in late endosomes and subsequent endolysosomal dilation in 
several cell types (Carstea et al., 1997; Kobayashi et al., 1999). In fact, this phenotype can 
be mimicked by treatment with the hydrophobic amine U18666A that has therefore 
been used to generate NPC-like cells (Mukherjee and Maxfield, 2004; Sobo et al., 2007).
Table 2. Lysosomal storage diseases and mutated proteins.
Lysosomal storage diseases are caused by point mutations in genes that code for proteins 
involved in late endocytic trafficking. NPC proteins are involved in cholesterol transport, 
whereas proteins responsible for the various forms of HPS mediate vesicular transport of 
lysosome-related organelles (BLOC) or general late endosomal trafficking (AP-3). Many point 
mutations have been described for the Lyst gene, all of which give rise to CHS of varying 
degrees of severity.
Mutations in several LRO biogenesis-related proteins give rise to recognizable 
hypopigmentation disorders due to malfunction of melanosome biogenesis or 
trafficking, as reviewed in (Dessinioti et al., 2009). Such is the case for Hermansky-
Pudlak syndrome (HPS), in which mutation of several specific proteins can elicit similar 
phenotypes, and Chediak-Higashi syndrome (CHS), resulting from mutations in the 
Lysosomal trafficking regulator (Lyst) protein, as will be discussed in detail below. There 
are eight human HPS subtypes (Table 2), which arise from mutations in key LRO 
trafficking and maturation machinery proteins, i.e. BLOC-3 mutations in HPS-1 and 
HPS-4, AP-3 in HPS-2, BLOC-2 in HPS-3, HPS-5 and HPS-6, and BLOC-1 in HPS-7 
and HPS-8, as reviewed in (Wei, 2006). Apart from LRO machineries, certain Rab 
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family proteins have been shown to play a role in HPS mouse models and perhaps in 
human pathology, for BLOC-3 acts as a Rab-GEF for Rab38 and Rab32 to recruit these 
proteins to premelanosomal membranes.  Furthermore, Rab38 co-localizes with BLOC-
2 and AP-3 at endosomal membranes, suggesting a role for this Rab in cargo trafficking 
during LRO biogenesis, as reviewed in (Krzewski and Cullinane, 2013).
4.1 Chediak-Higashi Syndrome
CHS is a rare autosomal recessive lysosomal storage disorder characterized by 
enlarged granules in many cell types, including melanocytes, neutrophils, leukocytes 
and neurons, among others. The large, dense granules are either lysosomes or LRO
destined for secretion and involved in diverse cellular functions such as immune 
responses, pigmentation or coagulation. These functions are compromised in CHS 
patients, as reflected by their clinical manifestations which include partial 
oculocutaneous albinism, bleeding disorders, neutropenia, recurrent infection and 
neurological dysfunction, that can lead to death associated to a severe phase due to 
uncontrolled proliferation of cytotoxic T lymphocytes (Ward et al., 2000). 
The genetic defects that underlie CHS consist of mutations in the CHS1/LYST
gene, homologous to the beige gene in mice. This gene codifies a cytosolic protein of 
3801 amino acids (approximately 429 kDa) with still unclear functions (Huizing et al., 
2001). The LYST protein is a member of the BEACH (BEige And Chediak–Higashi) 
protein family and mutations that are phenotypically similar to CHS have been found in 
numerous mammalian species (Ward et al., 2000). Enlarged lysosomes and LRO are 
found mainly at the perinuclear region of CHS cells, pointing to a disruption in vesicle 
trafficking (Burkhardt et al., 1993). 
There are several functional studies on CHS cells or murine beige models that 
describe alterations in late vesicular traffic and their cellular impact. Similarly to HPS, 
deficiency in CHS melanosome secretion underlies oculocutaneous albinism in these 
patients (Stinchcombe et al., 2004). Under physiological conditions, it has been 
established that cells are able to use their lysosomes as Ca2+-regulated secretory 
compartments to “parch” the plasma membrane after wounding, making them crucial 
in membrane resealing (Reddy et al., 2001). In CHS and beige cells, lysosomal exocytosis 
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and consequent plasma membrane repair are defective (Huynh et al., 2004). Also in line 
with these findings, other exocytic organelles seem to be responsible for CHS immune 
deficiencies. CHS patients suffer from a loss of secretion at the immunological synapse, 
where CTL normally discharge proteins such as perforin via secretory lysosomes 
(Stinchcombe et al., 2000). Furthermore, CHS B lymphocytes present deficient peptide 
loading onto MHC class II as well as delayed antigen presentation as a result of defects 
in MHC-II transport from the TGN into MVB (Faigle et al., 1998). It has been proposed 
that LYST could act as a scaffold for complexes involved in LRO biogenesis that are 
defective in HPS pathogenesis as well, such as AP-3 or BLOC-1 (Callahan et al., 2009). 
Yeast two-hybrid screens using truncated forms of LYST revealed direct interaction 
with several proteins involved in late endosomal dynamics such as Hrs and several 
SNARE proteins (Tchernev et al., 2002). Rab14 interaction with a LYST homolog (LsvB) 
has been observed in the amoeba Dictyostelium discoideum, proposing that LsvB 
regulates lysosomal size and maturation through Rab14, though these studies are yet to 
be replicated in human cells (Kypri et al., 2013). Recent findings using small interfering 
RNA-depletion of LYST in cancer cells also point to a role for this protein in lysosome 
size and quantity, which could be regulated by fission or fusion events, instead of being 
directly responsible for LRO biogenesis or general degradation pathways (Holland et al., 
2014). Indeed, in Dictyostelium, LsvB has been found to have an inhibitory role in 
vacuole fusion (Falkenstein and De Lozanne, 2014), whereas previous studies in beige
mouse cells suggested that LYST promotes lysosomal fission (Durchfort et al., 2012). 
Clearly, the exact function of this remarkably large protein in endolysosomal biogenesis 
or sorting still warrants further studies. 
AIMS AND OBJECTIVES
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Small GTPases control crucial cellular functions from specific membrane 
localizations. Among the factors involved in their regulation, modifications at C-
terminal sequences play key roles, though the involvement of lipidation and its interplay 
with other structural determinants in subcellular targeting of GTPases has not been fully 
elucidated. Therefore, the work presented in this dissertation is focused on analyzing the 
role of lipid modifications of RhoB cysteine residues on its intracellular sorting and 
determining whether its lipidation motif per se is able to reproduce the behavior of the 
full-length protein. Furthermore, the possibility that lipidation sequences could be 
targeted by other structurally diverse modifications, including reactive species arising in 
pathological scenarios, has not been explored. Therefore, the following objectives were 
projected:
! To study endosomal GTPase C-terminal sorting signals involved in subcellular 
localization.
! To evaluate the importance of C-terminal isoprenylation and palmitoylation in 
attachment to intracellular vesicles.
! To determine the subcellular localization of chimeras bearing the RhoB C-
terminal lipidation motif.
! To assess whether the latent sorting mechanisms for the RhoB C-terminus are 
conserved in cells from different species.
! To explore the potential role of key molecular machineries, i.e. ESCRT 
complexes, CD63 or lipid dynamics, in sorting of RhoB and related chimeras.
! To set the basis for studying the potential alteration of endosomal GTPase 
localization and modification in experimental models of disease.

MATERIALS AND METHODS
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1. Materials
1.1 General reagents
1.1.1 Cell culture reagents
Cell culture medium including DMEM, RPMI 1640, and TC100 as well as 
Newborn calf serum, penicillin/streptomycin, glutamine and trypsin-EDTA were from 
Gibco Life Technologies. NCTC 109 medium was from Sigma. Fetal bovine serum 
(FBS) was from Lonza Inc. Sterile plastic material for cell culture was obtained from 
Falcon (Beckton Dickinson). For cell imaging of live cells, 35-mm glass bottom dishes 
(p35) from MatTek Corp. were used.
1.1.2 Electrophoresis and Western Blotting reagents
For protein separation through polyacrylamide gel electrophoresis (PAGE), 
electrophoresis purity acrylamide, N,N’-methylenebisacrylamide, ammonium 
persulfate, N,N,N’,N’-tetramethylethylenediamine (TEMED), sodium dodecyl sulfate
(SDS), glycine and Tris were acquired from Bio-Rad. For DNA separation, molecular 
biology grade agarose from Pronadisa was used for gels. Polyvinylidene fluoride (PVDF) 
Immobilon-P membranes were from Millipore, the bicinchoninic acid (BCA) Protein 
Assay Kit for measuring protein concentration in cell lysates was from Pierce and the 
enhanced chemiluminescence (ECL) detection system was from Amersham Biosciences.
1.1.3 Other reagents
High purity salts, buffers and other reagents used for preparing solutions were 
mainly from Sigma and Merck. Milli-Q distilled water was from Millipore. 
Lipofectamine 2000, Lipofectamine RNAiMax, Lysotracker Red (LTR), 7-amino-4-
chloromethylcoumarin (CMAC, a.k.a. CellTracker Blue), scrambled siRNA and siRNA 
against Hrs or Tsg101 were from Life Technologies. Chloroquine, 2-bromopalmitate, 
phenylarsine oxide (PAO), dibromobimane (DBB), leupeptin, filipin, carbobenzoxy-L-
Materials and Methods
44
leucyl-L-leucyl-L-leucinal (Z-LLL, a.k.a. MG-132), C6 ceramide, dihydroceramide C6, 
and ethidium bromide were from Sigma. U18666A, simvastatin and zaragozic acid 
(ZGA) were from Merck. Cyto-ID Green Detection Reagent for autophagy monitoring
and Lyso-ID Red Detection Reagent were from Enzo Life Sciences. All prostanoids were 
from Cayman Chemical. Human recombinant proteins were from Calbiochem-
Novabiochem (H-Ras), Jena Bioscience (RhoB and K-Ras4B) or Abcam (N-terminal 
His-tagged Rap2B). GFP-Trap agarose beads were from ChromoTek.
1.2 Antibodies
Antibodies for immunoblotting were: Anti-RhoB (mainly sc-180 but also sc-
8048), anti-RhoGDI (sc-360), anti-Rab7 (sc-10767), anti-ubiquitin (sc-8017), anti-
Hsp90 (sc-7947), and anti-LAMP1 (sc-20011) from Santa Cruz Biotechnology; anti-
Tsg101 from Abcam; antiserum against Hrs, as described in (Raiborg et al., 2001); anti-
pan Ras (Ab-3) from Merck; anti-Rap2 form BD Biosciences; anti-GFP from Clontech 
or Roche; secondary anti-mouse and anti-rabbit Immunoglobulins (Ig) conjugated with 
horseradish peroxidase (HRP) from Dako. Streptavidin-HRP was from GE Healthcare 
Life Sciences. For immunofluorescence, anti-giantin from Covance and anti-rabbit 568 
from Invitrogen were used.
1.3 Primers
The primers used for sequencing or to generate plasmids by mutagenesis or PCR 
were synthesized automatically at the Protein Chemistry Facility at CIB-CSIC in an 
Applied Biosystems 3400 synthesizer and purified in Sephadex G25, NAPTM columns 
from Amersham.
1.4 Plasmids
Small-scale plasmid DNA preparation was carried out using the High Pure 
Plasmid Isolation Kit from Roche whereas large-scale plasmid isolation was performed 
with the EndoFree Plasmid Maxi Kit from Qiagen. All restriction enzymes are from 
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Promega. Digestion products were separated by electrophoresis on 1% agarose gels with 
5 ng/ml ethidium bromide in Tris-acetate-EDTA (TAE) buffer prior to visualization 
under UV light on a Gel-Doc XR Imaging System (Bio-Rad). DNA fragment 
purification from agarose gels was performed with the Geneclean Turbo Kit from MP 
Biomedicals. The LigaFast Rapid DNA Ligation System from Promega was used for 
plasmid ligation. In the case of point mutations, primer pairs were designed and used 
with the QuikChange II XL Site-Directed Mutagenesis Kit from Agilent Technologies. 
All plasmids were sequence verified at the DNA Sequencing Service, Secugen S.A. at 
CIB-CSIC.
1.4.1 Donated and commercial plasmids
The following plasmids were kindly provided by various colleagues:
• pcDNA3-HA-RhoB (Prof. G.C. Prendergast, Lankenau Institute for Medical 
Research, Wynnewood, PA) 
• Lamp1-GFP (Prof. J. Lippincott-Schwartz, NIH, MD)
• GFP-Rab7 (Prof. C. Bucci, University of Copenhagen, Denmark)
• GFP-Vps4 WT and E334Q (Prof. P. Woodman, University of Manchester, UK)
• GFP-Rab5 (Prof. J. Bonifacino, NIH, MD)
• GFP-2xFYVE and mCherry-2xFYVE (Prof. H. Stenmark, Radium Hospital, 
Oslo, Norway)
• GFP-H-Ras (Dr. J.M. Rojas, ISCIII, Majadahonda, Spain)
• RFP-LC3 (Prof. T. Yoshimori, Research Institute for Microbial Diseases, Osaka, 
Japan)
Other plasmids were obtained from commercial sources:
• GFP-Rab11, GFP-Rab9A, GFP-Rap2A, GFP-Rap2B, GFP-CD63 (all in a pEZ-
M29 backbone for N-terminal GFP fusion) and mCherry-CD63 (pEZ-M55 
backbone) were from Genecopoeia.
• pEGFP-C1, pmCherry-C1 and pDendra2-C were from Clontech.
• pTagRFP-C was from Evrogen.
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The following constructs were generated by Genewiz Inc. (South Plainfield, NJ) by 
oligonucleotide synthesis and cloning into parent vectors:
• GFP-CINCSKVL (GFP-8-C244S, isoprenylation defective GFP-8 mutant)
• GFP-SINSCKVL (GFP-8-C240,243S, palmitoylation defective GFP-8 mutant)
• tRFP-T-CINCSKVL (tRFP-T-8-C242S)
• tRFP-T-SINSCKVL (tRFP-T-8-C238,241S)
• GFP-HA-RhoB X (expressing RhoB from Xenopus laevis)
• tRFP-T-HA-RhoB X
• GFP-CINCCKVL Asp (GFP-8 for Aspergillus nidulans transformation using 
p1902 as template) (Pantazopoulou and Peñalva, 2009)
• GFP-SINSCKVL Asp (GFP-8-C239,242S, palmitoylation defective GFP-8 for A. 
nidulans transformation)
1.4.2 Previously generated plasmids
Using some of the plasmids above, several constructs were previously generated and 
described in publications from the Pérez-Sala laboratory and colleagues:
• pEGFP-C1-HA-RhoB WT (GFP-RhoB) (Stamatakis et al., 2002)
• pcDNA3.0-GFP-CINCCKVL (GFP-8), GFP plus the last 22 amino acids of RhoB 
(GFP-22), and GFP-CINCCLIT (GFP-8-TC10, from the TC10 C-terminus)
(Pérez-Sala et al., 2009)
• pTagRFP-RhoB (tRFP-RhoB) and pTagRFP-CINCCKVL (tRFP-8), tRFP 
plasmids containing a S162T mutation to improve photostability (Shaner et al., 
2008): tRFP-T-RhoB and tRFP-T-8, as well as the triple mutants of GFP-HA-
TC10 (K194N, K195Q, H196N; GFP-TC10-NQN) and GFP-HA-RhoB 
(insertion of KKH after L179, GFP-RhoB-KKH) (Valero et al., 2010)
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1.4.3 Plasmids generated for this work
1.4.3.1 mCherry-8 
 
Analogously to GFP-8, pmCherry-CINCCKVL was generated as described (Pérez-Sala 
2009) using pmCherry-C1 as a template, by attaching the last eight amino acids of 
RhoB, a stop codon, and an EcoRI site to the C-terminus of mCherry cDNA by PCR 
with the following forward and reverse primers, respectively: 
5’-GAGTAGAAGCTTATGGTGAGCAAGGGCGAGGAG-3’
5’-CCGAATTCTAGAGGACCTTGCAACAGTTGATACACTTGTACAGCTCGTC-
CATGC-3’ 
PCR products were digested with HindIII and EcoRI and cloned into pcDNA3.0.
1.4.3.2 pDendra2-CINCCKVL (Dendra-8)
Analogously to mCherry-8, pDendra2-8 was generated using pDendra2-C as a template, 
by attaching the last eight amino acids of RhoB and an EcoRI site to the C-terminus of 
Dendra2 cDNA by PCR with the following forward and reverse primers, respectively: 
5’-GCGCTAGCTCGAGGTACCGC-3’
5’-CCGAGCTCTAGAGGACCTTGCAACAGTTGATACACCACACCTGGCTGG-3’ 
PCR products were digested with HindIII and EcoRI and cloned into pDendra2-C.
1.4.3.3 mCherry-HA-RhoB
The cDNA of HA-RhoB was obtained from pEGFP-HA-RhoB by digestion with BglII 
and EcoRI. The fragment was purified and ligated with pmCherry-C1 previously 
digested with the same restriction enzymes.
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1.4.3.4 Plasmids generated by site-directed mutagenesis
• pEZ-mCh-CD63 Y235A and pEZ-GFP-CD63 Y235A: Mutation of the YXXF
motif tyrosine in CD63 was performed in both pEZ-mCherry-CD63 and pEZ-
GFP-CD63 WT plasmids using the following oligonucleotides:
5’-CTCGAGCTACATCACCTCGGCGCCACTTCTGATACTCTTC-3’
5’-GAAGAGTATCAGAAGTGGCGCCGAGGTGATGTAGCTCGAG-3’
2. Methods
2.1 Cell culture
The following cell lines were used throughout this work and cultured as described:
• HeLa adenocarcinoma cells from the American Type Culture Collection 
(ATCC) were cultured in DMEM supplemented with 10% FBS, 100 U/ml 
penicillin and 100 µg/ml streptomycin at 37ºC in an atmosphere with 5% CO2.
• Bovine aortic endothelial cells (BAEC) were obtained from Lonza and cultured 
in RPMI1640 medium supplemented with penicillin/streptomycin and 10% calf 
serum at 37ºC, 5% CO2. BAEC were used between passages 5 and 12 and were 
grown to near confluence for experiments.
• Human primary fibroblasts from healthy subjects (AG09309 and AG10803), 
CHS patients (GM02075), NPC1 patients (GM03123) and HPS-2 patients
(GM17890) were obtained from the NIGMS Human Genetic Cell Repository at 
the Coriell Institute for Medical Research, cultured in DMEM supplemented 
with 10% FBS and penicillin/ streptomycin at 37ºC, 5% CO2 and used up to 
passage 20. 
• Xenopus laevis A6 cells were obtained from Sigma and cultured at 28ºC in NCTC 
109 medium supplemented with 15% distilled H2O, 2 mM glutamine, 10% FBS 
and penicillin/ streptomycin.
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• High Five cells, derived from ovarian cells of the cabbage looper Trichoplusia ni, 
were from Invitrogen. These cells were cultured at 28ºC in TC100 medium 
supplemented with 10% FBS, penicillin/ streptomycin and 10 μg/ml gentamycin.
All cell lines were passaged by trypsin-EDTA detachment, complete medium wash and 
centrifugation at 1000xg for 5 min, suspension in fresh medium, and plating at the 
desired dilution.
2.1.1 Aspergillus nidulans culture
Aspergillus nidulans was cultured in complete medium (MCA) or synthetic complete 
medium (SC) containing 1% glucose and 5 mM ammonium tartrate (i.e. 10 mM NH4+) 
as carbon and nitrogen sources, respectively. GFP-8 and GFP-8-C239S,C242S were 
expressed under the control of the gpdAmini promoter, using a single-copy integration 
construct targeted to pyroA, as described previously (Pantazopoulou and Peñalva, 
2009).
Strains used in this work:
• MAD690: yA2; argB2::[argB*-alcAP::GFP]; pantoB100
• MAD4689: wA2; pyroA4::[pyroA*-gpdAmini::GFP-8]; pantoB100
• MAD4688: wA2; pyroA4::[pyroA*-gpdAmini::GFP-8-C239S,C242S]; pantoB100
2.2 Cell treatments
Treatments with the various agents described in each section were performed in 
the absence of serum, unless otherwise stated. As has been described for BAEC, this 
situation induces a near-quiescent state and does not reduce cell viability (Hernández-
Perera et al. 1998). Control cells received an equivalent amount of vehicle as required. 
• Inhibition of GTPase isoprenylation was elicited by treatment with 10 µM 
simvastatin for 24 h.
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• Palmitoylation was inhibited using 2-bromopalmitate (2-BP) at 20 µM for 6 h. 
• In order to disrupt the endolysosomal pathway, cells were treated with 10 µM 
chloroquine or U18666A for 20 h.
• For proteasome blockage, Z-LLL at 5 µM was used for 24 h.
• For cholesterol depletion, ZGA was added at 50 or 100 µM for 24 h, as indicated.
• Secretion was induced by treatment with C6 ceramide at 10 µM for 24h, using 
dihydroceramide C6 at the same concentration as control.
• For induction of autophagy, cells were incubated in amino acid-free medium 
(EBSS) for the times indicated. All further treatments and staining procedures 
were performed also in this medium to avoid autophagy reversion. 
2.3 Transient transfections
Transient cell transfection was carried out at 80% confluence with Lipofectamine 
2000 following the instructions of the manufacturer, i.e. using 1 μg of DNA and 3 μl 
(single transfections) or 4.5 μl (double transfections) of Lipofectamine per p35 dish. 
Unless otherwise indicated, after transfection, cells were allowed to recover for 24 h in 
complete medium before treatment with the indicated agents in the absence of serum. 
Imaging of live cells or biochemical analysis was performed 48 h after transfection to 
minimize its effects. 
2.4 Cell lysis
2.4.1 Lysis of mammalian cells
In preparation for SDS-PAGE, cells were homogenized by forced passes through 
a 26½-gauge needle in lysis buffer containing 50 mM Tris, pH 7.5, 0.1 mM EDTA, 0.1 
mM EGTA, 0.5% SDS, 0.1 mM β-mercaptoethanol, 50 mM sodium fluoride and 0.1 
mM sodium orthovanadate with 2 µg/ml of the protease inhibitors leupeptin and 
aprotinin as well as 1.3 mM Pefabloc prior to boiling at 95ºC for 5 min. Lysates for 
subcellular fractionation were obtained in the same buffer, without SDS. Alternatively, 
cells were scraped with a rubber scraper and directly lysed in Laemmli sample buffer
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containing the protease and phosphatase inhibitors mentioned above by boiling at 95ºC 
for 5 min prior to gel loading.
For immunoprecipitation procedures, cells were lysed in 
radioimmunoprecipitation assay (RIPA) buffer, i.e. 10 mM Tris/Cl pH 7.5, 150 mM 
NaCl, 0.5 mM EDTA, 0.1% SDS, 1% NP-40, 0.5% deoxycholate plus protease and 
phosphatase inhibitors.
2.4.2 Aspergillus nidulans lysis
Total protein extracts of the A. nidulans strains used in this work were obtained 
from 200-250 mg of mycelium filtered through Miracloth (22-25 μm pore), drained, 
frozen in dry ice and lyophilized. The lyophilized mycelium was ruptured by a 10 
second pulse in the FP120 Fast Prep Cell Disruptor (BIO101/Savant) at 4ºC using a 0.55 
cm ceramic sphere. Pulverized mycelium was resuspended in alkaline lysis buffer 
containing 0.2 M NaOH and 0.2% b-mercaptoethanol. Proteins were precipitated by 
adding trichloroacetic acid to 7.5% and incubation on ice for 10 min. Samples were 
centrifuged at 14000 rpm for 5 min at 4 ºC and the resulting pellet was neutralized with 
Tris Base at 1 M. Laemmli sample buffer with protease inhibitors was added to samples, 
which were vortexed and boiled at 100ºC for 2 min prior to loading on 12.5% 
polyacrylamide gels containing 0.1% SDS. 
2.5 Western blotting (WB)
Protein concentration was estimated by the BCA method. Volumes equivalent to 
20 µg of protein were run on 12.5 or 15% SDS-polyacrylamide electrophoresis gels and 
transferred to Immobilon-P membranes using a semi-dry, Whatman filter-based 
method. The proteins of interest were visualized using an ECL detection system. Protein 
levels were estimated by image scanning of the ECL exposures and their values were 
corrected by the band intensities of the signal given by an antibody against a non-related 
protein, where indicated. Blots were quantified using ImageJ software (US National 
Institutes of Health, Bethesda, MD, USA).
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Direct binding of DBB to recombinant proteins was assessed by visualization of 
the gel under UV light on a Gel-Doc XR Imaging System (Bio-Rad), as described (Sinz 
and Wang, 2001). Unbound DBB, which is essentially non-fluorescent, becomes 
fluorescent upon cysteine cross-linking (excitation maximum=385 nm, emission=477 
nm).
2.6 Subcellular fractionation
For S100/P100 fractionation, total cell lysates were obtained by disrupting cells 
in the detergent-free buffer described above. Lysates were centrifuged at 1000xg for 5 
min at 4 °C. Post-nuclear supernatants were further subjected to ultracentrifugation at 
100,000xg for 1 h at 4 °C to obtain soluble and membrane cellular fractions. 
Supernatants (S100) were collected and pellets (P100) were resuspended in lysis buffer 
containing 1% NP-40 and 0.1% SDS. These fractions were loaded onto gels for WB, as 
described above.
2.7 Gene knock-down using siRNA
HeLa cells were depleted of ESCRT components the day after plating by 
transfection with 75 nM Hrs siRNA or 25 nM Tsg101 siRNA, and control cells were 
transfected with 50 nM scrambled (scr) siRNA using Lipofectamine RNAiMax 
according to the manufacturer’s instructions. Cells were re-plated after 3 days, 
transfected with fluorescent constructs and grown for an additional 2 days before either 
live microscopy visualization or cell lysis and WB.
The following siRNA sequences were used:
Hrs: 5’-CGACAAGAACCCACACGUC-3’
Tsg101: 5’-CCGUUUAGAUCAAGAAGUAUU-3’
Scrambled siRNA was a double-stranded 21-mer RNA that does not correspond 
to any sequence encoded in the human genome. 
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2.8 Pull-down assays
GFP fusion proteins were immunoprecipitated using GFP-Trap agarose beads. 
After the described lysis, incubation with GFP-Trap took place for 1 h at 4ºC. Beads 
were washed three times with detergent-free lysis buffer and eluted with Laemmli 
sample buffer for 10 min at 95ºC. WB was performed on non-bound (not shown) and 
eluates as well as total lysates to assess protein retention.
2.9 Live cell microscopy
2.9.1 Confocal microscopy
For live visualization, cells were cultured on glass-bottom dishes, transfected 
with fluorescent constructs, treated with the indicated agents and visualized directly on 
a confocal microscope, either Leica DMRE2, Leica SP5 or Zeiss LSM 810 equipped with 
405, 488, 568 and 642 nm diode lasers. Unless otherwise stated, images shown are single 
channels or overlays of single Z-sections for co-localization visualization. All 
experiments were repeated at least three times and representative results are shown. 
Scale bars represent 20 μm.
For live lysosome tracking, cells were stained with 25 nM LTR for 15 min at 
37ºC. When staining with other lysosomal or autophagosomal probes such as Lyso-ID 
or Cyto-ID, images were obtained shortly after staining to minimize loss of 
fluorescence. Care was taken to briefly observe cells under the UV lamp before imaging 
to minimize fading of the probes. Lyso-ID and Cyto-ID were diluted in the total volume 
of serum-free culture medium to be used for staining at 37 °C for 30 min to maintain 
endothelial cell morphology and viability during cell imaging. In experiments in which 
autophagy was induced by incubation of cells in EBSS, staining and washing (for 
autophagy reversion experiments) was also performed in this medium. In the case of 
Cyto-ID/LTR co-staining, LTR was added to the medium of cells that had been 
incubated with Cyto-ID for 15 min, left for an additional 15 min to co-stain and 
visualized immediately afterwards. 
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2.9.2 Super-resolution microscopy
In vivo super-resolution 3D structured illumination microscopy (SIM) imaging 
was performed on a Deltavision OMX V4 system (Applied Precision, GE Healthcare) 
equipped with an Olympus 60x NA 1.42 objective, cooled sCMOS cameras and 405, 
488, 568 and 642 nm diode lasers. Z-stacks covering the whole cell were recorded with a 
Z-spacing of 125 nm. A total of 15 raw images (5 phases, 3 rotations) per plane were 
collected. Reconstruction and alignment of these raw images was performed using 
Softworx software (Applied Precision, GE Healthcare company).
2.9.3 Photoswitchable fluorescent protein tracking
Dendra-8 photoswitching and isoprenylation inhibition-and-release 
experiments were performed on transfected BAEC on glass-bottom dishes. The 
transfection medium was removed after 5 hours and replaced with serum-free medium 
with or without 10 μM simvastatin. Cells were observed 24 hours post-treatment on the 
Leica SP2 confocal microscope and photoswitching was performed by exposure to 405 
nm UV light. The resulting green-to-red conversion was recorded in both channels. 
Simvastatin was either added or removed to the corresponding dishes in serum-free 
medium and photoconverted, red Dendra-8 was tracked 24 hours later by confocal 
microscopy. 
2.9.4 Aspergillus nidulans microscopy
For microscopy experiments in Aspergillus, hyphae were cultured in Lab-Tek 
chambers (Thermo Fischer Scientific, 115411; 0.3 ml of medium per well) at 25–28°C in 
pH 6.5 ‘watch minimal medium’ (WMM) containing 100 mM sodium acetate and 5 
mM ammonium tartrate as carbon and nitrogen sources, respectively. Hyphae were 
visualized on an inverted fluorescence microscope (Leica DMI6000B) equipped with an 
EL6000 external light source with metal halide lamp epifluorescence excitation, driven 
by Metamorph® software (Molecular Dynamics) and coupled to a CCD camera (ORCA 
ER-II; Hamamatsu). Vacuoles were detected with CMAC.
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2.9.5 Image analysis
Co-localization analysis was performed with LAS-AF software from Leica on 
single z-sections of images to obtain co-localization rates (expressed as percentages) and 
Pearson coefficients (coefficient r x 100). Alternatively, ImageJ (Fiji) software was used 
to obtain Pearson coefficients. At least 30 cells were analyzed per experimental 
condition. For stained cells, whole-field images were analyzed, whereas in the case of 
transfected cells, regions of interest (ROI) including transfected cells and excluding 
non-transfected cells were delimited prior to image analysis. Results are presented as 
mean co-localization rates or Pearson coefficients ± standard error of mean (SEM). 
2.10 Immunofluorescence
For immunofluorescence with anti-giantin antibody, cells grown on glass 
bottom p35 were fixed in 4% paraformaldehyde for 20 min at room temperature (r.t.), 
washed twice in PBS and permeabilized with 0.05% saponin in PEM buffer (80 mM 
PIPES, 5 mM EGTA, 1 mM MgCl2 pH 6.8) for 5 min. Incubation with anti-giantin at 
1:500 dilution was carried out in PBS containing 0.05% saponin for 1h. After PBS 
washes, cells were incubated with anti-rabbit-Alexa 568 at 1:200 in 1% BSA in PBS for a 
further hour.
For filipin staining, fixed cells were washed 3× with PBS, incubated with 1.5 
mg/mL glycine in PBS for 10 min at room temperature and subsequently with 0.05 
mg/mL filipin in 10% normal goat serum in PBS for 2 h.
2.11 Mass spectrometry
Full-length H-Ras or RhoB protein or the H-Ras K170-K185 peptide were 
incubated at 5 µM in the presence of prostanoids, DBB or PAO at 50 µM or vehicle 
(DMSO) for 1 h. For some experiments, full-length protein incubation mixtures were 
then subjected to digestion with trypsin for 4 h at 37ºC. Purification on ZipTip C18 
(Millipore) was carried out prior to MALDI-TOF MS analysis on an AUTOFLEX III 
MALDI-TOF-TOF instrument (Bruker-Franzen Analytik) operated in the positive 
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mode, as reported in detail (Renedo et al., 2007). Selected peptides were further analyzed 
by MALDI-TOF-TOF MS-MS.
2.12 Statistical analysis
Data for WB quantification or co-localization analysis is shown as mean ± SEM
of at least three independent experiments. Statistical significance was calculated by
Student's t test for unpaired observations. A p value of less than 0.05 was considered 
significant and marked by asterisks, where indicated.
RESULTS 
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1. Structural determinants involved in RhoB endolysosomal 
localization
1.1 Subcellular localization of endosomal GTPases
Previous studies from the laboratory explored the subcellular localization of the 
small GTPase RhoB, as well as the pathways responsible for its degradation. In 
endothelial cells, RhoB is degraded through a lysosomal pathway, as discerned by 
treating cells with selective inhibitors of the major degradation pathways prior to 
protein analysis and microscopy studies (Pérez-Sala et al., 2009). Experiments with 
specific organelle markers using fluorescent RhoB fusion constructs showed RhoB 
association with late endosomal compartments, though their precise nature elicited 
further studies that are included within this section.
1.1.1 RhoB localization at endolysosomes
Several reports have shown that RhoB has a varied cell-type, activation- and 
lipidation-state dependent subcellular localization that comprises the plasma 
membrane, Golgi apparatus, early or late endosomes, MVB and lysosomes (Michaelson 
et al., 2001; Pérez-Sala et al., 2009; Rondanino et al., 2007; Wherlock et al., 2004). 
Therefore, studies were performed to define the basal subcellular localization of this 
GTPase under varying conditions in different cell types, as well as the structural 
determinants that elicit this pleiotropic distribution (Pérez-Sala et al., 2009; Valero et al., 
2010). In order to do so, several fluorescent constructs of wild-type RhoB, i.e. GFP-
RhoB, tRFP-T-RhoB, and mCherry-RhoB were transiently transfected into cells such as 
BAEC, human primary fibroblasts, HeLa cells, and others.
In BAEC, GFP-RhoB as well as a variety of specific organelle markers was
employed to outline the subcellular fate of this GTPase, as shown in Figure 12. Cells 
were treated with the amphiphilic amino-steroid, U18666A, as a pharmacological tool 
to alter late endocytic lipid dynamics and induce membrane invagination into MVB, 
which results in enlarged endolysosomes (Marchetti et al., 2004; Sobo et al., 2007).
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Figure 12. Subcellular distribution of GTPases following U18666A treatment.
(A) BAEC transfected with the indicated constructs were treated with U18666A as described 
in Methods, stained with LTR and observed live by confocal microscopy. Insets show zoom-
ins of areas with dashed lines, from which profiles are derived (right panels). (B) GFP and LTR 
co-localization in U18666A-treated cells is used as an indicator of internalization into acidic
compartments, expressed as percentage of the values compared to untreated cells. *p < 0.05 
versus the same condition in the absence of U18666A.
Staining of the endolysosomal lumen is commonly performed using 
LysoTracker® Red (LTR), which is a widely used cationic amphiphilic drug that marks
acidic compartments (Chazotte, 2011). GFP-RhoB amply co-localizes with this probe in 
many cell types including BAEC (Figure 12), particularly after treatment with U18666A. 
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In sharp contrast, a fusion protein of the early endosomal Rab5 (Bucci et al., 1992), used 
to mark membranes of early endosomes, does not appear at dilated endolysosomes 
induced by U18666A, as shown in Figure 12 by its lack of co-localization with LTR. In 
line with the above results, GFP-Rab5 does not co-localize with RhoB constructs (Pérez-
Sala et al., 2009). However, fluorescently tagged Rab7, which has been shown to
accumulate at late endocytic vesicles (Bucci et al., 2000), is present on endolysosomes, 
though retained at their limiting edge (Figure 12A, see profiles). As summarized from 
several works in Figure 13, endolysosomes containing RhoB constructs are also marked 
by late endocytic markers such as GFP-Rab9, Lamp1-GFP, LBPA, or cholesterol, but not 
considerably by the recycling endosome component, GFP-Rab11 (Patterson and 
Lippincott-Schwartz, 2002; Pérez-Sala et al., 2009; Ullrich et al., 1996; Valero et al., 
2010).
Figure 13. Schematic summary of GFP-RhoB subcellular localization.
A summary of previous work is shown here for conciseness. Full-length RhoB tagged with 
GFP is present at localizations depicted in green but not at those in gray. An orthogonal 
section of a model MVB shows its luminal content, where GFP-RhoB co-localizes with LBPA 
antibodies and cholesterol (stained by filipin). Likewise, the limiting membranes of both MVB 
and lysosomes have been found to be marked by fluorescent constructs of Rab7, Rab9 and 
Lamp1 that coincide with the presence of GFP-RhoB. In the lumen of MVB and lysosomes, 
LTR is found to co-localize with GFP-RhoB, eliciting a patchy, yellowish, red-to-green varied 
coloration. However, RhoB constructs tend not to overlap with the early endosomal 
component Rab5 or with Rab11 residing at recycling endosomes. See text for further details. 
ER, endoplasmic reticulum; N, nucleus.
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Making use of these varied protein and lipid markers, it becomes evident that 
RhoB constructs appear at very specific subcellular sites, namely late endocytic vesicles 
such as MVB, as well as the lysosomal lumen, with varying degrees of plasma membrane 
localization (Figure 13).
1.1.2 Small GTPase C-terminal sequences in subcellular localization
Previous studies from our group established that RhoB degradation via the 
endolysosomal pathway is dependent on the full lipidation of its hypervariable C-
terminus, i.e. isoprenylation and bipalmitoylation (Pérez-Sala et al., 2009; Stamatakis et 
al., 2002). However, several other small GTPases are similarly modified by these three 
lipids at their C-terminal sequences, as shown in Table 3, namely TC10, H-Ras, Rap2A 
or Rap2B.
Table 3. C-terminal sequences of isoprenylated and bipalmitoylated GTPases.
Hypervariable regions of several small GTPases that are isoprenylated at their CAAX cysteine, 
shown in green, and palmitoylated at two other cysteines further upstream, shown in red.
Residues removed by CAAX box proteolysis are shown in gray and basic residues are 
depicted in blue.
The spacing of cysteines amenable to lipidation, as well as the nature of the 
amino acids between them, differs among these proteins (Table 3). To explore the 
subcellular destination of these GTPases, fluorescent constructs were expressed in
BAEC and observed by confocal microscopy. Figure 14 shows the localization of these 
constructs under basal conditions and upon treatment with U18666A compared to that 
of GFP-RhoB. An H-Ras construct shows predominant plasma membrane localization 
instead of accumulation at endolysosomes (Figure 14). This behavior could be due to 
the fact that the two amino acids between the palmitoylatable cysteines in H-Ras are 
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different than those of RhoB. In the case of Rap2 proteins, they become palmitoylated at 
contiguous cysteines, whereas RhoB contains two amino acids that separate these 
cysteines. As shown in Figure 14, this sequence elicits GFP-Rap2B accumulation at the 
limiting membrane of dilated endolysosomes, resulting in lower co-localization with 
LTR compared to GFP-RhoB. Therefore, though these GTPases are all isoprenylated 
and bipalmitoylated, differences in their lipidation sequences or other determinants 
could confer differential subcellular localization.
Figure 14. Localization of isoprenylated and bipalmitoylated GTPases.
BAEC transfected with the indicated constructs were treated as in Figure 12. Zoom-ins are 
shown in the insets. Co-localization of GFP and LTR signals was assessed as in Figure 12. *p 
< 0.05 versus the same condition in the absence of U18666A by Student’s t-test.
RhoB and TC10 are highly homologous proteins (68% homology, 52% identity) 
with obvious differences in the –AAX amino acids of the CAAX box, as well as in the 
hypervariable region, with more basic residues present in TC10 but not RhoB. 
Nevertheless, their lipidation sequences are highly similar. Remarkably, when 
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comparing these proteins, TC10 is retained at the limiting membrane of late endocytic 
vesicles, instead of inside their lumen, as seen for RhoB constructs (Figure 14).
In order to study the structural determinants responsible for the differences 
observed between TC10 and RhoB constructs, protein chimeras of GFP fused to the last 
eight amino acids of these GTPases at its C-terminus were generated. Taking into 
account that the last three amino acids of these sequences would be cleaved after 
isoprenylation, the remaining sequences would be identical, as seen in Table 3. 
Moreover, since both CAAX boxes can undergo isoprenylation by either farnesyl or 
geranylgeranyl, the resulting lipidated chimeric proteins could become completely alike.
Therefore, the chimeric proteins GFP-CINCCKVL (a.k.a. GFP-8, derived from RhoB, 
extensively described in the next section) and GFP-CINCCLIT (referred to as GFP-8-
TC10) become identical once the cysteines have been lipidated. Indeed, as shown in 
Figure 15, the localization patterns of GFP-8 and GFP-8-TC10 are indistinguishable 
both in control cells and after U18666A treatment. 
Figure 15. Localization of chimeric proteins derived from the RhoB or TC10 C-terminus.
BAEC were transfected with constructs obtained by fusing the last eight amino acids of RhoB 
(GFP-8) or TC10 (GFP-8-TC10) to the C-terminus of GFP, treated with U18666A, stained with 
LTR and visualized live by confocal microscopy. The graph shows GFP and LTR co-
localization, as above. *p < 0.05 versus the same condition in the absence of U18666A.
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In light of the results above, the TC10 sequence must contain a sorting motif
upstream of these last amino acids that is responsible for full-length TC10 accumulation 
at the limiting membrane of MVB, as opposed to GFP-8-TC10 predominant 
localization inside endolysosomes. Indeed, TC10 contains a basic amino acid patch, “-
KKH”, that hinders its entry into the lumen of late endocytic compartments (Table 3). 
As seen in Figure 16, mutation of the basic amino acid patch in TC10 (TC10 NQN, 
Figure 16A) promotes entry into the endolysosomal lumen, as reflected by a significant 
increase in co-localization with LTR upon U18666A treatment (Figure 16C). 
Conversely, insertion of the basic amino acid patch into the RhoB sequence (RhoB 
KKH, Figure 16A) retains this chimera at the limiting membrane of endolysosomes
(Figure 16B). 
Figure 16. Role of basic residues in the hypervariable regions of TC10 and RhoB in 
subcellular localization.
(A) Sequences of the GTPase mutants generated by introducing either a basic residue patch 
(blue, in brackets) into RhoB (RhoB KKH) or a neutral amino acid patch (in yellow) into TC10 
(TC10 NQN). Isoprenylation cysteines are shown in green and palmitoylation cysteines in 
red. (B) BAEC transfected with the indicated constructs were treated as above. Insets show 
zoom-ins of areas with dashed lines, from which profiles are derived (right panels). (C) GFP 
and LTR co-localization in U18666A-treated cells was assessed as above. *p < 0.05 versus 
the same condition in the absence of U18666A.
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Therefore, fine-tuned regulation of small GTPase subcellular localization is 
determined by isoprenylation or palmitoylation cysteines and charged or uncharged
amino acids positioned at strictly specific positions within their hypervariable C-
terminal regions. The basic amino acids in TC10 “rescue” the protein from lysosomal 
degradation. Since this motif is not present in RhoB, it is constitutively sent towards the 
lysosome. However, posttranslational modifications altering the charge or the 
interactions of the hypervariable sequence of RhoB could hinder its entry into the 
degradative compartments and change its localization and/or degradation patterns.
1.2 RhoB C-terminus: CINCCKVL
1.2.1 Co-localization with endocytic markers
Studies from the laboratory using BAEC and chimeric fluorescent proteins 
bearing sequentially smaller parts of the RhoB sequence at their C-terminal end, from 
the last 22, 8 to 4 amino acids, determined that the minimum sequence eliciting 
endolysosomal localization and degradation corresponds to the motif that includes all 
three lipidated cysteines and the –CAAX box, namely –CINCCKVL (GFP-8) (Pérez-
Sala et al., 2009). Since subcellular localization mechanisms are finely regulated and may 
be cell type-dependent, localization of GFP-8 was studied in greater detail in several 
additional cell types. 
As shown in Figure 17, in human primary fibroblasts under resting conditions,
co-transfection of tRFP-T-CINCCKVL (tRFP-T-8) with the fluorescent constructs of 
several endocytic components highlighted the appearance of tRFP-T-8 inside vesicles 
surrounded by GFP-Rab7 and Lamp1-GFP. Only marginal co-localization of tRFP-T-8 
was observed with GFP-Rab11, which is used as a recycling endosome marker (Ullrich 
et al., 1996). Co-localization with the early endosome marker, GFP-Rab5 was negligible. 
Therefore, as seen for GFP-8 in BAEC, tRFP-T-8 in human fibroblasts displays a 
predominantly luminal endolysosomal localization, as deduced from the profiles in 
Figure 17.
Results
67
Figure 17. Localization of CINCCKVL chimeras in human primary fibroblasts
Human primary fibroblasts were co-transfected with tRFP-T-8 and the indicated endocytic 
membrane markers and observed live by confocal microscopy after 16 h in serum-depleted 
medium. Zoom-ins of original pictures and fluorescence intensity profiles along a section 
(marked by dotted lines and asterisks) appear to the right of every condition. F.I., 
fluorescence intensity.
The association of CINCCKVL chimeras with endolysosomal compartments was 
also confirmed in the widely used human adenocarcinoma cell line, HeLa. Similarly to 
the results shown in primary fibroblasts, tRFP-T-8 appeared inside Lamp1-GFP-positive 
vesicles in this cell line (Oeste et al., 2014). The specific localization of CINCCKVL 
chimeras in the context of endolysosomes was further pinpointed by co-transfecting 
HeLa with GFP-8 and the mCherry fluorescent construct of CD63, which is used as a 
marker of ILV of MVB. As described in the Introduction, different populations of ILV 
could exist within MVB (Edgar et al., 2014). However, the resolution provided by 
confocal microscopy is not able to discern discrete ILV, so that localization at these 
small vesicles appears as luminal fluorescence within endolysosomes. As seen in Figure 
18, of all the probes and fluorescent proteins used to characterize CINCCKVL chimeras, 
mCherry-CD63 displayed the highest degree of co-localization (Pearson coefficient = 
0.77 ± 0.015).
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Figure 18. GFP-8 co-localization with the MVB marker, mCherry-CD63.
HeLa cells were co-transfected with GFP-8 and mCherry-CD63 and cultured in serum-
depleted medium for 16 h prior to live confocal fluorescence microscopy. Fluorescence 
intensity profiles along a section (marked by dotted lines and asterisks) appear to the right of 
the overlay. F.I., fluorescence intensity.
A closer look at these specific structures was obtained using higher resolution in 
vivo three-dimension structured illumination microscopy (SIM), which provides super-
resolution imaging, as seen in Figure 19. 
Figure 19. Super-resolution imaging of CINCCKVL chimeras.
HeLa cells were transiently transfected with the indicated constructs and stained with LTR as 
indicated in the Methods section, prior to live super-resolution microscopy. Lower panels 
show zoom-ins of compartments with internal vesicles marked by CINCCKVL constructs.
HeLa cells transfected with either GFP-8 or tRFP-T-8 revealed the unequivocal 
presence of these chimeras in vesicles consistent with ILV of MVB (Figure 19). Inside 
these compartments, whereas tRFP-T-8 showed a more diffuse pattern, GFP-8 outlined 
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the inner membranes, which could be due to the decrease in GFP fluorescence resulting 
from its quenching in acidic pH environments (Kneen et al., 1998). It is thus apparent 
that the –CINCCKVL sequence can target proteins to specific domains of
endolysosomes, some of which are ultimately internalized to form vesicles inside MVB.
1.2.2 Lack of –CINCCKVL chimera co-localization with autophagy 
markers
As mentioned earlier, -CINCCKVL-mediated RhoB sorting to endolysosomes 
results in rapid lysosomal degradation, a behavior that also holds for other chimeras 
with this sequence attached to their C-terminal ends (Pérez-Sala et al., 2009). 
Considering the lysosomal degradation fate of RhoB and CINCCKVL chimeras as well 
as the high degree of intracellular crosstalk between endolysosomal and autophagic 
pathways, autophagy could be involved in breakdown of this GTPase and related 
constructs. This degradation pathway is often monitored by microscopy in live cells 
using constructs of the microtubule-associated protein 1 light chain 3 protein, LC3
(Bampton et al., 2005), as shown in Figure 20. 
Figure 20. Lack of co-localization between GFP-8 and the autophagic probe, RFP-LC3.
BAEC were co-transfected with GFP-8 and RFP-LC3 and incubated in serum-free medium 
(control) or amino acid-depleted medium (EBSS) for 20 h prior to live confocal visualization. 
The right panels show fluorescence intensity of the single channels along the lines pictured in 
the images.
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Upon autophagy induction by e.g. amino acid depletion, LC3 becomes lipidated 
by a phosphatidylethanolamine moiety, forming LC3-II (Barth et al., 2010; Kabeya et al., 
2000; Mizushima and Yoshimori, 2007), which attaches to autophagosomal membranes 
that can be readily detected by fluorescence microscopy (Barth et al., 2010; Mizushima 
et al., 2010). Taking advantage of this behavior, RFP-LC3 was co-transfected with GFP-8 
in BAEC (Figure 20), in which the autophagic pathway had not yet been described or 
characterized. We observed that, under normal cell culture conditions, RFP-LC3 
showed a diffuse distribution. Following autophagy induction by incubation in the 
amino-acid free medium, Earle’s Balanced Salt Solution (EBSS), RFP-LC3 adopted a 
punctate pattern characteristic of autophagosome formation. Remarkably, co-
localization of GFP-8 with RFP-LC3 was negligible under both conditions, as shown in 
Figure 20. A similar lack of co-localization with other autophagy markers such as 
monodansylcadaverine or CytoID was also observed (Oeste et al., 2013). These results 
indicate that GFP-8 and LC3-positive vesicles are distinct entities, namely 
endolysosomes and autophagosomes, so that GFP-8 incorporation into the autophagic 
pathway is unlikely.
1.2.3 CINCCKVL chimera endolysosomal localization depends on lipid
modifications 
Membrane association of full-length, endogenous RhoB depends on a series of 
modifications at its C-terminus, including irreversible isoprenylation and reversible 
bipalmitoylation (Adamson et al., 1992). To confirm whether this is the case for 
CINCCKVL chimeras, mutants corresponding to the cysteine residues amenable to lipid 
modification were used in fractionation and microscopy studies. Cells transfected with 
GFP constructs of these mutants were subjected to whole cell lysis (Figure 21, upper 
panels) or subcellular fractionation (Figure 21, lower panels) into S-100 (soluble) or P-
100 (membrane) fractions to assess the extent of membrane attachment. WB analysis 
showed that untagged GFP was fully soluble, whereas GFP-8 was detectable only in the 
membrane fraction. Cysteine mutants that cannot be isoprenylated (GFP-8-C244S) or 
palmitoylated (GFP-8-C241,243S) and therefore have restricted access to membranes 
appear mostly in the soluble fraction, with minimal membrane association. Of note, 
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lower levels of GFP-8 than of GFP or the mutated constructs were detected in whole cell 
lysates (Figure 21, upper panels), consistent with a rapid turnover of this endolysosome-
targeted protein. 
Figure 21. Subcellular fractionation of GFP-8 posttranslational modification mutants.
HeLa cells were transfected with GFP-8 or its indicated lipidation-deficient cysteine mutants. 
Cell lysis and fractionation were performed as described in the Methods section. Upper 
panels show total cell lysates whereas lower panels correspond to chimeric protein levels in 
the soluble (S-100) or particulate (P-100) fraction, assessed by WB with an anti-GFP 
antibody. Hsp90 was used as a loading control and 25 or 100 kDa markers are shown for 
electrophoretic mobility reference.
In order to study membrane localization of CINCCKVL cysteine mutants,
confocal microscopy studies were carried out. In contrast to the high degree of 
localization between GFP-8 and LTR (co-localization rate: 62.6±2.5%), the 
palmitoylation-deficient mutant GFP-8-C241,243S presents a cytosolic distribution that 
excludes the nucleus (Figure 22), as expected for a mono-prenylated construct bearing 
only a CAAX box (Pérez-Sala et al., 2009). Furthermore, the isoprenylation mutant
(GFP-8-C244S) appears as a cytosolic, non-lipidated protein that excludes some small 
organelles, thus following a pattern indistinguishable from that of untagged GFP (Figure 
22, last two panels). This last construct does indeed contain the palmitoylation cysteines, 
but the fact that it does not associate with membranes indicates the dependence of 
palmitoylation on previous isoprenylation and CAAX processing (Wang and Sebti, 
2005). 
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Figure 22. Endolysosomal localization of GFP-8 depends on posttranslational lipidation.
HeLa cells were transfected with GFP-8, its palmitoylation-deficient mutant (GFP-8-
C240,243S), the isoprenylation-deficient mutant (GFP-8-C244S), or untagged GFP. Cells 
were stained with LTR prior to live confocal microscopy observation. 
It has been previously described for several Ras family members that they shuttle 
from the plasma membrane to the Golgi in a palmitoylation-dependent manner (Rocks 
et al., 2005). Indeed, whereas GFP-8 did not present high co-localization with the Golgi 
protein giantin (Figure 23, first panel), in the case of the isoprenylated but
palmitoylation-deficient mutant GFP-8-C241,243S, cells contained cytoplasmic 
accumulations that co-localized to a greater extent with the Golgi (Figure 23, second 
panel). In turn, the isoprenylation mutant as well as untagged GFP showed a similar 
pattern in which Golgi localization was only partial and collateral to its diffuse 
distribution (Figure 23, last two panels). Therefore, Golgi localization of GFP-8 
probably occurs transiently when its CAAX motif has been isoprenylated and awaits 
further processing through bipalmitoylation.
Figure 23. Golgi staining of cells transfected with GFP-8 and its lipidation mutants.
HeLa cells were transfected with the indicated constructs and fixed after 16 h in serum-
depleted medium. The Golgi compartment was marked by immunofluorescence using anti-
giantin antibodies, as explained in Methods.
As a proof of concept, GFP-8 isoprenylation and palmitoylation inhibition were 
carried out pharmacologically rather than through cysteine mutation.  Treatment with 
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2-bromopalmitate to block palmitoylation elicited a GFP-8 subcellular localization 
similar to the corresponding mutant, i.e. diffuse cytosolic and excluding the nucleus 
(Figure 24A, left panel). Similarly, simvastatin treatment for inhibition of isoprenoid 
biosynthesis resulted in a totally diffuse pattern, as observed for the equivalent cysteine 
mutation (Figure 24A, right panel). It is hence possible to pharmacologically modulate 
the selective localization of CINCCKVL proteins to subcellular membranes by 
inhibiting lipidation of the C-terminal cysteines. 
Figure 24. Lipidation inhibition by pharmacological treatment of cells expressing 
CINCCKVL-chimeras.
(A) HeLa cells were transfected with GFP-8 and treated with 2-bromopalmitate to inhibit 
palmitoylation or simvastatin to block isoprenylation, as described in Methods, prior to LTR 
staining and live observation under a confocal microscope. (B) BAEC were transfected with 
Dendra-8 and treated with simvastatin for 24 h (left panel) prior to UV light exposure to 
induce green-to-red photoswitching (middle panel). Simvastatin was removed directly after 
photoswitching and 24 h later subcellular localization of the photoconverted red protein was 
monitored (right panel).
A question that remains unanswered in this field is whether lipid 
posttranslational modifications occur only on newly synthesized proteins, or whether a 
previously existing pool of non-lipidated protein in the cytosol can be processed and 
subsequently attach to membranes. As seen above, simvastatin treatment elicits a fully 
cytosolic population of GFP-8 and can therefore be used to address this issue. 
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Furthermore, the photoswitchable fluorescent protein Dendra2 switches from green to 
red fluorescence emission after UV light exposure and can be used to track transfected 
cells before and after photoexcitation. Taking advantage of these tools, BAEC were 
transfected with a Dendra2-CINCCKVL fusion protein (Dendra-8) and treated with 
simvastatin to obtain a pool of green, fully cytosolic construct with no lipid 
modifications (Figure 24B, left). Specific cells were then exposed to UV light on a 
confocal microscope for photoswitching, providing a pool of red, unprocessed Dendra-8 
to be followed (Figure 24B, middle). Simvastatin was removed immediately following 
green to red conversion to release isoprenylation inhibition, which, as shown in Figure 
24, right, allowed endolysosomal targeting of the red protein that had previously been 
diffuse throughout the cytosol. Therefore, pre-existing cytosolic CINCCKVL proteins 
may be sorted to endolysosomal localizations upon C-terminal processing, indicating 
that this process does not need to occur directly on nascent proteins. 
1.3 CINCCKVL sorting is conserved from fungi to human cell models
We have shown that RhoB and CINCCKVL-chimeric proteins are targeted to 
endolysosomal membranes in several mammalian cell types, including human primary 
fibroblasts, HeLa cells or BAEC. This behavior is consistent with the fact that the C-
terminal sequence of RhoB is conserved in mammalian species and birds (Table 4), 
which must necessarily contain the cellular machinery required for RhoB sorting. 
However, organisms from other branches of evolution contain either a RhoB protein 
with a different C-terminal sequence or Ras- or Rho-related proteins with similarities to 
RhoB that have not been identified as bona fide RhoB homologs (Table 4). These 
proteins contain CAAX boxes and nearby cysteines that could become palmitoylated, 
but the different spacing between these residues along with other structural 
determinants could elicit unique subcellular localization patterns, as seen in Section 1.1
for other GTPases. It was therefore uncertain whether non-mammalian organisms that 
do not present the CINCCKVL sequence in any of their proteins could sort these 
chimeras to their specific endolysosomal/MVB destinations.
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Table 4. C-terminal sequences of CINCCKVL chimeras, RhoB homologs and related 
proteins from diverse species.
On top, the C-terminal sequences of GFP-8 and tRFP-T-8 are shown. Below, several RhoB 
homologs or related proteins along with their PubMed accession numbers and their C-
terminal sequences. In red, potential palmitoylation sites. In green, isoprenylation cysteines.
1.3.1 CINCCKVL sorting in amphibian and insect cells
Within the genome of the amphibian Xenopus laevis, an endogenous RhoB 
protein is encoded with a C-terminal sequence that encloses several distinct structural 
features (Table 4). Though it presents a very similar CAAX box and two cysteines 
spaced similarly to human RhoB, the two amino acids between the palmitoylatable 
cysteines differ. Where human RhoB reads “IN”, Xenopus RhoB contains the amino 
acids “MS”, similarly to the H-Ras sequence that elicits binding to the plasma 
membrane, primarily. Furthermore, Xenopus RhoB contains the basic amino acid patch
“KKH” upstream of the lipidated cysteines, reminiscent of the human TC10 protein, 
which is retained at the limiting membrane of endolysosomes. The effect of these 
unique structural determinants was assessed by transfection of Xenopus epithelial A6 
cells with GFP tagged Xenopus RhoB (GFP-RhoB X), as seen in Figure 25A, left panel. 
Compared to the typical endolysosomal localization of GFP-8 (Figure 25A, middle 
panel) and consistent with its H-Ras- and TC10-like motifs, GFP-RhoB X appears 
mainly at the plasma membrane and scarcely at endolysosomes, as underscored by its 
low co-localization with LTR (Figure 25A, right panel). However, human GFP-RhoB 
and tRFP-T-8 are still sorted to endolysosomes, as gathered from their mutual co-
localization as well as overlap of the latter with Lamp1-GFP (Figure 25B).
Species Protein Accession no. C-terminal sequence
(synthetic construct) GFP-8 N/A TAAGITLGMDELYKCINCCKVL
(synthetic construct) tRFP-T-8 N/A RYCDLPSKLGHKLNCINCCKVL
Homo sapiens RhoB NM_004040 TRAALQKRYGSQNGCINCCKVL
Bos taurus RhoB NM_001077922 TRAALQKRYGSQNGCINCCKVL
Mus musculus RhoB AF481943 TRAALQKRYGSQNGCINCCKVL
Gallus gallus RhoB NM_204909.1 TRAALQKRYGTQNGCINCCKVL
Xenopus laevis RhoB NM_001096461.1 TRAALQKKHGRSGECMSCCKLL
Drosophila mojavensis uncharacterized CH933808.1 TRASLQVKKRKKRSGCWSLSCKLL 
Schizosaccharomyces pombe Rho2 NM_001019998.3 TRAALTVRDSENDKSSTKCCIIS
Aspergillus fumigatus RasA XM_748433 TRAPEGKMDVSEPGDNAGCCGKCVIM
Aspergillus nidulans uncharacterized AN4953 TRAALLTFDKRKSSCCIVL
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It is thus apparent that the combination of sorting motifs in Xenopus RhoB 
elicits a localization pattern distinct from both human RhoB and CINCCKVL chimeras. 
Nevertheless, Xenopus cells are able to sort proteins derived from the human RhoB C-
terminus though they do not code for this sequence endogenously. 
Figure 25. Localization of RhoB-related proteins in amphibian cells.
(A) Xenopus laevis A6 cells were transfected with Xenopus laevis RhoB (GFP-RhoB X) or GFP-
8 and stained with LTR. GFP/LTR co-localization is shown in the right panel as Pearson 
coefficients (x100) or co-localization rates (in percentages). Asterisks represent p<1 x 10-6 
versus GFP-8 (B) A6 cells were co-transfected with human GFP-RhoB or Lamp1-GFP and 
tRFP-T-8.
Going further down the evolutionary scale to assess the ability of different 
organisms to sort CINCCKVL chimeras to the late endocytic pathway, cells of the 
invertebrate Trichoplusia ni were transfected with tRFP-T-8. The High Five insect cell 
line showed tRFP-T-8 sorted into vesicles surrounded by Lamp1-GFP, marking their 
lysosomal character (Figure 26).
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Figure 26. Localization of tRFP-T-8 in High Five insect cells.
High Five cells derived from the cabbage looper Trichoplusia ni were co-transfected with 
Lamp1-GFP and tRFP-T-8 before live observation by confocal microscopy. The left panel 
shows overlays of single fluorescent channels to which the Differential Interference Contrast
(DIC) image has been juxtaposed in the right panel.
In the insect species Drosophila mojavensis, an uncharacterized protein
containing a CAAX box, an extended basic amino acid patch and only one 
palmitoylatable cysteine among heterogeneous residues may be found (see Table 4). 
However, Trichoplusia ni, from which High Five cells are derived, does not encode an 
endogenous RhoB protein. Nonetheless, the structural determinants of the CINCCKVL 
sequence are robust enough to bestow endolysosomal localization upon its chimeras in 
this organism, as well.
1.3.2 CINCCKVL localization in Aspergillus nidulans
Though palmitoylation occurs on a multitude of proteins and is highly 
conserved throughout evolution, the mechanisms responsible for this process have
remained elusive (Aicart-Ramos et al., 2011). Actually, palmitoyl transferases were 
discovered roughly a decade ago in yeast (Lobo et al., 2002; Roth et al., 2002), where 
many crucial proteins undergo this posttranslational modification to regulate their 
subcellular localization (Roth et al., 2006). A putative Rho-related protein bearing a 
CAAX box and a possible palmitoylation site is expressed in the fungus Aspergillus 
nidulans (Table 4), but the CINCCKVL motif does not appear in its proteome. To 
explore whether CINCCKVL sorting can take place in this compelling model organism 
for vesicular trafficking, Aspergillus nidulans strains expressing GFP-8 and its 
palmitoylation-deficient mutant were established (Figure 27). 
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Figure 27. GFP-8 and its palmitoylation mutant in Aspergillus nidulans.
Aspergillus nidulans strains established by transformation with GFP-8 (A) or its palmitoylation 
deficient mutant GFP-8-C240,243S (B) were observed live as described in Methods. Staining 
with the vacuole marker CMAC is shown in the middle panels and overlays in the bottom 
panels. Gray scale insets of yellow boxed-in areas are shown for better contrast. (C) 
Aspergillus nidulans strains expressing the indicated constructs were processed for SDS-PAGE
and WB using a GFP antibody. Dotted lines indicate a 5-fold shorter exposure time for the 
last lane than the two preceding ones. The 25 kDa marker is shown for reference.
In the wild-type strain, GFP-8 appears at the plasma membrane as well as in late 
endosomes and vacuoles stained by the acidic organelle marker CMAC (Figure 27A). In 
contrast, its palmitoylation-deficient mutant GFP-8-C240,243S is cytosolic and 
excluded from nuclei, the plasma membrane and CMAC-positive compartments 
(Figure 27B). Dependence on posttranslational modifications for targeting is similar to 
that observed in human cells, in which isoprenylation alone is also unable to elicit 
endolysosomal localization. Lack of GFP-8-C240,243S processing is further evidenced 
by the appearance of a doublet of slower migrating bands in SDS-PAGE, as described 
for other Ras superfamily proteins in mammalian cells (Hancock et al., 1989), and
shown in Figure 27C. Indeed, levels of the mutant are significantly higher than those of 
fully lipidated GFP-8, which could be undergoing constitutive vacuolar degradation 
analogous to its lysosomal degradation in mammalian cells (see Figure 27C, caption). 
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Moreover, GFP-8 and GFP-8-C240,243S localization patterns are distinct from that of 
untagged GFP, which appears diffusely throughout the cytoplasm and nucleus, similarly 
to mammalian cells (not shown).  
The filamentous nature of Aspergillus nidulans makes it a highly suitable model 
for tracking the movement of endocytic organelles by time-lapse microscopy (Peñalva et 
al., 2012). Indeed, GFP-8-positive vesicles could be readily detected travelling within the 
cell, avoiding nuclei and possibly fusing with large vacuoles also presenting GFP-8 
fluorescence (Figure 28A, colored arrows and black arrowhead).
Figure 28. Tracking GFP-8-positive compartments in Aspergillus nidulans.
(A) The Aspergillus nidulans GFP-8 strain was observed live to follow localization of the 
construct by time-lapse microscopy. The plasma membrane is marked by GFP-8, as well as a 
large, sessile vacuole (black arrowhead in all frames). Smaller, motile vesicles also contain 
GFP-8 (colored arrows). The vesicle marked by a red arrow undergoes both basipetal and 
acropetal movement, whereas the teal-colored arrow follows a vesicle with acropetal 
movement only, which is not detectable in the second frame due to movement along the z-
axis. (B) Kymograph showing GFP-8-positive compartments in motion from a representative 
experiment using a GFP-8-expressing strain. Black arrows highlight fast-moving vesicles, 
whereas black arrowheads mark static vesicles. Asterisks mark possible points of contact or 
fusion between them. (C) Velocities of individual endosomes travelling in both directions 
were tracked and are represented in the graph. See text for details.
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Fluorescent vesicles can be tracked and their trajectories represented by using 
kymographs, as shown for GFP-8-positive vesicles of a representative cell in Figure 28B. 
Thick, straight lines correspond to large, sessile vacuoles (Figure 28B, arrowheads) 
whereas thin, diagonal lines trace several smaller, fast-moving endosomes (Figure 28B, 
arrows). Both of these contours come together at certain points that could be indicative 
of endosome-vacuole fusions (Figure 28B, asterisks). Furthermore, the speed of 
individual endosomes can be calculated from this type of representation by calculating 
the slope of their trajectory, be it basipetal or acropetal (Figure 28C). Similar average 
speeds of approximately 1 to 3 µm per second for GFP-8-containing endosomes in both 
directions, i.e. fully bidirectional movement, suggests that trafficking of these fast and 
small vesicles is dependent on microtubules, as has been previously described for other 
vesicles (Abenza et al., 2012; Abenza et al., 2009). Taken together, these results highlight 
the presence of GFP-8 along the endocytic pathway in Aspergillus nidulans and imply 
that CINCCKVL sorting occurs through mechanisms conserved in fungi, as well.
2. Mechanisms potentially involved in RhoB sorting
RhoB fluorescent constructs show a very specific subcellular localization at ILV 
of MVB and lysosomes as well as the plasma membrane, as summarized in Section 1.1.1. 
This behavior indicates that RhoB follows an endocytic route and accumulates at late 
compartments to which several sorting machineries escort their cargo, as described in 
the Introduction (see Figure 9). Therefore, this section comprises studies that attempt to 
elucidate specific mechanisms involved in driving RhoB constructs and related chimeras 
to their subcellular destinations, including ILV or the lysosomal lumen, by focusing on 
protein machineries as well as lipid dynamics.
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2.1 Role of the ESCRT machinery in RhoB sorting
The canonical pathway for proteins that enter MVB to be degraded in the 
lysosome is often represented by ESCRT-mediated internalization of EGFR upon cell 
stimulation with its agonist. Indeed, RhoB has been shown to be involved in EGFR 
trafficking in several cell types and its expression is upregulated by EGF stimulation 
(Canguilhem et al., 2005; Gampel et al., 1999; Lajoie-Mazenc et al., 2008; Tillement et 
al., 2008). It could be the case that RhoB associates with vesicles on which EGFR travels 
and therefore follows a similar ESCRT-mediated internalization pathway. Therefore,
experiments were carried out in cells in which ESCRT components were altered to study
potential ESCRT involvement in sorting of RhoB and its related chimeras. 
2.1.1 ESCRT-related processes in sorting of RhoB and related chimeras
ESCRT complexes act sequentially beginning with recognition of ubiquitin by 
Hrs (the core ESCRT-0 protein) and ending with ESCRT-III disassembly mediated by 
the ATPase, Vps4. These two major events were approached experimentally in the 
context of cells expressing RhoB constructs to initially evaluate whether the ESCRT 
machinery could play a role in their sorting.
There are few studies in which RhoB ubiquitination has been addressed, and 
those in which RhoB has been found to be ubiquitinated show that this is a cell type-
and context-dependent process (Engel et al., 1998; Wang et al., 2014). To establish 
whether the fluorescent constructs used throughout this study were ubiquitinated, they 
were expressed in HeLa cells and immunoprecipitated to assay ubiquitin association, as 
shown in Figure 29. Neither GFP-RhoB nor GFP-8 samples presented signals 
compatible with ubiquitinated forms of these constructs. Interestingly, the construct 
GFP-22, which contains a lysine residue potentially susceptible to ubiquitination, was 
the only sample showing a putative mono-ubiquitinated species, marked by an asterisk 
in Figure 29A. 
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Figure 29. Ubiquitination assays by immunoprecipitation of RhoB constructs.
(A) HeLa cells were transfected with the indicated agents and immunoprecipitated using GFP 
antibodies conjugated with agarose beads (GFP-Trap) as described in the Methods section.
Immunoblots were performed against the indicated proteins. Arrowheads highlight unspecific 
signals, possibly representing keratin doublets. The asterisk marks faint signals detected
consistently in GFP-22 samples. (B) Whole cell lysates (WCL) of samples shown in (A).
Arrows mark the GFP and GFP-8 signals.
Therefore, if GFP-RhoB and/or GFP-8 are ubiquitinated, they are so at levels 
that are undetectable under basal conditions in this type of assay.  However, ubiquitin-
independent, ESCRT-dependent sorting into ILV of MVB has been previously 
described (Babst, 2011), as discussed in the Introduction. The ESCRT-associated 
component, Vps4, was consequently addressed in cells in which the last step of ILV 
formation was impaired, namely, HeLa cells transfected with a dominant negative form 
of this protein (Figure 30). 
In HeLa cells, transfection of the wild-type GFP-Vps4 construct presents a 
diffuse pattern throughout the cytosol and does not affect localization at endolysosomes 
of tRFP-T-RhoB (Figure 30A, top panels) or tRFP-T-8 (not shown), either under 
control conditions or upon treatment with chloroquine. However, overexpression of 
dominant negative GFP-Vps4 hinders tRFP-T-RhoB entry into vesicular structures, as 
shown in the bottom panels of Figure 30A and its profiles. Instead, fluorescent RhoB 
constructs are mislocalized to the limiting membrane of vesicles formed upon GFP-
Vps4 DN expression, defined as aberrant Class E compartments (Bishop and 
Woodman, 2000), recapitulating the results obtained in BAEC (Pérez-Sala et al., 2009).
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Figure 30. Effect of GFP-Vps4 DN overexpression on RhoB and CINCCKVL chimera
localization.
HeLa cells were co-transfected with the indicated constructs and treated with chloroquine for 
24 h where specified prior to live confocal microscopy observation. Underneath the panels 
of cells expressing GFP-Vps4 DN, fluorescence intensity profiles along a section marked by 
dotted lines and asterisks are shown. F.I., fluorescence intensity.
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In contrast, the CINCCKVL construct, tRFP-T-8 is able to enter into the lumen 
of these compartments in cells expressing the dominant negative mutant of Vps4, as 
shown in Figure 30B (see profiles). These results point to a possible role for ESCRT 
proteins in RhoB sorting, so that further studies concerning the ESCRT machinery per 
se were carried out in HeLa cells, as shown below.
2.1.2 ESCRT component depletion in RhoB and –CINCCKVL protein
sorting
To further substantiate the role of ESCRT proteins, either control (scr) siRNA or 
siRNA against either the ESCRT-0 component Hrs or the ESCRT-I protein Tsg101 was 
transfected into cells to reduce protein levels prior to expression of GFP-RhoB or GFP-8
and chloroquine treatment. The efficiency of ESCRT silencing was analyzed in these 
cells by SDS-PAGE and WB. As shown in Figure 31A, cells transfected with Hrs-specific 
siRNA were practically devoid of this ESCRT component as compared to their control 
(scr). In turn, Tsg101 silencing reduced its protein levels by 72.2 ± 5.3% (Figure 31B). 
Figure 31. Depletion of ESCRT components by specific siRNA.
(A) HeLa cells were transfected with scrambled (scr) or Hrs-targeted siRNA. Cell lysis was 
carried out 48 h later and WB against Hrs is shown. (B) Tsg101 levels were assessed 
similarly to (A). 50 and 100 kDa markers are shown for reference.
As shown by confocal microscopy analysis in Figure 32A, HeLa cells transfected 
with control siRNA (scr) were able to sort GFP-RhoB to LTR-positive vesicles, as seen 
above for several cell types. However, knock-down of the ESCRT-0 component, Hrs or 
the ESCRT-I component, Tsg101 reduced the appearance of GFP-RhoB at acidic 
vesicles (Figure 32A, see profiles).
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Figure 32. Knock-down of the ESCRT components Hrs or Tsg101 and their effect on 
localization of RhoB fluorescent constructs.
(A) HeLa cells were transfected with either scrambled siRNA (scr) or siRNA targeting either 
Hrs or Tsg101 to silence these ESCRT components, replated, and transfected with GFP-RhoB. 
Cells were treated with chloroquine to induce accumulation at endolysosomes, stained with
LTR and observed live by confocal microscopy. Fluorescence intensity profiles along a 
section (marked by dotted lines and asterisks) appear underneath each condition. KD, knock-
down; F.I., fluorescence intensity. (B) HeLa cells transfected with either scrambled siRNA 
(scr) or siRNA targeting Hrs were further co-transfected with tRFP-T-RhoB and Lamp-GFP. 
After 24 h of chloroquine treatment, they were visualized live by structured illumination 
super-resolution microscopy (SIM). Insets show individual MVB and their ILV decorated with 
RhoB fluorescent protein. The right panel inset highlights the emptier MVB that appear upon 
Hrs knock-down.
To explore the effect of Hrs knock-down on sorting of RhoB constructs in more 
detail, the red tRFP-T-RhoB construct was co-transfected with Lamp1-GFP in cells in 
which Hrs was silenced and observed live under a super-resolution microscope (Figure 
32B). Localization of tRFP-T-RhoB at ILV was unmistakably observed in control cells 
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within MVB surrounded by Lamp1-GFP at their limiting membrane (Figure 32B, left 
panel). On the other hand, Hrs knock-down cells presented Lamp1-positive structures 
with a marked reduction of tRFP-T-RhoB inside their lumen, despite treatment with 
chloroquine that usually causes RhoB construct accumulation inside these vesicles 
(Figure 32B, right panel inset). Taken together, these results suggest involvement of 
early ESCRT components in sorting of full-length RhoB constructs.
In order to study the role of the ESCRT machinery on sorting of CINCCKVL 
constructs, assays analogous to those above were performed on cells transfected with 
GFP-8. Strikingly, GFP-8 seemed unaffected by either Hrs or Tsg101 knock-down and 
was still able to enter the lumen of LTR-positive compartments, analogously to its 
control (Figure 33), in contrast to the marked reduction in endolysosomal localization 
detected above for GFP-RhoB.
Figure 33. Knock-down of the ESCRT components Hrs or Tsg101 and their effect on GFP-8 
localization.
HeLa cells transfected with siRNA targeting ESCRT components, transfected with GFP-8 and 
treated with chloroquine prior to LTR staining were observed live by confocal microscopy, 
similarly to Figure 32A. Profiles along a section traced by dotted lines and marked with 
asterisks show intensity profiles underneath each condition. KD, knock-down. F.I., 
fluorescence intensity.
In sum, there appears to be a differential effect of ESCRT component knock-
down as to the subcellular localization of either full-length RhoB constructs or 
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CINCCKVL chimeras (compare Figure 32A to Figure 33). These findings are the first 
studies in which we have encountered dissimilar behavior between full-length RhoB and 
its sorting motif  –CINCCKVL, suggesting that further regulatory determinants in the 
RhoB protein could be involved in ESCRT interaction, whereas –CINCCKVL bypasses 
this regulation and enters ILV of MVB independently of ESCRT.
2.2 Lipid-mediated endolysosomal sorting of CINCCKVL
The results above point to ESCRT involvement in full-length RhoB sorting, 
whereas the C-terminal motif CINCCKVL seems to be targeted to endolysosomes, more 
specifically ILV of MVB, independently of this protein machinery. Considering that ILV 
formation can be ESCRT-dependent or –independent (Section 3.2 of the Introduction), 
other mechanisms possibly involved in CINCCKVL-chimeric protein sorting were 
assessed. Taking advantage of the fact that inward budding from the limiting membrane 
of MVB is regulated by its lipid composition (Matsuo et al., 2004; Trajkovic et al., 2008),
CINCCKVL chimera subcellular localization was monitored in cells treated with several 
compounds that modulate late endosomal lipid dynamics.
The precursor mevalonate is used by cells for membrane cholesterol biosynthesis 
and formation of isoprenoid moieties destined towards protein posttranslational 
modification, as schematized in Figure 34. The mevalonate pathway can be disrupted at 
several stages by blocking key enzymes with inhibitors, such as HMG CoA reductase 
inhibition by statin treatment in cells, which inhibits protein isoprenylation (Figure 34). 
Furthermore, the lysosomotropic agent U18666A inhibits cholesterol synthesis as well 
as its trafficking (Figure 34), thus causing its internalization and accumulation into ILV 
of MVB along with the lipid LBPA, eliciting an NPC-like phenotype (Cenedella, 2009; 
Kobayashi et al., 1999; Sobo et al., 2007). In turn, the squalene synthase inhibitor 
zaragozic acid (Figure 34) reduces cellular cholesterol levels and could affect ILV lipid
composition significantly, since most of the cholesterol of the endocytic pathway is 
contained within these vesicles (Möbius et al., 2003).
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Figure 34. Schematic of the mevalonate pathway and compounds used for its modulation.
Simplified schematic of the mevalonate pathway showing formation of the isoprenylation 
precursors farnesylpyrophosphate and geranylgeranylpyrophosphate, used in protein 
modification. The former can be further processed for cholesterol biosynthesis. In red, 
structures of compounds used in this work to disrupt particular steps of the pathway. Statins 
such as simvastatin, shown here, inhibit HMG-CoA reductase and therefore halt both protein 
isoprenylation and cholesterol biosynthesis. In turn, zaragozic acid blocks squalene synthase, 
blocking subsequent steps of the cholesterol pathway. Similarly, the amphiphilic amino-
steroid U18666A hinders cholesterol synthesis and transport. Truncated arrows represent 
intermediate steps that are not shown here for the sake of clarity.
To assess the effect of lipid alterations in CINCCKVL chimera localization, cells 
transfected with these constructs were treated with U18666A or ZGA and observed live
by confocal microscopy (Figure 35). 
Figure 35. Agents modulating lipid dynamics alter GFP-8 localization.
BAEC transfected with GFP-8 were treated with 10 µM U18666A or 50 µM ZGA for 24 h. 
Insets show zoom-ins and lower panels represent fluorescence intensity profiles (F.I.) along a 
section marked by dotted lines and asterisks. 
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Indeed, these compounds produced drastic phenotypes in several cell types 
including HeLa cells, BAEC and Xenopus laevis cells (Oeste et al., 2014), and the results 
obtained for BAEC are presented here for clarity. As shown in the middle panel of 
Figure 35, cells treated with U18666A displayed intensely compact endolysosomes in 
which GFP-8 accumulated prominently, along with LTR, consistent with results shown 
in Section 1.1. In sharp contrast, ZGA elicited dilated MVB with either scarce, diffuse 
staining with GFP-8 or MVB practically devoid of GFP-8, in which GFP-8 was retained 
at the limiting membranes of MVB and LTR staining was weaker and sometimes patchy 
(Figure 35, right panel profile). However, ZGA treatment of BAEC transfected with 
GFP-RhoB showed dilated MVB with patches of LTR in which this construct seemed to 
enter freely, similarly to its control and conversely to GFP-8, as seen in Figure 36.
Figure 36. GFP-RhoB appears inside MVB in cells treated with ZGA.
BAEC transfected with GFP-RhoB were treated with ZGA and stained with LTR prior to 
confocal microscopy observation, as in Figure 35. Insets show details of vesicles and profiles 
represent fluorescent intensity (F.I.) along sections marked by dotted lines and asterisks.
In order to investigate whether impairment of GFP-8 sorting into the lumen of 
endolysosomes could be due to a reduction of GFP-8 membrane association, we 
performed subcellular fractionation studies (Figure 37). For this we used HeLa cells, in 
which we previously confirmed the inhibitory effect of ZGA on endolysosomal 
internalization of GFP-8 by confocal microscopy (Oeste et al., 2014). As shown in 
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Figure 37, cholesterol depletion does not reduce the levels of membrane-associated 
GFP-8, practically all of which still appears in the particulate (P-100) fraction.
Figure 37. Subcellular fractionation of HeLa cells treated with ZGA.
HeLa cells were transfected with GFP or GFP-8, treated with 100 µM ZGA for 24 h, lysed, 
and fractionation was performed as described in the Methods section. Upper panels show 
total cell lysates whereas lower panels correspond to chimeric protein levels in the soluble 
(S-100) or particulate (P-100) fraction, assessed by WB with an anti-GFP antibody. The 25 
kDa marker is shown for electrophoretic reference.
2.3 The tetraspanin CD63 in RhoB and CINCCKVL sorting
The results shown above suggest that sorting of full-length RhoB constructs is
mediated partly by the ESCRT machinery, whereas CINCCKVL chimeras seem to enter 
ILV of MVB regardless of ESCRT disruption. As described in Section 3.1.3 of the 
Introduction, evidence pointing to ESCRT-independent sorting accumulating in recent 
years indicates a role for CD63 in trafficking to ILV as well as in biogenesis of ILV 
destined for release as exosomes (Pols and Klumperman, 2009). Furthermore, the small 
ILV that still form after Hrs depletion carry CD63 and its cargo (Edgar et al., 2014), so 
that the internalization of GFP-8 into MVB in cells after Hrs knock-down observed 
above in Section 2.1.2 could be CD63-mediated. These findings warranted further 
studies to explore the role of CD63 in sorting of CINCCKVL proteins and full-length 
RhoB.
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2.3.1 Impact of CD63 overexpression on localization of RhoB and 
CINCCKVL constructs
In HeLa cells, RhoB and CD63 constructs co-localize to a very high degree in 
their small endolysosomes, as seen in Figure 18. Therefore, co-transfection studies were 
carried out in BAEC to observe more specific localization inside their larger MVB, 
particularly after chloroquine treatment (Figure 38). Co-localization was apparent in 
cells expressing wild-type mCherry-CD63 and GFP-8 (Pearson coefficient = 0.63 ±
0.04), and treatment of these cells with chloroquine further increased co-localization 
(Pearson coefficient = 0.81 ± 0.03). In contrast, GFP-RhoB and mCherry-CD63 co-
localization was significantly lower respect to GFP-8 in control cells (Pearson coefficient 
= 0.41 ± 0.04). The large vesicles typical of BAEC also presented several GFP-RhoB- or 
GFP-8-positive structures that did not contain fluorescent CD63 and vice versa (Figure 
38)..
Figure 38. Wild-type mCherry-CD63 co-localization with GFP-8 or GFP-RhoB.
BAEC co-transfected with mCherry-CD63 wild-type (mCh-CD63 WT) and either GFP-RhoB 
or GFP-8 were visualized by live confocal microscopy after treatment with chloroquine, 
where indicated. White arrowheads mark the extracellular material in the lower left panel.
The graph shows average co-localization between constructs, assessed as described in 
Methods in the image analysis section. *p < 0.01
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In this cell type, whereas co-transfection of CD63 and full-length RhoB 
constructs was well tolerated under the conditions studied, CD63 in combination with 
CINCCKVL proteins elicited accumulation of extracellular, vesicular material 
throughout the culture dish that was positive for GFP-8 and mCherry-CD63 (marked 
by arrowheads in Figure 38, bottom left panel)
The differential effect of overexpressing CD63 with full-length RhoB constructs 
versus CINCCKVL proteins could imply that this tetraspanin is involved in sorting, or 
interacts with, the lipidated RhoB motif. To further explore this possibility, similar 
studies were carried out with the mCh-CD63 YA construct in which the tyrosine found 
in the C-terminal lysosomal targeting motif YEVM was mutated to alanine (Figure 39). 
It has been reported that this mutant is unable to interact with the sorting complex AP-3 
and is therefore largely localized to the plasma membrane (Rous et al., 2002).
Figure 39. mCherry-CD63 Y235A mutant co-localization with GFP-8 or GFP-RhoB.
BAEC co-transfected with the mCherry-CD63 lysosomal targeting tyrosine mutant (mCh-
CD63 YA) and either GFP-RhoB or GFP-8 were visualized by live confocal microscopy after 
treatment with chloroquine, where indicated. Note the extracellular material marked by 
arrowheads in the bottom left panel. Co-localization is shown in the graph, as described in 
Figure 38.
Under the conditions used throughout this work, the proportion of plasma 
membrane to endolysosomal localization of the CD63 mutant varies in a cell-type 
dependent manner for, as seen in Figure 39, mCh-CD63 YA is only partially associated 
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with the plasma membrane in BAEC and is still prominently present at endolysosomes. 
GFP-8 co-localization with the mCherry-CD63 YA mutant was significantly reduced 
with respect to the wild-type protein, particularly upon chloroquine treatment (Pearson 
coefficient = 0.66 ± 0.02 versus 0.81 ± 0.03). Furthermore, large amounts of GFP-8-
positive extracellular vesicles were detectable in the medium as well as at the 
extracellular surface of the plasma membrane in many cells, particularly upon 
chloroquine treatment (Figure 39, left panels). In contrast, GFP-RhoB co-localization 
with mCherry-CD63 YA was similar to co-localization with its wild-type form, both for 
control conditions and after chloroquine treatment (Pearson coefficient = 0.41 ± 0.04 
for the YA construct and 0.40 ± 0.05 for the wild-type, control; 0.67 ± 0.04 versus 0.71 ±
0.08, chloroquine treatment). It is therefore possible that the tetraspanin CD63 is 
involved in CINCCKVL protein sorting, which could potentially result in extracellular 
localization of the chimera under certain conditions.
2.3.2 Effect of C6 ceramide treatment on RhoB construct localization
Targeting to MVB precedes an important step in protein sorting, for ILV 
pinched off into the MVB lumen can be sorted to lysosomes for degradation or be 
secreted into the extracellular milieu by MVB fusion with the plasma membrane, as 
depicted in Figure 40A. Considering CD63 function in the biogenesis of exosomes and 
the extracellular destination detected for CINCCKVL proteins in a scenario of aberrant 
CD63 overexpression, it is possible that this RhoB motif could be preferentially targeted 
for ILV destined for secretion instead of those destined for degradation in the lysosome, 
which are usually associated with ESCRT-dependent mechanisms. Furthermore, cell 
material can be secreted from the cell by direct shedding of microvesicles from the 
plasma membrane. In fact, a closer look by super-resolution imaging at the plasma 
membrane of HeLa cells transfected with GFP-8 shows what appear to be discrete 
compartments possibly corresponding to microvesicles, as well as protruding areas of
the plasma membrane budding outwards (Figure 40B). Therefore, it is plausible that 
CINCCKVL targets its chimeric proteins to be secreted either directly at the plasma 
membrane or through the late endosomal pathway, into MVB and out of the cell in 
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exosomes. Nevertheless, it must be taken into account that due to the tight z-sections 
obtained by super-resolution microscopy, the structures that appear to be vesicles could 
in fact correspond to undulations still attached to the plasma membrane.
Figure 40. Extracellular vesicle release routes as potential destinations for GFP-8.
(A) Schematic representing pathways for extracellular release of vesicles and their cargo. 
Whereas microvesicles bud directly from the plasma membrane, exosomes are formed by 
inward budding of ILV into MVB that can fuse to the plasma membrane, releasing their 
internal vesicles. MVB can also be destined for fusion with lysosomes for cargo degradation. 
It has not yet been fully established whether whole MVB are either exocytic or degradative or 
if ILV destined for either fate can co-exist within the same MVB. Note that budding of small 
ILV begins at the early endosome stage. Red rods represent transmembrane receptors and 
blue squares depict proteins destined for secretion. Green circles represent GFP-8 and its 
possible destinations. Modified from (Raposo and Stoorvogel, 2013). (B) Detailed inspection 
of the super-resolution image presented in Figure 19 shows GFP-8 at several LTR-positive 
endolysosomes and MVB (bottom left in inset). The inset further shows structures budding 
directly from the membrane, morphologically consistent with shed microvesicles.
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To approach the possibility of CINCCKVL sorting to extracellular vesicles, cells 
transfected with either GFP-RhoB or GFP-8 were treated with C6 ceramide (Figure 41), 
which has been shown to induce ESCRT-independent formation of ILV that are 
secreted as exosomes (Trajkovic et al., 2008). An inactive form of this compound, 
dihydroceramide C6, was used as a negative control.
Figure 41. Effect of C6 ceramide on GFP-8 or GFP-RhoB endolysosomal localization.
HeLa cells transfected with the indicated agents were treated with either dihydroceramide C6 
(control) or C6 ceramide and stained with LTR prior to live confocal microscopy observation.
The graph represents co-localization with LTR of either GFP-8 or GFP-RhoB after the 
indicated treatments. *p < 0.001
As seen in the left panels of Figure 41, upon ceramide treatment, GFP-8 
accumulated less at perinuclear, LTR-positive vesicles, its localization at the plasma 
membrane was in part diminished, and GFP-8-positive material was detected in the 
proximity of the plasma membrane as well as throughout the culture dish. This behavior 
was reflected by a significant decrease in co-localization of GFP-8 with LTR upon 
ceramide treatment (Pearson coefficient = 0.71 ± 0.03 for control compared to 0.51 ±
0.02 after ceramide treatment). However, after treatment with ceramide, GFP-RhoB was 
retained at the plasma membrane in polarized accumulations that were positive for LTR
and did not seem to reach the extracellular space (Figure 41), hence eliciting a 
significant increase in GFP-RhoB co-localization with LTR (Pearson coefficient = 0.29 ±
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0.02 control versus 0.59 ± 0.03). Taken together, these results suggest that CINCCKVL 
is able to reach the extracellular medium whereas the full-length protein is retained 
within the cell, possibly due to further sorting signals precluding its secretion or an 
active role in these processes. These results warrant further studies regarding the 
extracellular fate of CINCCKVL chimeras and the involvement of the CINCCKVL 
sequence in this process in the context of full-length RhoB.
3. Small GTPases in pathological scenarios
The plethora of signaling cascades in which small GTPases are involved 
highlights their importance in maintaining cellular homeostasis. Indeed, as described in 
the Introduction, members of this protein family have been found to play roles in many 
pathological processes such as tumorigenesis, inflammation or lysosomal diseases. The 
experiments described in this section are focused first on exploring GTPase involvement 
in lysosomal storage diseases, specifically, Chediak-Higashi Syndrome. Secondly, the 
amenability of several GTPases to be modified by reactive compounds produced during 
inflammatory or oxidative stress conditions was assessed, for these modifications could
alter their subcellular localization and activation, resulting in unfavorable cellular 
outcomes.
3.1 Endosomal GTPases in cells from patients with lysosomal storage diseases
Cells derived from patients suffering from lysosomal storage disorders are used 
alongside mouse models not only to study the pathogenesis of these diseases, but also to 
study the basic processes involved in general trafficking towards the lysosome. Much 
information about the endocytic route and the trafficking partners involved has been 
obtained by detection of mutations leading to these pathologies (Ballabio and 
Gieselmann, 2009). Therefore, GTPase localization was studied in the context of these 
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models for altered endolysosomal sorting. Several of these cell models have been 
previously employed in other works from the laboratory (Pérez-Sala et al., 2009; Valero 
et al., 2010); hence, attention here is focused on Chediak-Higashi Syndrome.
3.1.1 Studies in cells from patients with Chediak-Higashi Syndrome
The enlarged lysosomes found in many cell types of Chediak-Higashi patients 
were detected by optical microscopy early on and have since been found to accumulate 
cellular material of different kinds (Oliver et al., 1976). Several lysosomal storage 
diseases such as NPC present increased cholesterol levels in aberrant compartments as 
part of their pathogenic scenario. Moreover, a study on the lipid composition of CHS 
erythrocyte membranes pointed to higher levels of cholesterol (Chico et al., 2000), but 
to the best of our knowledge, intracellular cholesterol has not been studied in fibroblasts 
from this disease. Since cholesterol homeostasis can affect sorting of RhoB or 
CINCCKVL chimeras, unesterified cholesterol levels were assessed in CHS fibroblasts 
by filipin staining and confocal microscopy observation. As shown in Figure 42, CHS 
fibroblasts contain significantly higher levels of free cholesterol in their endolysosomes 
than control cells, quantified to almost double the value of control cells by fluorescence 
intensity detection.
Figure 42. Cholesterol staining in control and Chediak-Higashi fibroblasts.
Confocal imaging of fixed fibroblasts from control subjects versus CHS cells after filipin 
staining. Images were acquired with identical settings. Quantification of confocal image 
intensities was performed on wide fields containing several cells and is shown to the right of 
the images. F.I., fluorescence intensity. *p, 0.05 versus control.
In addition to lipids, several proteins have been found to accumulate at the 
enlarged endolysosomes of CHS cells, including proteins involved in the endocytic 
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pathway (Burkhardt et al., 1993). In order to further characterize CHS endolysosomes, a 
systematic approach was set up whereby the subcellular localization of several 
endosomal GTPases was compared to endolysosomal markers. Similarly to control 
fibroblasts, in CHS fibroblasts GFP-Rab7 and Lamp-GFP co-localized with LTR, 
whereas GFP-Rab5 appeared at smaller, more peripheral vesicles consistent with early 
endosomes (Oeste et al., unpublished observations). As shown in Figure 43, GFP-RhoB 
is internalized into the enlarged endolysosomes that appear in CHS cells and co-
localizes with LTR at these vesicles. However, GFP-Rab9 elicited an even further 
enlargement of CHS endolysosomes and was retained at their limiting membrane, in 
sharp contrast to the normal-sized endolysosomes that contain GFP-Rab9 in control 
fibroblasts.
Figure 43. GFP-Rab9 subcellular localization in CHS fibroblasts.
Fibroblasts from control subjects or from CHS patients were transfected with GFP-RhoB or 
GFP-Rab9 and treated with 25 nM LTR for 15 min prior to live observation by confocal 
microscopy.
Taken together, these results suggest that the endolysosomal malfunction 
derived from LYST mutations involves an alteration in lipid composition, as seen by 
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cholesterol accumulation, that could be responsible for the inadequate localization of 
Rab9 constructs, as seen in NPC1 cells (Ganley and Pfeffer, 2006).
3.1.2 CINCCKVL localization in cells from lysosomal storage disease 
patients
Taking into account the aberrant behavior observed in late endolysosomal 
pathways of lysosomal storage diseases and the results shown above in Chediak-Higashi 
cells, it was deemed necessary to explore CINCCKVL localization in these lysosomal
pathologies. As shown in Figure 44, the distribution of GFP-8 reflected the 
morphological alterations affecting lysosomal compartments in various diseases. 
Figure 44. GFP-8 localization in lysosomal storage diseases.
Fibroblasts from control subjects or from patients with the indicated lysosomal diseases were 
transfected with GFP-8 and treated with 25 nM LTR for 15 min prior to live confocal 
microscopy observation.
Whereas in control cells, GFP-8 co-localized substantially with lysosomes 
detected by LTR staining, in fibroblasts from Chediak-Higashi patients, GFP-8 was 
located at the edge of the abnormally dilated acidic compartments typical of this 
condition. Interestingly, CHS cells present defects in regulated secretion (Ward et al., 
2000). The inset shows that even LTR has difficulty entering the dense lysosomes that 
accumulate large amounts of ceroid-like material (Figure 44, second panel). On the 
other hand, as we previously observed (Pérez-Sala et al., 2009), fibroblasts from 
Niemann Pick type C1 patients, a disease characterized by alterations in intracellular 
cholesterol traffic, showed increased accumulation of GFP-8 inside lysosomes, probably 
arising from the altered late endosomal lipid dynamics in this disease. Similarly, 
fibroblasts from Hermansky-Pudlak Syndrome patients also showed an increase in the
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appearance of GFP-8 at LTR-positive compartments. Considering the possible 
mechanisms responsible for CINCCKVL sorting described in Section 2 of the Results 
and the altered GFP-8 localization found in CHS cells, further studies could shed light 
on the sorting mechanisms that are defective in this disease and could find their 
correlation in other endolysosomal malfunctions.
3.2 Modifications of small GTPase cysteine residues by electrophilic 
compounds
As described throughout this dissertation, several small GTPases contain 
cysteine residues at their C-terminal ends that are amenable to palmitoylation and 
mediate their association with endomembranes of different nature. However, in 
situations associated with oxidative or electrophilic stress, as occurs in many 
pathological conditions such as inflammatory processes, diabetes or neurodegeneration, 
cysteines can suffer non-enzymatic modifications. These include direct oxidation or 
addition of compounds of electrophilic nature that could preclude palmitoylation and 
thus proper localization, as previously described for cyPG binding to H-Ras in works 
from the laboratory (Oeste et al., 2011; Renedo et al., 2007). The assays presented in this 
section explore whether other small GTPases bearing lipidation cysteines additionally to 
that of their CAAX box could also be directly modified by cyPG or other small cysteine-
reactive compounds, hence eliciting conformation changes in their C-termini that could 
spread to other areas of the protein, changing their biochemical properties.
3.2.1 Direct binding of cyPG to small GTPases
Previous results from the laboratory established that dienone cyPG such as 15d-
PGJ2 and 12-PGJ2 covalently modify H-Ras at its C-terminal peptide, which bears the 
palmitoylation cysteines, i.e. C181 and C184 (Renedo et al., 2007). Therefore, binding of 
biotinylated 15d-PGJ2 (15d-PGJ2-B) to other small GTPases containing two 
palmitoylation cysteines at their C-terminus was assessed. As shown in Figure 45, the 
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negative control K-Ras4B, which does not have palmitoylatable cysteines in its C-
terminus, does not present a detectable biotin signal, as previously reported in cell 
assays (Renedo et al., 2007). However, binding of 15d-PGJ2-B was readily observable in 
the case of H-Ras, RhoB and Rap2B (Figure 45), all of which contain palmitoylation 
cysteines near the isoprenylation site (see Table 3). Therefore, of the GTPases studied, 
only those containing cysteine residues that are known to undergo palmitoylation are 
modified by 15d-PGJ2-B in vitro.
Figure 45. Binding of biotinylated 15d-PGJ2 to small GTPases.
Human recombinant K-Ras4B, H-Ras, RhoB or His-tagged Rap2B at 5 µM were incubated 
with 15d-PGJ2-B at 10 µM for 2 h at room temperature. Incorporation of the biotinylated 
cyPG was assessed by SDS-PAGE, protein blot and detection with horseradish peroxidase 
(HRP)-streptavidin (upper panel) or WB with anti-pan Ras, anti-RhoB or anti-Rap2 antibodies. 
The dashed gray line indicates different exposures due to saturation of the K-Ras4B signal. 20 
and 25 kDa markers are shown for reference.
To assess binding of other cyPG to RhoB, in vitro studies were carried out with 
either single enone cyPG or dienone cyPG, as shown in Figure 46. Detection of the 
biotin signal shows binding of the biotinylated single enones PGA1 and PGA2. 
Interestingly, the trans side chain isomer of PGA2, i.e. the isoprostane 8-iso-PGA2, 
displayed a higher biotin signal than its cis isomer. Similarly to above, binding of the 
dienone cyPG 15d-PGJ2-B was detected, as well. A biotinylated PG devoid of 
electrophilic carbons, PGE2, did not bind to RhoB, as expected for this negative control.
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Figure 46. Binding of several cyPG to recombinant RhoB in vitro.
Recombinant RhoB at 5 µM was incubated with the indicated biotinylated cyPG at 10 µM for 
2 h at room temperature prior to SDS-PAGE analysis, as in Figure 45. The gray dashed line 
represents two different exposures due to higher biotin levels in the last two lanes.
3.2.2 Binding of small reactive compounds to H-Ras and RhoB
It is possible that other small, bifunctional, thiol-reactive molecules could mimic 
the behavior of dienone cyPG with respect to binding to GTPases with C-terminal 
cysteines amenable to palmitoylation. A compound that meets these criteria and is 
commonly used in cell signaling studies, phenylarsine oxide (PAO, mass 168.02, 
structure shown in Figure 49B), acts as a tyrosine phosphatase inhibitor that forms
adducts with proteins containing sulfhydryl groups close enough to form thioarsine 
rings (Gerhard et al., 2003; Wang et al., 2003). Indeed, as shown by MALDI-TOF MS in 
Figure 47A, PAO binding to H-Ras results in a mass increment compatible with 
addition of a single PAO molecule, which MS-MS analysis detected to be at the C-
terminal palmitoylatable cysteines (Oeste et al., 2011). Additionally, since biotinylated 
15d-PGJ2 (15d-PGJ2-B) binds to full-length H-Ras at its C-terminus, competition assays 
were performed to determine whether PAO could abrogate dienone cyPG addition. 
Figure 47B shows that pre-incubation with PAO reduced 15d-PGJ2-B binding to H-Ras, 
as reflected by a reduction in biotin detection (28%±7 reduction for PAO versus vehicle-
treated Ras). Similarly, the small reactive thiol cross-linker, dibromobimane (DBB, mass 
350.01, structure shown in Figure 49B), also elicited a decrease in the biotin signal 
corresponding to 15d-PGJ2-B (55% reduction, Figure 47C). The distance between the 
bromide ions in DBB that are lost upon binding to thiols of cysteines within close range
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has been calculated to be approximately 3-6 Å (Sinz and Wang, 2001). Furthermore, 
DBB is known to undergo a fluorescent shift after bromine loss resulting from cysteine 
cross-linking (Kim and Raines, 1995), and can indeed be detected directly in gels when 
incubated with H-Ras (Figure 47C).
Figure 47. PAO and DBB binding to recombinant H-Ras in vitro.
(A) MALDI-TOF MS analysis of human recombinant H-Ras incubated with PAO. (B) 
Recombinant H-Ras at 5 µM was incubated for 30 min with 50 µM PAO before addition of 1 
µM biotinylated 15d-PGJ2 (15d-PGJ2-B) for 1 h, where indicated. Incorporation of the 
biotinylated cyPG was assessed by SDS-PAGE, protein blot and detection with horseradish 
peroxidase (HRP)-streptavidin (upper panel) or WB with anti-pan Ras antibody (lower panel). 
(C) Competition of 15d-PGJ2-B binding to H-Ras by DBB. Full-length H-Ras was incubated 
similarly to (B) with DBB. Incorporation of DBB was assessed by UV fluorescence detection 
(middle panel).
In light of the results obtained by SDS-PAGE analysis of RhoB modification by 
15d-PGJ2-B, competition experiments between 15d-PGJ2-B and PAO or DBB were 
performed with RhoB, as well. There is a clearly detectable reduction in the biotin signal 
representing 15d-PGJ2-B binding when the protein is pre-incubated with either PAO 
(Figure 48A) or DBB (Figure 48B). Similarly to the results obtained with H-Ras, UV gel 
fluorescence indicating direct DBB binding was also observed.
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Figure 48. 15d-PGJ2, PAO and DBB binding to recombinant RhoB in vitro.
(A) Recombinant RhoB at 5 µM was incubated for 30 min with 50 µM PAO before addition 
of 10 µM biotinylated 15d-PGJ2 (15d-PGJ2-B) for 1 h, where indicated. Incorporation of the 
biotinylated cyPG was assessed by SDS-PAGE, protein blot and detection with horseradish 
peroxidase (HRP)-streptavidin (upper panel) or western blot with anti-RhoB antibody (lower 
panel). (B) Competition of 15d-PGJ2-B binding to RhoB by DBB. Full-length RhoB was 
incubated similarly to (A) with DBB. Incorporation of DBB was assessed by UV fluorescence 
detection (middle panel).
Several bifunctional reagents have therefore been shown to bind to either full-
length H-Ras or RhoB (Figure 47 and Figure 48). Since these proteins contain vicinal 
cysteines, these compounds could be binding to both cysteine residues simultaneously.
Moreover, as mentioned above, direct detection of DBB fluorescence upon incubation 
of H-Ras or RhoB with this compound indicates that it is bound to two cysteines within 
3-6 Å of each other (Kim and Raines, 1995). To directly observe the cross-linking of 
palmitoylation cysteines elicited by bifunctional compounds, a synthetic peptide 
corresponding to the H-Ras C-terminus was used as a model in MALDI-TOF MS 
analyses. This peptide is equivalent to the fragment obtained by tryptic digestion of H-
Ras, namely K170-K185 (m/z 1662.7, sequence in Figure 49B), which contains the 
palmitoylatable cysteines, and presents a more favorable sequence than the equivalent 
peptide of RhoB, in which the tryptic fragment would include the isoprenylation 
cysteine in addition to those amenable to palmitoylation. Peptide incubation with 15d-
PGJ2 presents a predominant peak corresponding to the addition of one PG molecule 
(m/z 1979.80,), as well as two oxidation peaks (m/z 1994.9 and 2010.7), as described in 
earlier works (Oliva et al., 2003; Renedo et al., 2007).
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Figure 49. Modification of the K170-K185 H-Ras C-terminal peptide by 15d-PGJ2, PAO and 
DBB.
(A) Sequence of the K170-K185 peptide with the modified cysteines in larger, bold font and 
summary of the theoretical peptide adducts for which compatible peaks were observed by 
MALDI-TOF mass spectrometry. (B) Incubation of the synthetic H-Ras C-terminal peptide, 
K170-K185, with either 15d-PGJ2, PAO or DBB resulted in adducts detected by MALDI-TOF 
MS. Structures of the compounds employed are shown to the right of the spectra, with a 
schematic of adduct formation with two thiol groups in the case of PAO and DBB. 
Incubation of the K170-K185 peptide with PAO gave rise to a single peak with
m/z 1812.7 that represents the simultaneous binding to both cysteines, as depicted to
the right of the PAO spectrum (Figure 49B). Likewise, DBB bound to the K170-K185 
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peptide, resulting in the appearance of a single peak of m/z 1850.81, compatible with a 
1:1 adduct of peptide:DBB (Figure 49B). The small span of the DBB reactive groups and 
the fact that peptide dimers were not detected upon DBB incubation (Oeste et al., 2011)
suggest that C181 and C184 are within close range of each other and hence amenable to 
intramolecular cross-linking by DBB (Figure 49B, bottom). 
It should be noted that the H-Ras hypervariable domain does not present a well-
defined structure in solution (Thapar et al., 2004), whereas membrane binding induces a 
more rigid conformation (Gorfe et al., 2007). Therefore, cross-linking of C181 and C184 
by 15d-PGJ2, PAO or DBB binding could potentially stabilize a fixed conformation and 
disturb H-Ras membrane interactions. These results pave the way for studies in cells to 
determine the functional repercussion of direct modification by small electrophilic 
moieties. Assays performed on cells transfected with H-Ras constructs have shown that, 
indeed, its localization and activation shift from the plasma membrane to 
endomembranes upon treatment with PAO or DBB (Oeste et al., 2011). Preliminary 
assays using RhoB have proven unfruitful due to its rapid degradation and low basal 
levels in cells, though further studies are warranted to determine the cellular effect of 
binding of these compounds to RhoB.
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1. Role of the hypervariable motif in small GTPase 
subcellular localization
Many small GTPases are singly or doubly isoprenylated and some of them 
undergo further post-translational modifications by palmitoylation. In addition to C-
terminal lipidation, the hypervariable region of some Ras superfamily proteins contain 
basic residue patches that interact with anionic phospholipids that accumulate at 
particular subcellular membranes and others include further sorting elements such as 
motifs recognized by adaptors (Bonifacino and Traub, 2003). Significantly, these 
structural motifs determine subcellular localization patterns that derive from or elicit 
conformational changes extending to the totality of the protein, which ultimately govern 
GTPase activation states and signaling functions. In fact, hypervariable regions 
containing very similar motifs can give rise to different endomembrane sorting on the 
basis of distinct lipid moiety spacing or even the nature of a few neighboring amino 
acids.
1.1 Endosomal GTPases appear at distinct subcellular membranes
Studies regarding the hypervariable region sequences of several small GTPases 
were carried out to assess the structural determinants involved in subcellular 
localization. Previous studies from the laboratory established the RhoB C-terminal 
sequence as a motif for sorting to endolysosomes and lysosomal degradation (Pérez-Sala 
et al., 2009). This behavior depends on its isoprenylation and double palmitoylation, 
which begged the question of whether other similarly lipidated small GTPases such as 
H-Ras, Rap2A and B, or TC10 presented similar subcellular localization. As has been 
performed in detail for H-Ras (Gorfe et al., 2007), short constructs bearing sequences 
pertaining only to the isoprenylation and palmitoylation motifs of these proteins aided 
in determining the impact on sorting and degradation of their full-length counterparts.
The results shown in Section 1.1 of the Results indicate that sorting into MVB 
and subsequent lysosomal degradation is highly specific for RhoB. Though the TC10 C-
terminus is very similar to that of RhoB, a basic amino acid patch upstream of the 
palmitoylation cysteines is responsible for retention at limiting membranes of MVB and 
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hampers inclusion into ILV (Valero et al., 2010). Indeed, this basic residue motif could 
mediate an electrostatic interaction of TC10 with the most abundant negatively charged 
phospholipid, i.e. phosphatidylserine, which is found mainly on the cytosolic surface of 
endosomes and the plasma membrane (Leventis and Grinstein, 2010; Urade et al., 1988; 
Yeung et al., 2008), hence obstructing entry into the lumen of MVB and subsequent 
degradation. Other bipalmitoylated proteins were found similarly retained at the 
limiting membranes of endolysosomes, such as the Rap2 isoforms (Valero et al., 2010). 
In this case, the alternate spacing between lipidated residues could confer a distinct 
overall three-dimensional conformation at the C-terminus of Rap2 proteins that 
promotes association with membrane microdomains of singular properties. Short 
constructs derived from the H-Ras C-terminal sequence were mainly present at the 
plasma membrane, as previously described (Gorfe et al., 2007). It could therefore be 
postulated that combinations of electrostatic interactions and reversible palmitoylation 
are responsible for endowing C-termini with conformations that allow binding to 
membrane regions of well-defined characteristics. Taken together, these results indicate 
that the isoprenylation and palmitoylation motif of RhoB constitutes a precise structure 
with affinity for particular membrane domains that determines its selective sorting 
through the endolysosomal pathway into the lumen of MVB.
1.2 The RhoB C-terminus CINCCKVL is an MVB and endolysosomal marker
Several studies from our laboratory have shown that the fully processed RhoB C-
terminal sequence CINCCKVL co-localizes with endolysosomal probes such as LTR, 
Lamp1, Rab7, Rab9 and CD63 constructs, or LBPA, as well as appearing directly at ILV 
of MVB (Oeste et al., 2014; Pérez-Sala et al., 2009; Valero et al., 2010). These results 
were confirmed through the use of several fusion proteins containing this sequence, 
including varied fluorescent constructs such as GFP, RFP and its photostable forms 
(tagRFP, tagRFP-T), mCherry, or photoswitchable Dendra2. Intracellular live markers 
are not devoid of pitfalls, such as endosome enlargement induced by overexpression of 
Lamp1 or Rab7 constructs and induction of stress fibers by transfecting with full-length 
RhoB fusion proteins (unpublished observations). In the case of CINCCKVL chimeras, 
no detectable morphological abnormalities have been encountered during its use, so far. 
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Furthermore, work from the laboratory in live BAEC and HeLa reported a lack of 
overlap with several autophagy probes after induction of autophagy such that 
independent GFP-8-positive structures were clearly distinct from RFP-LC3 
autophagosomes (Oeste et al., 2013). CINCCKVL localization to Golgi compartments is 
also negligible when full modification is allowed (Oeste et al., 2014). As will be discussed 
below, lipidation status is crucial to CINCCKVL sorting through the endocytic pathway, 
and can hence be regulated to track subcellular organelles or detect overall 
isoprenylation precursor status through statin switch assays. Therefore, CINCCKVL 
fusion proteins may be used as markers amenable to pharmacological modulation for 
dynamic tracking of MVB and endolysosomes in live cells.
1.3 CINCCKVL localization at endolysosomes depends on lipid modifications
The presence of CINCCKVL proteins at endolysosomes is completely dependent 
on full post-translational processing by lipids. It is shown in this work that isoprenylated 
but non-palmitoylated constructs are diffuse within the cytoplasm but exclude the 
nucleus and are in part retained at the Golgi apparatus, where palmitoyl transferases are 
usually accumulated, which could represent species that are awaiting palmitoylation, 
(Aicart-Ramos et al., 2011). In contrast, non-lipidated forms spread throughout the cell, 
leaving some small, LTR-positive vesicles empty. It therefore becomes apparent that 
palmitoylation is a sine qua non for CINCCKVL entry into endolysosomes, as shown 
schematically in Figure 50. Similarly, studies involving the Ca2+ sensor synaptotagmin 7
described that its palmitoylation elicits association with CD63 and subsequent sorting to 
lysosomes, whereas non-palmitoylated forms are retained in the Golgi (Flannery et al., 
2010). However, these instances are in contrast with the more numerous cases of 
proteins in which palmitoylation precludes access to lysosomes, as seen in (McCormick 
et al., 2008; Pérez-Sala et al., 2009). For example, recycling of the M6P receptor from 
lysosomes to the Golgi is dependent on its N-terminal palmitoylation, for 
palmitoylation-defective mutants accumulate into dense lysosomes (Schweizer et al., 
1996).
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Figure 50. GFP-8 subcellular localization depends on its lipid modifications.
The GFP structure appears as a ribbon diagram in green, with the CINCCKVL motif 
represented as a green squiggle attached to it. Totally unlipidated forms are completely 
diffuse throughout the cytoplasm and the nucleus (gray font), whereas isoprenylated forms 
exclude the nucleus, are predominantly cytosolic and are sometimes associated with the 
Golgi apparatus (red font). However, isoprenylated and bipalmitoylated GFP-8 appears at 
late endosomes/MVB and the plasma membrane (blue font). See text for details.
Concerning the GPCR, PAR-1 (protease-activated receptor 1), there seems to be 
an interplay between its YXXF sorting motifs and palmitoylation, such that correct 
sorting mediated by the tyrosine motif requires correct modification by palmitate and
PAR-1 mutants lacking palmitoylation cysteines are degraded in lysosomes to a higher 
extent (Canto and Trejo, 2013). The yeast protein Vac8 is localized at the vacuolar 
membrane in yeast, though internalization into this compartment has not been 
described (Peng et al., 2006). Hence, a general role for palmitoylation in protein sorting 
is lacking, since the consequences of modification by this lipid seem to be protein-
specific and cell-type dependent. Additionally, palmitoylation of RhoB constructs is 
probably accountable for the lack of interaction between either GFP-8 or GFP-RhoB 
with RhoGDIa as compared to that detected for GFP-RhoA (Oeste et al., unpublished 
observations), as previously hypothesized (Michaelson et al., 2001). Nevertheless, it still 
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remains to be established whether non-palmitoylated RhoB constructs interact with 
RhoGDI in the cytosol (Ho et al., 2008).
Upon isoprenylation inhibition, full-length RhoB-derived constructs behave as 
cytosolic proteins, similarly to unprenylated GFP-8 (see Figure 50). Therefore, both 
membrane and RhoGDI binding cannot occur and RhoB could be degraded through the 
expected proteasomal pathway followed by soluble proteins. In fact, excessive 
overexpression of fluorescent RhoB constructs elicits diffuse accumulation in the 
cytosol, most likely due to saturation of the lipidation machinery and subsequent lack of 
precursors. Such “extra” proteins could become ubiquitinated and degraded through the 
proteasome, which is a putative scenario for a study detecting RhoB ubiquitination 
upon overexpression of RhoB and ubiquitin in cells treated with proteasomal inhibitors 
(Engel et al., 1998). Indeed, RhoB is an early response gene and its levels can rise quickly 
within the cell to overcome damage by UV exposure (Canguilhem et al., 2005). It would 
be interesting to detect whether, following this stimulus, the newly synthesized proteins 
are capable of becoming isoprenylated and bipalmitoylated to follow the endolysosomal 
pathway described herein, or whether full lipidation occurs to maintain low RhoB levels 
principally in resting state conditions.
Pharmacological statin treatment, which is widely prescribed for 
hypercholesterolemia, greatly increases levels of unprocessed RhoB in the cytosol
(Stamatakis et al., 2002). Another report determined that an increase in non-prenylated 
Rho protein translates into overall elevated levels of GTP-bound Rho as compared to 
untreated cells expressing normal levels, suggesting that Rho-dependent signaling 
pathways are more active in statin-treated cells (Turner et al., 2008). Furthermore, it has 
been previously described that accumulation of unprocessed, soluble forms of Rho 
proteins (mostly RhoA) are partly responsible for the serious side effects resulting from 
abrupt statin withdrawal, which implies a sudden lift of the blockade on isoprenoid 
precursor formation. The accumulated Rho protein is rapidly modified by newly 
synthesized geranylgeranyl moieties and translocates to the plasma membrane, strongly 
activating its signaling cascades, including repression of endothelial nitric oxide 
synthase (eNOS). This phenomenon causes a dangerously abrupt drop in nitric oxide 
production in cardiac endothelial cells, hence impairing vascular function (Laufs et al., 
2000). These effects were studied in detail in the context of RhoA, but the concomitant 
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increase in unprocessed RhoB concentration in cells from patients undergoing statin 
treatment warrants further investigation.
1.4 CINCCKVL sorting is conserved from fungi to human cell models
Cells from very diverse species including ascomycetous fungi, insects, 
amphibians and several mammals are all able to sort RhoB C-terminus constructs to the 
vacuole or endolysosomes. However, they endogenously express different sets of Ras 
superfamily proteins, and in some cases a clear RhoB homolog has not been identified 
or is not localized to endosomes. Mammals and birds express identical RhoB proteins, 
but organisms studied in this work that are lower on the evolutionary scale differ in
their C-terminal RhoB sequence or do not encode a RhoB homolog, as seen in insect 
cells. In the case of Schizosaccharomyces pombe, there is a RhoB homolog termed Rho2 
that appears at the plasma membrane, the septation site and growing ends (Hirata et al., 
1998). However, this protein contains only one palmitoylated cysteine close to the 
isoprenylation site (Roth et al., 2006), which is modified by a farnesyl moiety (Ma et al., 
2006) in lieu of the preferential geranylgeranylation that takes place on RhoB in cells 
(Roberts et al., 2008). RhoB can become alternatively isoprenylated, though studies with 
constructs containing CAAX boxes more inclined to either modification, namely GFP-
CINCCKVL and GFP-CINCCLVM (geranylgeranylated or farnesylated, respectively), 
did not present detectable differences as to their endolysosomal localization, so that a 
crucial role for the length of the C-terminal isoprenoid is not likely (Oeste et al., 
unpublished observations). Another yeast protein, RasA, is indeed bipalmitoylated, but 
it accumulates at the plasma membrane and disrupting its palmitoylation elicits a 
patchy intracellular distribution (Fortwendel et al., 2012). Aspergillus nidulans codes for 
a putative Rho2-like protein expected to be geranylgeranylated and palmitoylated, 
though a homolog for GGTase I has not yet been biochemically identified in this 
species. 
The instances of lipidated proteins in lower organisms described above highlight 
the fact that, though these species are able to sort CINCCKVL to endolysosomes, none 
of their endogenous proteins have been described to follow this route directly. It is 
therefore worth examining whether the sorting machineries potentially responsible for 
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RhoB construct sorting in mammals, i.e. Rabs, ESCRT or the tetraspanin CD63, are 
conserved from fungi to human cells. Indeed, the basic Rab components of the 
endocytic route are conserved throughout metazoan evolution. In-depth phylogenetic 
studies on Rab family proteins highlight the existence of a large number of Rabs early on 
in evolution (Elias et al., 2012; Klöpper et al., 2012). Moreover, it has been proposed that 
the latest eukaryotic common ancestor (LECA) contained more than 20 core Rab 
proteins that have suffered expansions by gene duplication or losses throughout 
eukaryotic evolution (Klöpper et al., 2012). Further human Rabs have arisen from gene 
duplication of the fundamental Rabs associated either to early endosomes (Rab5), late 
endosomes (Rab7 and Rab9) recycling endosomes (Rab11) and so on, up to the ten 
subfamilies identified through phylogenetic studies of mammalian Rabs (Pereira-Leal 
and Seabra, 2000). Interestingly, CINCCKVL chimeras are present inside vesicles that 
are marked at their limiting membranes by proteins included in a category containing 
late endosomal LECA Rabs (group III), such as Rab7. 
As is the case for Rab proteins, at least one component from each of the ESCRT-
I, -II or –III complexes is present in fungi and metazoans (Wideman et al., 2014). 
However, outside Ophisthokonta, ESCRT-0 is completely absent, so that other 
mechanisms for ubiquitin recognition must exist in organisms present before the LECA 
branched off from other life forms (Leung et al., 2008). Considering the role of ESCRT 
proteins in MVB biogenesis, it would be expected that organisms with defined 
intracellular compartments would require their action for correct endosomal sorting. 
However, Archaea have also been shown to contain ESCRT components, though only 
ESCRT-III and Vps4 (Samson et al., 2008). Such is the case due to the vital role of 
several ESCRT proteins in membrane abscission during cytokinesis (Rusten et al., 2012). 
Furthermore, ESCRT proteins are also involved in virus budding, such as human 
immunodeficiency virus-1 (HIV-1) egress from the plasma membrane, which follows an 
“inside-out” route from the cytoplasm that is topologically similar to ILV formation 
(Garrus et al., 2001; Morita and Sundquist, 2004).
Therefore, the Rab and ESCRT proteins found to co-localize with CINCCKVL 
and RhoB constructs or involved in their sorting could potentially be present in the 
diverse species studied. In the case of tetraspanin proteins, fungi have been found to 
contain homologs, though in Aspergillus nidulans only a tetraspanin-like protein has 
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been proposed by sequence homology but has not been characterized (Lambou et al., 
2008).
2. RhoB subcellular sorting mechanisms
The structural determinants guiding endosomal small GTPase sorting include 
lipidation motifs and amino acids of specific characteristics. In the case of RhoB, its C-
terminus CINCCKVL represents a unique structure upon lipidation that attaches to the 
very specific subcellular localization of late endosomal pathway vesicle lumina that is 
conserved in cells from many organisms. In human cells, targeting to ILV of MVB such 
as occurs for RhoB does not necessarily mean degradation at lysosomes, though RhoB 
constructs are indeed degraded mainly through this pathway (Pérez-Sala et al., 2009). As 
described previously, proteins present at MVB can also be exocytosed by fusing with the 
plasma membrane or recycled back to the Golgi apparatus as well as being delivered to 
the lysosome (Futter et al., 1996; Lu and Hong, 2014; Murk et al., 2002; Vlassov et al., 
2012). However, there is still debate as to whether the same MVB contains ILV directed 
towards different sites or if there are specialized MVB that deliver all their ILV to the 
same subcellular destination (Edgar et al., 2014; van Niel et al., 2011; Vlassov et al., 
2012). Therefore, it was crucial to investigate some of the trafficking pathways that lead 
proteins to and from MVB in eukaryotic cells to determine their role in sorting of RhoB 
and its last eight amino acids. The interplay between protein sequence and lipid 
modifications in sorting of these proteins warranted the study not only of protein 
complexes involved in shuttling material within the cell, but also of the lipid features of 
the membranes to which they attach.
2.1 Differential role of the ESCRT machinery in sorting of RhoB versus
CINCCKVL constructs
Protein sorting into MVB is at the convergence of several endocytic routes, as 
well as a hub towards other intracellular destinations. ESCRT proteins regulate the 
canonical pathway described for entry into MVB of many proteins, such as the EGF 
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receptor. Previous work from the laboratory suggested the involvement of this 
machinery in RhoB sorting through the use of Vps4 dominant negative constructs in 
BAEC (Pérez-Sala et al., 2009). Furthermore, other routes to the MVB such as 
autophagy, microautophagy or chaperone-mediated autophagy are highly unlikely 
routes for trafficking this GTPase, as discussed in (Oeste et al., 2014). It was therefore 
possible that the ESCRT machinery played a role in RhoB sorting. 
ESCRT-mediated sorting into MVB, when dependent on the whole machinery, 
begins by ubiquitination of cargo such as EGFR. Ubiquitin-independent mechanisms 
also exist, but these usually involve only late ESCRT components and ESCRT-III-
associated proteins such as Alix. Many attempts at detecting ubiquitination of RhoB 
constructs were undertaken for this work, including stimulation with EGF, treatment 
with proteasomal or lysosomal degradation inhibitors, or simvastatin treatment to 
accumulate RhoB, though none of them resulted in a clear signal of ubiquitinated full-
length RhoB or CINCCKVL proteins, rendering these results inconclusive (not shown). 
Interestingly, the GFP-22 construct that showed a faint ubiquitin signal contains a lysine 
residue that could become ubiquitinated, but might be less exposed in full-length RhoB, 
such that regulated processes could mediate its amenability to ubiquitination. However, 
use of ESCRT siRNA to silence some components of the machinery and observation of 
GFP-RhoB and GFP-8 by live microscopy revealed differential phenotypes, so that 
ESCRT could be involved regardless of ubiquitination. Strikingly, by using these
constructs in parallel, a distinctive subcellular localization was observed upon depletion 
of the ESCRT components Hrs and Tsg101. These were the first studies to show 
differential behavior between full-length RhoB, which showed impaired sorting in cells 
depleted of these ESCRT, and its chimera, GFP-8, which was sorted into endolysosomes 
in these cells. It is possible that RhoB is in fact ubiquitinated but we have not achieved 
its detection, either because its ubiquitination is fast and transient or because it is 
rapidly degraded in the lysosome upon ubiquitination, or both. In any case, our results 
suggest that GFP-RhoB would follow an ESCRT-mediated pathway into the lumen of 
endolysosomes, be it ubiquitin-dependent or -independent. In contrast, GFP-8 would 
not become ubiquitinated and could therefore follow ceramide and CD63-driven 
budding into MVB and pinch off to become ILV regardless of alterations in the ESCRT 
machinery.
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Differences encountered between GFP-8 and GFP-RhoB give rise to a working 
hypothesis for the molecular players involved in RhoB and CINCCKVL localization and 
sorting. This view is schematized in Figure 51 and will aid in discussing the possible 
sorting mechanisms throughout the following sections, as well as in future studies. 
Figure 51. Schematic of possible membrane platforms for GFP-RhoB and GFP-8.
Zoom-in on putative differential ILV of MVB containing either GFP-RhoB or GFP-8. The 
results shown in this work point to a possible role for the ESCRT proteins Hrs and Tsg101 in 
GFP-RhoB sorting (left membrane), but not for that of GFP-8. The larger ILV into which GFP-
RhoB enters would contain the late endosome lipid, LBPA (light green). In contrast, CD63 
could be involved in GFP-8 sorting, as well as cholesterol dynamics (right membrane). 
Furthermore, ceramide treatment could induce the appearance of GFP-8 in small ILV 
containing CD63, which could putatively be secreted to the extracellular space.
2.2 Effects of agents altering cellular lipid dynamics on CINCCKVL and full-
length RhoB sorting
Apart from the protein machineries involved in intracellular sorting, the lipid 
composition of endosomal membranes plays a key role in cargo trafficking and MVB 
biogenesis (Bissig and Gruenberg, 2013; Bissig et al., 2012). In fact, lipid microdomains 
in the Saccharomyces cerevisiae vacuole were recently found to mediate protein 
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segregation (Toulmay and Prinz, 2013). On one hand, bulk lipids can convey specific 
conformations to membranes according to their three-dimensional properties, so that 
conical lipids induce curvature and straight molecules increase membrane order, i.e. 
diacylglycerol and cholesterol, respectively (Bigay and Antonny, 2012). Altering 
cholesterol dynamics in several cell types by pharmacological treatment indeed disrupts 
the association of CINCCKVL constructs to endolysosomes. On one hand, treatment 
with U18666A, which increases membrane invagination into MVB (Marchetti et al., 
2004), gives rise to prominent accumulations of CINCCKVL chimeras within 
endolysosomes containing LBPA, cholesterol and delimited by markers such as Lamp1-
GFP, GFP-Rab7 or -Rab9 (Valero et al., 2010), reflecting their specific association with 
ILV. On the other hand, inhibiting cholesterol biosynthesis by ZGA treatment induced 
MVB dilation and a striking retention of proteins at MVB limiting membranes, i.e. 
GFP-8 or CD63 constructs, which normally internalize into ILV in control cells (Oeste 
et al., 2014), though this retention was not observed for GFP-RhoB, which still entered 
endolysosomes upon ZGA treatment (Figure 36). 
The results observed for GFP-8 agree with previous reports describing ILV as the 
major cholesterol-containing vesicles in the endosomal pathway (Möbius et al., 2003). It 
is possible that overall cholesterol depletion would therefore affect these structures more 
markedly, hampering the route followed by GFP-8 for invagination into MVB (see 
Figure 51). In fact, endothelial cells have been shown to contain cholesterol-rich 
membrane domains in their MVB (Amiya et al., 2013). Moreover, mice deficient in the 
last enzyme of the cholesterol biosynthetic pathway (24 sterol reductase) present 
reduced ILV material within their MVB, which follows the same pattern as the 
reduction of GFP-8 and CD63 constructs in the lumen of MVB upon ZGA treatment 
(Gilk et al., 2013). Cholesterol has also been found to stabilize particular microdomains 
containing specialized phosphoinositides (Jiang et al., 2014), so that altering its 
dynamics could affect these small signaling platforms, as well. Furthermore, specific
lipids exist at defined membrane microdomains, as is the case for the curvature-
inducing lipid LBPA in endolysosomes (Matsuo et al., 2004), or particular 
phosphoinositides along the endocytic pathway (Di Paolo and De Camilli, 2006). In this 
regard, full-length RhoB constructs co-localize to a large extent with LBPA in the 
endolysosomal lumen (Pérez-Sala et al., 2009), whereas the PI(3)P marker 2xFYVE 
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appears at small, dispersed vesicles that do not overlap with RhoB or CINCCKVL 
constructs (Oeste et al., unpublished observations). Therefore, sorting of RhoB 
constructs is dependent on lipid-mediated mechanisms of ILV formation for which 
cholesterol and LBPA are essential. 
2.3 CD63 overexpression has differential effects on full-length RhoB and
CINCCKVL localization
Sorting mediated by tetraspanins and TEM are a telling example of the intrinsic 
relationship between protein sequence, lipid modifications and membrane organization. 
In the case of CD63, its four transmembrane domains direct insertion into membranes, 
its YXXF motif guides intracellular trafficking, and palmitoylation at cysteine residues 
determines attachment to membranes of specific characteristics in a cholesterol-
dependent manner (Charrin et al., 2003; Israels and McMillan-Ward, 2010; Pols and 
Klumperman, 2009; Yang et al., 2002). These features give rise to CD63 sorting to 
specific membrane microdomains, which are also the destination for RhoB chimeras, 
i.e. ILV of MVB and the plasma membrane, to a varying extent. In fact, co-localization 
studies in resting cells show almost total overlap between wild-type CD63 constructs 
and CINCCKVL chimeras, and to a lesser degree with full-length RhoB constructs. As 
depicted in Figure 51, it could be hypothesized that GFP-8 is intimately connected to 
TEM through its palmitate residues by a similar cholesterol-dependent mechanism that 
keeps CD proteins together (Charrin et al., 2003). The lack of further sorting 
determinants in GFP-8 would render the protein quite dependent on TEM dynamics. 
Therefore, disruption of CD63 intracellular trafficking such as that which could take 
place upon overexpression of CD63 constructs, particularly the Y235A mutant, would 
hinder binding to AP-3 complexes, which could alter CD63 sorting to TEM at MVB and 
therefore result in a concomitant misplacement of GFP-8. AP-3 has been shown to 
contribute to the regulated secretory pathway, as AP-3 depletion reduces regulated 
secretion of secretogranin II, though it elicits an increase in its constitutive secretion as a 
compensatory mechanism (Asensio et al., 2010). Therefore, a putative indirect 
association of GFP-8 to AP-3 via CD63 could be abolished in a scenario of altered CD63 
sorting such as cells overexpressing CD63 constructs, sending CINCCKVL proteins
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towards constitutive exocytosis. In contrast, additional sorting motifs, interactions with 
effectors, or an active role in endosomal dynamics could be responsible for full-length 
RhoB localization at endolysosomes without partaking in secretion mechanisms, 
regardless of changes in CD63 sorting. In any case, these results set forth the possibility 
that CINCCKVL chimeras could also appear in the extracellular space, which is 
congruent with their localization at ILV of MVB containing CD63 and possibly destined 
for exocytosis.
Biogenesis of ILV destined towards exocytosis, which contain CD63, can occur
independently of the ESCRT machinery; instead, the curvature-inducing lipid, 
ceramide, mediates inward budding from the MVB limiting membrane (Trajkovic et al., 
2008). Follow-up studies to determine whether CINCCKVL proteins can be delivered to 
the extracellular space were performed by exogenous treatment with C6 ceramide. 
These studies revealed that this lipid elicits an “emptying out” of cells co-transfected 
with GFP-8 and CD63, with a concomitant appearance of fluorescent extracellular 
material and reduction of GFP-8/mCherry-CD63 co-localization. On the other hand, 
GFP-RhoB was retained at several subcortical sites below the plasma membrane and did 
not appear in secreted membranous structures. Full-length RhoB could therefore 
contain a motif(s) upstream from the CINCCKVL sequence acting as a retention signal 
to bar its exit from the cell. Indeed, very few instances of human extracellular vesicle-
associated RhoB have been described, including one report in exosomes of colorectal 
cancer cells, another report describing RhoB in exosomes from urine, and three studies 
in which microvesicles were found to contain RhoB (www.microvesicles.org). 
Furthermore, under the conditions employed in preliminary assays for isolating an 
extracellular vesicle fraction by sequential ultracentrifugation, we were unable to detect 
RhoB (unpublished observations).
It is worth noting that a study using numerous chimeric proteins postulates that 
cytosolic proteins with a tendency to oligomerize, when attached to a lipid anchor, 
become secreted into the extracellular medium. Indeed, a GFP-tagged, oligomeric, 
cytosolic protein with a RhoB-related isoprenylation and mono-palmitoylation 
sequence attached (CCKVL) is detectable in an exosome/microvesicle fraction, albeit to 
a much lesser degree than the positive controls containing either an N-myristoylation 
tag or a PIP2-binding domain (Shen et al., 2011). However, throughout this work we 
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have used different fluorescent proteins besides GFP, some of which are theoretically 
expressed as monomers and therefore would not necessarily follow this oligomerization 
trend per se, e.g. mCherry, which stands for monomeric Cherry (Shaner et al., 2004). 
Interestingly, the Hrs domain 2xFYVE is practically incapable of eliciting a secretory 
phenotype in the study mentioned above. It could be hypothesized that the potential 
RhoB-Hrs interaction hinted at by Hrs KD cells guides RhoB constructs into ILV 
destined towards degradation at the lysosome, hindering its entry into exocytic ILV into 
which GFP-8 is sorted and retaining GFP-RhoB within the cell, as described above. 
These distinct phenotypes only appear upon altering cellular homeostasis, such as 
ESCRT depletion or C6 ceramide treatment, but not under resting conditions. Whether 
these distinct ILV subpopulations exist within the same MVB will be the subject of 
further studies, though co-transfection of CINCCKVL and RhoB constructs has proven 
highly toxic, perhaps due to lipid precursor depletion (results not shown).
Considering that lipidated CINCCKVL constructs are fused directly to GFP and 
have no other RhoB-derived sequences, the differences encountered between these 
proteins and full-length RhoB constructs point to other sorting, signaling, or interaction 
sequences upstream of the lipidation sites. A close look at the RhoB sequence does 
indeed bring up interesting sequences and residues as hypothetical recognition motifs, 
as shown in Figure 52. 
Figure 52. RhoB sequence and possible sorting motifs upstream of its lipidation region.
The full-length human RhoB sequence is shown. The lipidation motif, CINCCKVL is 
highlighted in blue, while possible AP-interaction motifs are boxed in red or black. The 
YDYLE sequence fits with a putative motif recognized by AP-4, namely “YX[FYL][FL]E”. The 
second is a putative YXXF motif that is recognized by several AP complexes. The “KRXX” 
sequence is a hypothetical AP-3 binding motif. Arrows mark a possibly ubiquitinated lysine 
residue and a serine that becomes phosphorylated. See text for details.
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Indeed, it has been reported that serine 185 of RhoB, close to its palmitoylation 
cysteines (see Figure 52), is phosphorylated by casein kinase-1, which hampers stress 
fiber formation and EGF receptor stabilization (Tillement et al., 2008). As discussed 
above, a few amino acids upstream, there is a lysine residue included in the GFP-22 
construct that could be amenable to ubiquitination. RhoB also possesses a sequence 
matching a recently described, non-canonical AP-3 interaction motif of interferon-
induced transmembrane (IFITM) protein 1, i.e. the dibasic patch “KRXX”, as shown in 
Figure 52. Interestingly, two possible YXXF motifs appear in regions upstream of the 
CAAX box that are unique to RhoB. As seen in Figure 52, that which is closest to the C-
terminus, “YGSQ”, follows a rather canonical pattern and could hence be recognized by 
several AP complexes (Bonifacino and Traub, 2003).  Furthermore, this sequence 
includes the phosphorylatable serine and its recognition by AP complexes could 
therefore depend on its phosphorylation state. The other YXXF motif, “YDYLE”, 
appears further upstream (Figure 52), beginning with Tyr154, and is a striking match to
the motif that mediates AP-4 binding for trans-Golgi to endosome sorting of the 
amyloid precursor protein, namely YX[FYL][FL]E (Burgos et al., 2010; Park and Guo, 
2014). RhoB interaction with AP-4 would hypothetically be consistent with exit from 
the Golgi after palmitoylation, en route towards its endosomal localization.
Preliminary localization studies were carried out with mutants of tyrosines 
belonging to these hypothetical YXXF motifs, namely, GFP-RhoB-Y154A and GFP-
RhoB-Y183A. However, there were no apparent changes in subcellular localization in 
basal conditions compared to wild-type GFP-RhoB by live confocal microscopy 
observation. Further studies are needed to address the possibility that response to 
stimuli such as EGF or alteration of endocytic components such as those used 
throughout this work would yield discrete phenotypes, or to assess the behavior of these 
mutants at different time points to detect whether their trafficking is delayed or 
expedited due to hypothetical disruption with AP complexes. 
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3. Small GTPases in pathological scenarios
3.1 RhoB constructs appear at endolysosomes in cell models with impaired 
endolysosomal dynamics
Mutations in several proteins involved in intracellular sorting or lipid 
homeostasis give rise to an array of lysosomal storage diseases characterized by 
oculocutaneous albinism, deficiencies in immune processes and neurodegenerative 
defects (Ballabio and Gieselmann, 2009). These cell models have been widely studied to 
elucidate intracellular sorting machineries and the routes followed by particular 
proteins, so that it was deemed necessary to benefit from this approach in the context of 
RhoB trafficking. Among these disorders, Niemann-Pick Type C Disease is clearly 
linked to altered cholesterol dynamics, since the mutated protein NPC-1 is responsible 
for shuttling cholesterol at endolysosomes (Mukherjee and Maxfield, 2004). In turn, 
Hermansky-Pudlak Syndrome patients develop this disease due to mutation of several 
proteins, including AP-3 or Rab27, both involved in LRO biogenesis and transport
(Wei, 2006). In both of these diseases, GFP-8 appears at intra-endolysosomal 
accumulations co-localizing with LTR. However, Chediak-Higashi cells, which contain
enlarged endolysosomes, show GFP-8 accumulation at their limiting membrane instead 
of inside the lumen, in spite of the elevated intraluminal cholesterol and LBPA content
of these compartments in CHS. Point mutations responsible for CHS occur on the very 
large scaffolding protein LYST (Karim et al., 2002), of mostly unknown function, 
though recent studies suggest it could regulate lysosomal size and quantity but not 
trafficking (Holland et al., 2014). Interestingly, reports using expression constructs of 
LYST fragments have detected a direct interaction of LYST and the ESCRT component
Hrs (Tchernev et al., 2002), further substantiating its involvement in late endosomal 
dynamics. Considering the results presented in this work with respect to the possible 
dependence of RhoB sorting on Hrs function, retention of CINCCKVL constructs at the 
periphery of CHS vesicles could also be due to indirect LYST-mediated mechanisms. 
However, full-length RhoB constructs do internalize into enlarged CHS endolysosomes,
which questions this interpretation.
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Another striking phenotype found in CHS fibroblasts was the endolysosomal 
dilation caused by GFP-Rab9 overexpression, indicating a potential impairment of 
Rab9-mediated shuttling of material from the trans Golgi network to late endosomes 
and vice versa. In fact, there seems to be an overall entrapment of many small GTPases, 
i.e. RhoB, Rab7, TC10 and Rab9, co-localizing in endolysosomal compartments, hinting 
at impaired traffic from that point onwards, be it towards the plasma membrane by 
exocytosis or endocytic recycling, or towards the Golgi apparatus in biosynthetic 
recycling (Huynh et al., 2004; Zhang et al., 2007). Another possibility would be that CHS 
lysosomes possess inefficient degradation mechanisms, though studies with EGFR or 
RhoB argue against this hypothesis. Recently, degradation of EGFR was found to occur 
normally in LYST knock-down HeLa cells (Holland et al., 2014). These findings are in 
line with preliminary studies from the laboratory that showed similar degradation rates
for several GTPase constructs in CHS and control fibroblasts (results not shown). These 
results merit further studies regarding the subcellular functions of the large LYST 
protein in the context of GTPase involvement in subcellular traffic, ultimately aiming at 
new therapeutic opportunities for CHS patients.
3.2 Small GTPases as targets for electrophilic lipids
The plethora of posttranslational modifications that can occur on Ras proteins is 
largely responsible for their ability to act as stimulus sensors from different sites in the 
cell. In addition to CAAX processing, isoprenylation, palmitoylation or phosphorylation
(Hancock et al., 1989; Kim et al., 2009), it has also been established that Ras family 
proteins (H-Ras, N-Ras or K-Ras) undergo non-enzymatic modifications including 
nitrosylation, thiolation or addition of lipid electrophiles (Mallis et al., 2001; Oliva et al., 
2003). However, the results presented in this work are the first to detect modification by 
cyPG of RhoB and Rap2B.
Previous results from the laboratory have reported that H-Ras is a target for 
modification by cyPG and isoprostanes (Oliva et al., 2003; Renedo et al., 2007). 
Specifically, single enone compounds preferentially modified C118, whereas the
dienone compound, 15d-PGJ2, bound preferentially to C181 and 184 of its C-terminal 
peptide. Since these latter cysteine residues represent the palmitoylation sites of H-Ras, 
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binding of 15d-PGJ2 to RhoB and Rap2B, which also contain palmitoylatable cysteines 
close to each other at their C-termini, could represent cross-linking of these two 
residues, similarly to that detected for H-Ras and its synthetic C-terminal peptide (Oeste 
et al., 2011). In assays addressing modification of RhoB by other cyPG, results showed 
that biotinylated 15d-PGJ2 bound to a great extent, as determined by WB. Furthermore, 
incubation with biotinylated 8-iso-PGA2 elicited a stronger signal than that of its cis
isoform, PGA2. These results suggest that single enones can also bind to RhoB cysteines 
and that the isoprostane form of PGA2 is more easily accessible to the cysteine to which 
it binds. Further experiments are required to ascertain the binding sites of these cyPG 
and the molecular characteristics responsible for the different signal intensities detected 
for each cyPG.
As has been described in detail for H-Ras (Oeste et al., 2011), if it is the case in 
cells that these bipalmitoylated and prenylated proteins are modified by dienone cyPG 
at the cysteines in their C-termini, their subcellular localization and signaling properties 
could become significantly altered. The half-life of H-Ras palmitoylation has been 
estimated as approximately 20 min, which is a small timeframe compared to its 20 h 
half-life or even the 2-3 h half-life of RhoB, if its palmitoylation dynamics are assumed 
to be of a similar magnitude (Pérez-Sala et al., 2009; Rocks et al., 2005). Furthermore, 
Ras activation can induce its depalmitoylation (Omerovic et al., 2007), so that during 
the palmitoylation-depalmitoylation cycle of H-Ras, it could be that C181 and C184 
become available for chemical modification by cyPG or other agents. These 
modifications could obstruct subsequent rounds of palmitoylation and the 
microdomain partitioning or subcellular localization prompted by palmitate binding to 
H-Ras. As will be discussed below, modification of H-Ras by several agents does indeed 
disrupt its activation patterns and subcellular localization (Oeste et al., 2011). However, 
whether this is also the case for the other bipalmitoylated and isoprenylated GTPases 
explored in this work will be the subject of further investigations. 
cyPG production is significantly increased upon oxidative stress, suggesting that 
GTPases that can be modified by these compounds in vitro could do so in cells in an 
oxidative scenario.  Furthermore, increased generation of reactive oxygen or nitrogen 
species that takes place within cells in situations such as inflammation affects 
unsaturated lipids with a tendency for oxidation (Koenitzer and Freeman, 2010). This is 
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the case for polyunsaturated fatty acids at membranes, which suffer non-enzymatic 
oxidations to produce compounds of diverse structure that can modify proteins and 
affect their subcellular functions (Ceaser et al., 2004). Since the structures and 
electrophilic groups of these reactive endogenous compounds are similar to those of 
cyPG, the possibility is set forth that the GTPases studied in this work could become 
targets for species such as nitrated fatty acids or oxidized phospholipids, which could 
have a profound impact on their biological actions.
3.3 Electrophilic reagents bind to C-terminal cysteines in H-Ras and RhoB
Additionally to reactive lipids that can be found in biological systems, we have 
used exogenous, small, bifunctional cysteine reagents as biochemical tools to 
characterize the structural requirements and functional consequences of C-terminal 
modification of H-Ras and RhoB. Binding of DBB to two cysteines is only feasible if 
these are within 3-6 Å of each other, so that the results shown in this work place the 
palmitoylation cysteines within that range. As addressed above, cyPG could interfere 
with palmitoylation cycles of H-Ras and hence elicit changes in its subcellular behavior.
Similarly, binding of small reactive compounds such as PAO and DBB to C-terminal 
cysteines can abrogate palmitoylation, though their effects on GTPase activation and 
localization need not match those of cyPG. Indeed, cells transfected with a fluorescent 
construct of the Ras binding domain (RBD) of the Ras effector, Raf, and treated with 
PAO or DBB show that active Ras is recruited to endomembranes. Treatment with these 
compounds also hampers Ras translocation to the plasma membrane upon EGF 
stimulation (Oeste et al., 2011). Interestingly, depalmitoylated H-Ras has been shown to 
travel back to the Golgi complex for addition of new palmitate moieties, and 
palmitoylation cysteine mutants signal from this localization upon stimulation with 
growth factors (Chiu et al., 2002). It is therefore possible that PAO or DBB bind to 
depalmitoylated H-Ras at the Golgi and induce its activation at this site, as summarized 
in Figure 53. Another approach resulting in alteration of the H-Ras hypervariable region 
structure is the mutation of C184 for a leucine residue, as appears naturally in N-Ras,
which was suggested to replace the palmitate chain that is usually present and results in 
H-Ras association with the plasma membrane and recycling endosomes (Misaki et al., 
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2010). Taken together, cyPG and bifunctional cysteine reagent modification of H-Ras 
highlights the relevance of hypervariable cysteines and the proximity between them as 
crucial structural determinants for selectivity of posttranslational modifications.
Figure 53. H-Ras C-terminal modifications and their functional outcomes.
The three C-terminal H-Ras cysteine residues are shown in red, the last of which becomes 
irreversibly farnesylated (blue chain). The “-AAX” amino acids removed upon CAAX box 
processing are shown in gray. Palmitoylation cysteines, i.e. C181 and 184, can undergo 
modification by electrophilic compounds with varying structures (shown in black), resulting 
in diverse functional outcomes.
Modification of H-Ras at its C-terminus by compounds with distinct structural 
features and the functional outcomes that result from them have been explored by our 
laboratory and others (Figure 53). As described above, binding of several cyPG, 
including 15d-PGJ2, elicits H-Ras activation at the plasma membrane, whereas addition 
of PAO or DBB molecules to the C-terminal cysteines results in activation at 
endomembranes. Similarly, guanylation of C184 induces Ras activation at the plasma 
membrane (Nishida et al., 2012). In contrast, glutathionylation of the H-Ras C-terminus
in cells hinders palmitoylation and concomitant plasma membrane binding, as well as 
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inducing apoptosis (Burgoyne et al., 2012). Additionally, this study showed that 
metabolic stress induces oxidation of reactive cysteine thiolates, which also alters H-Ras 
palmitoylation, both in cells and mouse models (Burgoyne et al., 2012). Hence a 
scenario is set forth in which the physicochemical characteristics of the agents that 
modify palmitoylation cysteines determine the specificity of GTPase subcellular 
localization or activation.
As seen in this work, small differences in amino acid sequences can have a 
profound impact on binding to membranes of distinct nature, illustrated by TC10 and 
RhoB. Furthermore, processed lipidation motifs endow each of these proteins with a 
defined structural membrane-binding unit. Modification with reactive lipids occurring 
in pathological settings adds another layer of complexity to the determinants driving 
intracellular localization of small GTPases such as RhoB. Binding of cyPG or reactive 
compounds with varied structures to RhoB in vitro paves the way for studies in cells to 
define putative impediments in RhoB palmitoylation due to these modifications, which 
could alter its subcellular localization pattern and hence its biological actions.

CONCLUSIONS
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As a result of the work presented in this dissertation, in which localization and 
subcellular trafficking of endosomal GTPases have been assessed in the context of their 
posttranslational modifications, the following conclusions have been arrived at:
1.1. Structural determinants present at the hypervariable region of the endosomal 
GTPases RhoB and TC10, when exchanged, interconvert their behavior 
regarding association with distinct subcellular membranes.
1.2. Endolysosomal targeting of RhoB and chimeras of its lipidation motif 
(CINCCKVL) depends on isoprenylation and palmitoylation at C-terminal 
cysteines.
1.3. RhoB and CINCCKVL chimeras appear inside endolysosomes and are detected
at intraluminal vesicles of multivesicular bodies by super-resolution microscopy.
1.4. CINCCKVL sorting is conserved in cells from diverse model organisms, 
including fungi, insects, amphibians, and mammals.
These results shed light on the interplay between lipidated residues and other 
structural determinants in subcellular targeting of GTPases.
2.1 In cells depleted of the ESCRT components Hrs and Tsg101, sorting of full-
length RhoB into endolysosomal compartments is impaired, but not that of 
CINCCKVL chimeras.
2.2 Agents altering late endosomal lipid dynamics differentially disturb RhoB and
CINCCKVL chimera localization inside endolysosomes.
2.3 Overexpression of CD63 constructs alters CINCCKVL chimera localization, but 
not that of full-length RhoB.
Taken together, these results imply that sorting of full-length RhoB and CINCCKVL 
constructs could be regulated by distinct subcellular trafficking machineries.
3.1 RhoB or CINCCKVL constructs recapitulate endolysosomal defects in cells of 
patients with lysosomal storage diseases.
3.2 The palmitoylation cysteines of the small GTPases RhoB and H-Ras are targets 
for modification by structurally diverse electrophilic lipids in vitro.
These results suggest that subcellular localization of endosomal GTPases could 
become altered in pathological scenarios such as genetic diseases or processes 
involving the generation of reactive species.
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Small GTPases of the Ras superfamily are key to cellular processes such as 
differentiation, proliferation or regulation of the cytoskeleton (Takai et al., 2001). These 
proteins undergo lipid modifications that elicit their attachment to membranes and are 
crucial to their activity. Specifically, Ras protein isoprenylation serves as an anchor to 
the membrane, and Ras proteins are further amenable to reversible palmitoylation, 
which contributes to their dynamic localization at distinct subcellular compartments 
(Hancock et al., 1989). Lipid modifications take place at cysteine residues in the C-
terminal region. Furthermore, these cysteines can undergo oxidation or addition of 
electrophilic compounds, e.g. cyclopentenone prostaglandin binding. These compounds 
are formed by non-enzymatic oxidation of arachidonic acid or from dehydration of 
other prostaglandins, which endows them with electrophilic carbons (Funk, 2001).
Rho proteins are a group of Ras superfamily proteins that are crucial to cell 
adhesion and migration, hence modulating cardiovascular pathophysiology and 
tumorigenic processes (Ridley, 2001). RhoB is a member of this family with roles in 
vesicular trafficking, tumor suppression and localization of signaling proteins. RhoB 
lipid modifications (isoprenylation and double palmitoylation) are necessary for its 
localization to endolysosomes and its degradation through this pathway (Pérez-Sala et 
al., 2009; Stamatakis et al., 2002). The last eight amino acids of RhoB, which correspond 
to the lipidation motif, constitute an endolysosomal localization and degradation 
sequence for chimeric proteins to which this extension is added at their C-terminal end 
(Pérez-Sala et al., 2009).
In the context of this dissertation, in vitro and cell models have been used to 
study mechanistic and structural aspects of Ras and Rho protein modification, 
particularly that of RhoB, and its influence on localization and trafficking of these 
proteins or their chimeras modified by lipids and other compounds. Though lipid 
modifications of Ras proteins have been described as important regulatory factors, the 
involvement of lipidation and its interplay with other structural determinants in 
subcellular targeting of GTPases has not been fully elucidated. Therefore, the role of 
lipid modifications of RhoB cysteine residues and other important residues at the 
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hypervariable region on its intracellular sorting has been analyzed. Furthermore, studies 
were carried out to determine whether the RhoB lipidation motif per se (CINCCKVL) is 
able to mimic the full-length protein. Cell models from different species were used to 
evaluate whether the latent sorting mechanisms for CINCCKVL proteins are conserved 
in these model organisms. Using this C-terminal construct in parallel to the full-length 
protein, the potential involvement of key molecular machineries, i.e. ESCRT complexes, 
CD63 or lipid dynamics, in their sorting was assessed. Considering the potential 
alteration of subcellular localization of Ras proteins by modification, targeting of 
lipidation sequences by other structurally diverse moieties, including reactive species 
arising in pathological scenarios, was also explored. In addition, assays were carried out 
to study the potential alteration of endosomal GTPase localization in genetic models of 
lysosomal disease.
In order to characterize the precise subcellular localization of RhoB, constructs 
of fluorescent proteins fused to this protein were compared to those of other small 
GTPases used as markers of endocytic vesicles. Co-localization with fusion proteins of 
Rab7, Rab9 or Lamp and negligible overlap with early endosome markers, i.e. Rab5 
fusion proteins, or the Golgi marker, giantin, underscore RhoB localization within the 
endolysosomal lumen. These studies also include assays with autophagy probes, with 
which RhoB or its chimeras show negligible co-localization. The small GTPase, TC10, 
contains a C-terminal sequence that is very similar to that of RhoB, though a basic 
amino acid patch upstream of the lipidation sequence elicits retention at the limiting 
membrane of endolysosomes. Insertion of this basic patch into the RhoB sequence 
hinders its entry into endolysosomes, highlighting that exchange of structural 
determinants between these proteins elicits interconversion of their subcellular 
localization patterns. Furthermore, it has been determined that chimeras bearing the 
RhoB C-terminal sequence, CINCCKVL, are also internalized into endolysosomes. 
It was also described that chimeric proteins fused to the C-terminal sequence of 
RhoB (CINCCKVL) enter into the endolysosomal lumen. Therefore, studies were 
carried out to assess whether the CINCCKVL sequence can travel to endolysosomes in 
cells from diverse species, which in some cases lack an endogenous RhoB homolog 
sequence. The universality of endolysosomal localization of chimeras bearing the RhoB 
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C-terminus was set forth by detection of these proteins in endolysosomes of cells as 
phylogenetically distant as amphibians, insects and fungi.
In order to explore the possible localization mechanisms of RhoB, advanced 
confocal and super-resolution techniques were employed. By means of these tools, 
RhoB and CINCCKVL chimeras were unequivocally detected at intraluminal vesicles of 
multivesicular bodies. Cells were transfected with small interfering RNA to silence 
components of the ESCRT machinery, which is responsible for endolysosomal 
trafficking and formation of multivesicular bodies (Raiborg and Stenmark, 2009). By 
blocking the function of some of these components, RhoB is not internalized into 
endolysosomes, which reflects a possible role of ESCRT proteins in RhoB endosomal 
trafficking. However, CINCCKVL chimeras are not similarly affected by ESCRT knock-
down. Therefore, other protein and lipid components of multivesicular bodies could 
play a role in localization of these chimeras, e.g. the tetraspanin CD63. This protein 
presents a high degree of co-localization with RhoB and related chimeras at 
multivesicular bodies. Interestingly, it was shown that overexpression of fluorescent 
constructs of CD63 alter the subcellular localization pattern of CINCCKVL proteins, 
possibly towards extracellular destinations, but not that of RhoB. To explore the role of 
lipid dynamics in localization of these proteins, cells were treated with compounds that 
alter cholesterol dynamics at membranes. In these cells, internalization of C-terminal 
RhoB chimeras into endolysosomes was reduced, whereas the full-length protein was 
able to access these compartments. Furthermore, ceramide treatment induced changes 
in cell morphology that affect RhoB and related protein localization. Taken together, 
these results suggest that CINCCKVL chimeras can follow a subcellular destination 
mediated by machineries that are different to those responsible for sorting of full-length 
RhoB, which implies that RhoB contains further structural determinants for localization 
or interaction, beyond those that appear at its lipidation sequence.
It has been previously described that RhoB is involved in diverse pathologies 
such as tumorigenic processes and cardiovascular malfunction (Prendergast, 2001). The 
results obtained showing RhoB localization to endolysosomal membranes warranted 
studies in models of lysosomal diseases such as Chediak-Higashi or Niemann-Pick. 
These disorders result in oculocutaneous albinism, immunodeficiency and cognitive 
impairment of varying degree (Huizing et al., 2008). Comparing RhoB to other 
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endosomal GTPases in cells of patients suffering from these diseases, confocal laser 
microscopy shows that RhoB is localized to the dilated endolysosomes typical of these 
diseases.
In many pathological scenarios, proteins suffer modifications due to alterations 
in overall cellular redox status. By means of electrophoretic assays (SDS-PAGE) or 
proteomic approaches (MALDI-TOF), it was shown that proteins of the Ras 
superfamily, particularly H-Ras and RhoB, could be modified in vitro at their C-
terminal cysteine residues by structurally diverse electrophilic lipids. Specifically, 
dienone cyclopentenone prostaglandins, derived from non-enzymatic oxidation of 
arachidonic acid or dehydration of other prostaglandins, bind to these residues. 
Recombinant RhoB protein is also selectively modified by biotinylated dienone 
cyclopentenone prostaglandins, as well as by other bifunctional cysteine reagents such 
as phenylarsine oxide and dibromobimane. It is therefore possible that regulation of 
small GTPases can occur through processes related to cellular redox status that can have 
implications beyond the canonical signaling pathways that are mediated by these 
proteins.
As a result of the work presented in this dissertation, in which localization and 
subcellular trafficking of endosomal GTPases have been assessed in the context of their 
posttranslational modifications, several conclusions have been arrived at. Regarding 
localization sequences at the hypervariable regions of small GTPases, these studies have 
shown that interplay between lipidated residues and other structural determinants such 
as basic residue patches elicits specific patterns of subcellular targeting. Furthermore, in 
the case or RhoB, endolysosomal targeting of full-length or CINCCKVL chimeras 
depends on isoprenylation and palmitoylation at C-terminal cysteines. These proteins, 
when fully lipidated, appear inside endolysosomes and are detected at intraluminal 
vesicles of multivesicular bodies by super-resolution microscopy. Endolysosomal or 
vacuolar sorting of CINCCKVL chimeras was shown to be conserved in cells from 
diverse model organisms, including fungi, insects, amphibians, and mammals. As 
referred to the molecular mechanisms involved in sorting, results imply that sorting of 
full-length RhoB and CINCCKVL constructs could be regulated by distinct subcellular 
trafficking machineries, for full-length RhoB sorting is impaired upon ESCRT 
component depletion, whereas CINCCKVL construct localization is altered in cells 
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overexpressing CD63 constructs or after treatment with cholesterol-reducing agents. 
Experiments performed in pathological scenarios such as genetic models of 
endolysosomal malfunction or processes involving the generation of reactive species 
show that RhoB or CINCCKVL constructs recapitulate endolysosomal defects in cells of 
patients with lysosomal storage diseases and that the palmitoylation cysteines of the 
small GTPases RhoB and H-Ras are targets for modification by structurally diverse 
electrophilic lipids in vitro. These results pave the way for exploring the extent to which 
diverse modifications of Ras proteins at C-terminal cysteines can disturb their 
subcellular localization and consequently alter their functional outcomes. 
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1. Introducción
Las GTPasas de bajo peso molecular comprendidas en la superfamilia Ras son 
proteínas fundamentales para procesos celulares como la diferenciación celular, la 
regulación del citoesqueleto y la proliferación (Takai et al., 2001). Estas proteínas sufren 
modificaciones lipídicas que les permiten asociarse con las membranas celulares y son 
clave para su actividad. En concreto, las proteínas Ras están isopreniladas para anclarse 
a la membrana, además de ser susceptibles de palmitoilación reversible, lo cual 
contribuye a su localización dinámica en distintos compartimentos subcelulares 
(Hancock et al., 1989). Estas modificaciones lipídicas tienen lugar sobre residuos de 
cisteína en la región carboxilo-terminal (C-terminal). Además, estas cisteínas pueden 
sufrir oxidaciones o adición de compuestos de naturaleza electrofílica, como por 
ejemplo, la unión de prostaglandinas ciclopentenonas (Oeste and Pérez-Sala, 2014). 
Estos compuestos se forman por oxidación no enzimática del ácido araquidónico o por 
deshidratación de otras prostaglandinas, lo cual las dota de carbonos electrófilos (Funk, 
2001).
Las proteínas Rho juegan papeles cruciales en la adhesión y migración celular 
que repercuten sobre la fisiopatología cardiovascular y procesos tumorigénicos (Ridley, 
2001). RhoB es un miembro de esta familia con funciones reguladoras del tráfico 
vesicular, la supresión de tumores y la localización de proteínas señalizadoras. Las 
modificaciones lipídicas de RhoB (isoprenilación y doble palmitoilación) son necesarias 
para su localización endolisosomal y posterior degradación por esta vía (Pérez-Sala et 
al., 2009; Stamatakis et al., 2002). Los últimos ocho amino ácidos de RhoB, zona donde 
se encuentran las cisteínas que se lipidan, comprenden una secuencia de localización y 
degradación endolisosomal para proteínas quiméricas a las que se les añade esta 
extensión en su extremo carboxilo-terminal (Pérez-Sala et al., 2009).
En el contexto de esta tesis se han estudiado, tanto in vitro como en modelos 
celulares, aspectos mecanísticos y estructurales de la modificación de proteínas Ras y 
Rho, en concreto RhoB, y su repercusión sobre la localización y tráfico de estas 
proteínas o sus quimeras modificadas por lípidos y otros compuestos.
Summary in Spanish
146
2. Objetivos
Las GTPasas de bajo peso molecular ejercen diversas funciones celulares desde 
localizaciones de membrana específicas. Entre los factores que las regulan, la 
modificación en secuencias C-terminales juegan un papel crucial, aunque la 
participación de la lipidación y su interacción con otros determinantes estructurales en 
la localización subcelular de las GTPasas no ha sido completamente dilucidado. Por ello, 
el trabajo presentado en esta tesis se centra en analizar el papel de las modificaciones 
lipídicas en residuos de cisteína de RhoB sobre su tráfico intracelular y determinar si el 
motivo de lipidación per se es capaz de reproducir el comportamiento de la proteína 
completa. Además, la posibilidad de que las secuencias de lipidación puedan ser dianas 
de modificación por otros compuestos de estructura diversa, incluidas especies reactivas 
que se producen en situaciones patológicas, no se ha explorado. Por tanto, los siguientes 
objetivos fueron planteados:
! Estudiar el papel de las secuencias C-terminales de GTPasas endosomales en su 
localización subcelular.
! Valorar la importancia de la isoprenilación y la palmitoilación en la asociación 
de estas proteínas a vesículas intracelulares.
! Determinar la localización subcelular de quimeras que contienen la secuencia 
de lipidación del C-terminal de RhoB.
! Evaluar si los mecanismos latentes de localización del C-terminal de RhoB 
están conservados en células de diversas especies.
! Explorar el posible rol de maquinarias moleculares clave, tales como los 
complejos ESCRT, CD63 o la dinámica lipídica, en la localización de RhoB y 
quimeras relacionadas.
! Asentar las bases para estudiar posibles alteraciones en la localización y 
modificación de GTPasas endosomales en modelos experimentales de 
enfermedad.
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3. Resultados
Se ha llevado a cabo una caracterización de RhoB fusionada a proteínas 
fluorescentes en el contexto de las endomembranas al comparar su localización y 
degradación con las de otras GTPasas pequeñas. Su colocalización con proteínas 
fluorescentes fusionadas a Rab7, Rab9 o Lamp y falta de coincidencia con marcadores 
de endosomas tempranos (GFP-Rab5) o aparato de Golgi (giantin) atestiguan su 
localización en el lumen endolisosomal. Los estudios aquí presentados incluyen también 
la utilización de sondas de la vía autofagocítica, con las cuales ni RhoB ni sus proteínas 
quimera colocalizan de forma detectable. La GTPasa de bajo peso molecular, TC10, cuya 
secuencia C-terminal es muy similar a la de RhoB, contiene unos amino ácidos básicos 
que sin embargo la retienen en la membrana limitante de dichas vesículas. La inserción 
de la secuencia polibásica de TC10 en la secuencia de RhoB impide su entrada a  
endolisosomas, lo cual pone de manifiesto que hay determinantes estructurales que al 
intercambiarse entre estas proteínas dan lugar a patrones subcelulares específicos. 
Se describió además que las proteínas quimera fusionadas a la secuencia C-
terminal de RhoB (CINCCKVL) también acceden al lumen endolisosomal. Por lo tanto, 
se exploró si la secuencia CINCCKVL accede a los endolisosomas no sólo en células de 
mamíferos, sino en células de organismos que pueden contener o no una secuencia 
endógena para proteínas homólogas a RhoB. La universalidad de la localización 
endolisosomal de quimeras con el C-terminal de RhoB se pone de manifiesto al 
detectarse en endolisosomas de células de organismos muy alejados entre sí en la escala 
filogenética, tales como anfibios, insectos y hongos.
Para explorar los posibles mecanismos de localización de RhoB, se emplearon 
técnicas de microscopía láser avanzada confocal y de superresolución. Por medio de 
estas potentes herramientas se ha podido establecer la localización inequívoca de RhoB 
y quimeras CINCCKVL en vesículas intraluminales de cuerpos multivesiculares. Se 
transfectaron células con RNA de interferencia para así silenciar componentes de la 
maquinaria ESCRT, responsable del tráfico endolisosomal y la formación de cuerpos 
multivesiculares (Raiborg and Stenmark, 2009). Al bloquear la función de algunos de 
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estos componentes, RhoB no se internaliza en los endolisosomas, lo cual refleja un 
posible papel de las proteínas ESCRT en el tráfico endosomal de RhoB. Sin embargo, las 
quimeras CINCCKVL no se ven igualmente afectadas por el bloqueo de componentes 
ESCRT. Se estudiaron pues otros componentes proteicos y lipídicos de los cuerpos 
multivesiculares que podrían jugar también un papel en la localización de proteínas 
CINCCKVL, como por ejemplo la tetraspanina CD63. Esta proteína presenta una alta 
colocalización con RhoB y quimeras relacionadas en cuerpos multivesiculares. 
Curiosamente, se observó que la sobreexpresión de construcciones fluorescentes de 
CD63 cambian el patrón de localización subcelular de quimeras CINCCKVL, 
posiblemente hacia destinos extracelulares, pero no así el de RhoB. Para explorar el 
papel de la dinámica lipídica en la localización de estas proteínas, se realizaron ensayos 
de tratamiento celular con compuestos que alteran la dinámica de colesterol en las 
membranas. En estas células, se redujo la internalización de quimeras del C-terminal de 
RhoB hacia el lumen de cuerpos multivesiculares, mientras que la proteína completa 
siguió su camino hacia el interior de estos compartimentos. Además, el tratamiento con 
ceramida indujo cambios en la morfología celular que afectan la localización de RhoB y 
proteínas relacionadas. En conjunto, estos resultados sugieren que las quimeras 
CINCCKVL pueden seguir un destino subcelular mediado por maquinarias distintas a 
las responsables del transporte de RhoB completa, lo cual sugiere que RhoB contiene 
determinantes estructurales de localización o interacción más allá de los que aparecen 
en su secuencia de lipidación.
Se ha descrito que RhoB interviene en diversas patologías como procesos 
tumorigénicos y afecciones cardiovasculares (Prendergast, 2001). Debido a los 
resultados obtenidos sobre la localización de RhoB en membranas endolisosomales, se 
quiso estudiar su papel en modelos de enfermedades lisosomales como Chediak-Higashi 
o Niemann-Pick. Estas patologías cursan con albinismo oculocutáneo, 
inmunodeficiencias y retrasos cognitivos de severidad variada (Huizing et al., 2008). Al 
comparar RhoB con otras GTPasas endosomales en células de pacientes que sufren estas 
enfermedades, se detectó por microscopía láser confocal la localización de RhoB en los 
endolisosomas dilatados típicos de estas patologías. 
En muchos escenarios patológicos, las proteínas sufren modificaciones al verse 
alterado el estado redox global de las células. Se determinó que proteínas de la 
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superfamilia Ras, en concreto H-Ras y RhoB, se pueden modificar in vitro en sus 
residuos de cisteína del extremo carboxilo-terminal por compuestos electrófilos de 
diversa índole utilizando ensayos de electroforesis (SDS-PAGE) o métodos proteómicos 
(MALDI-TOF). En concreto, las prostaglandinas ciclopentenonas dienonas, derivadas 
de la oxidación no enzimática del ácido araquidónico o deshidratación de otras 
prostaglandinas, se unen a estos residuos. La proteína recombinante RhoB también se 
modifica por derivados biotinilados de prostaglandinas ciclopentenonas dienonas de 
manera selectiva, además de por otros reactivos bifuncionales de unión a cisteínas, 
como el óxido de fenilo arsénico o el dibromobimano. Se establece así una capacidad 
reguladora de GTPasas pequeñas por medio de procesos relacionados con el estado 
redox de la célula que puede tener implicaciones más allá de las vías de señalización 
canónicas mediadas por estas proteínas.
4. Conclusiones
Como resultado del trabajo presentado en esta tesis, en la que la localización y 
tráfico subcelular de GTPasas endosomales se han evaluado en el contexto de sus 
modificaciones postraduccionales, se ha llegado a las siguientes conclusiones:
1.1. Ciertos determinantes estructurales de la región hipervariable de las GTPasas 
endosomales RhoB y TC10, al intercambiarse, permutan su comportamiento en 
cuanto a la asociación con membranas subcelulares concretas.
1.2. La localización endolisosomal de RhoB y quimeras de su secuencia de lipidación 
(CINCCKVL) depende de la isoprenilación y palmitoilación en las cisteínas C-
terminales.
1.3. Quimeras de RhoB y CINCCKVL aparecen en el interior de endolisosomas y se 
detectan en vesículas intraluminales de cuerpos multivesiculares mediante 
microscopía de superresolución.
1.4. La localización de proteínas CINCCKVL está conservada en células de diversos 
organismos modelos, incluidos modelos de hongo, insecto, anfibio y mamíferos.
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Estos resultados ponen de manifiesto la interacción entre residuos modificados por 
lípidos y otros determinantes estructurales a la hora de guiar la localización 
subcelular de GTPasas. 
2.1. En células en las que componentes ESCRT (Hrs y Tsg101) han sido silenciados 
mediante RNA de interferencia, disminuye la localización de la proteína RhoB 
completa en endolisosomas, pero no así la de quimeras CINCCKVL.
2.2. El uso de compuestos que perturban la dinámica lipídica de endosomas tardíos 
altera diferencialmente la localización de quimeras de RhoB o CINCCKVL 
dentro de los endolisosomas.
2.3. La sobreexpresión de construcciones de CD63 altera la localización de quimeras 
CINCCKVL, pero no así la de RhoB completa.
En conjunto, estos resultados sugieren que la localización de RhoB completa y de 
construcciones de CINCCKVL podría verse regulada por diferentes maquinarias de 
tráfico subcelular. 
3.1. Las quimeras de RhoB o CINCCKVL recapitulan los defectos endolisosomales 
en células de pacientes con enfermedades por almacenamiento lisosomal.
3.2. Las cisteínas de palmitoilación de las GTPasas pequeñas RhoB y H-Ras son 
dianas de modificación in vitro por lípidos electrófilos de estructura variada.
Estos resultados sugieren que la localización subcelular de GTPasas endosomales 
podría verse alterada en situaciones patológicas como enfermedades genéticas o 
procesos que cursan con generación de especies reactivas.
5. Aportaciones fundamentales
Este trabajo muestra resultados obtenidos mediante técnicas de microscopía 
avanzada como la microscopía láser confocal y de superresolución, para determinar las 
localizaciones subcelulares concretas de la proteína RhoB fusionada a diversas proteínas 
fluorescentes, además de quimeras fluorescentes fusionadas a una secuencia corta 
derivada del C-terminal de RhoB. Además, se ha determinado la importancia de la 
lipidación de los residuos de cisteína para la localización endolisosomal de las proteínas 
de fusión mediante la generación de mutantes no susceptibles de modificación. Por 
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primera vez, se ha llevado a cabo el estudio de la distribución de la proteína RhoB y 
quimeras relacionadas en células con alteraciones de la función lisosomal (síndromes de 
Chediak-Higashi, Niemann-Pick y Hermansky-Pudlak). Por medio de las quimeras 
fluorescentes del C-terminal de RhoB, se ha caracterizado la especificidad de la 
localización de dicha secuencia en varias líneas celulares humanas y de especies diversas, 
incluidos insectos y hongos. Además, estos estudios son los primeros en analizar el 
papel de mediadores del tráfico intracelular como los complejos ESCRT, la tetraspanina 
CD63 o la dinámica lipídica en la localización subcelular de RhoB o su secuencia C-
terminal.
Se han realizado estudios sobre la modificación de GTPasas de bajo peso 
molecular, particularmente H-Ras y RhoB, por compuestos que se unen a cisteínas por 
mecanismos no enzimáticos. Se ha detectado la unión de prostaglandinas 
ciclopentenonas dienonas a dos residuos del C-terminal de H-Ras. Las diversas técnicas 
empleadas han servido para caracterizar los motivos estructurales de GTPasas pequeñas 
que son susceptibles de modificaciones y que pueden repercutir en la actividad o 
localización de dichas proteínas.
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